Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific OPALIN HTMP10, TMEM10, TMP10 ENSG00000197430 Oligodendrocytic myelin paranodal and inner loop protein 10 96343216-96359365 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014372 Supported Tissue enriched 866 cerebral cortex: 86.6 adipose tissue: 0.0 GFAP FLJ45472 ENSG00000131095 Glial fibrillary acidic protein 17 44905008-44916937 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000039, HPA056030, HPA063513 Supported Supported Supported Intermediate filaments Tissue enriched 431 cerebral cortex: 4111.0 bone marrow: 9.5 OMG OMGP ENSG00000126861 Oligodendrocyte myelin glycoprotein 17 31272013-31297539 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008206, HPA012693 Supported Tissue enriched 318 cerebral cortex: 137.8 bone marrow: 0.4 OLIG2 BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17 ENSG00000205927 Oligodendrocyte lineage transcription factor 2 21 33025845-33029196 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA003254, CAB019381 Supported Uncertain Nucleoplasm
Plasma membrane Tissue enriched 239 cerebral cortex: 91.2 duodenum: 0.3 NEUROD6 Atoh2, bHLHa2, Math-2, Nex1, NEX1M ENSG00000164600 Neuronal differentiation 6 7 31337461-31340894 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA027046 Approved Tissue enriched 225 cerebral cortex: 22.4 epididymis: 0.0 GRIN1 GluN1, NMDAR1 ENSG00000176884 Glutamate receptor, ionotropic, N-methyl D-aspartate 1 9 137138390-137168762 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB006831 Approved Tissue enriched 202 cerebral cortex: 152.3 prostate: 0.7 RFX4 ENSG00000111783 Regulatory factor X, 4 (influences HLA class II expression) 12 106582907-106762803 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050527 Supported Approved Nucleus Group enriched 184 cerebral cortex: 30.9;testis: 135.3 prostate: 0.4 SLC17A7 BNPI, VGLUT1 ENSG00000104888 Solute carrier family 17 (vesicular glutamate transporter), member 7 19 49429401-49442360 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037183, HPA050458, HPA063679 Supported Tissue enriched 178 cerebral cortex: 586.2 adipose tissue: 3.2 CREG2 ENSG00000175874 Cellular repressor of E1A-stimulated genes 2 2 101345551-101387595 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038224 Supported Tissue enriched 159 cerebral cortex: 91.2 fallopian tube: 0.5 NEUROD2 bHLHa1, NDRF ENSG00000171532 Neuronal differentiation 2 17 39603536-39609777 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 146 cerebral cortex: 14.9 stomach: 0.1 C1orf61 CROC4 ENSG00000125462 Chromosome 1 open reading frame 61 1 156404250-156430701 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 131 cerebral cortex: 505.2 testis: 3.8 KCNJ9 GIRK3, Kir3.3 ENSG00000162728 Potassium channel, inwardly rectifying subfamily J, member 9 1 160081570-160090563 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA070478 Supported Tissue enriched 112 cerebral cortex: 52.5 testis: 0.4 OLIG1 BHLHB6, bHLHe21 ENSG00000184221 Oligodendrocyte transcription factor 1 21 33070144-33072420 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 103 cerebral cortex: 143.0 kidney: 1.3 CACNG7 ENSG00000105605 Calcium channel, voltage-dependent, gamma subunit 7 19 53909335-53943941 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 101 cerebral cortex: 63.9 adrenal gland: 0.6 NCAN CSPG3 ENSG00000130287 Neurocan 19 19211973-19252233 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036814 Supported Uncertain Vesicles
Centrosome Tissue enriched 101 cerebral cortex: 183.9 testis: 1.8 TMEM235 ENSG00000204278 Transmembrane protein 235 17 78231310-78240987 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053939 Uncertain Tissue enriched 101 cerebral cortex: 15.7 testis: 0.1 NXPH1 ENSG00000122584 Neurexophilin 1 7 8433955-8752963 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA020062 Uncertain Group enriched 83 adrenal gland: 52.3;cerebral cortex: 47.3 breast: 0.5 MMD2 PAQR10 ENSG00000136297 Monocyte to macrophage differentiation-associated 2 7 4905989-4959213 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 82 cerebral cortex: 41.3;testis: 12.4 adrenal gland: 0.3 SLITRK1 KIAA1910, LRRC12 ENSG00000178235 SLIT and NTRK-like family, member 1 13 83877205-83882393 Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012414 Supported Tissue enriched 82 cerebral cortex: 23.9 seminal vesicle: 0.2 SNCB ENSG00000074317 Synuclein, beta 5 176620084-176630556 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002681, HPA035876 Supported Tissue enriched 70 cerebral cortex: 330.1 adrenal gland: 4.6 POU3F2 BRN2, OCT7, OTF7, POUF3 ENSG00000184486 POU class 3 homeobox 2 6 98834592-98839490 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047081, HPA056261 Approved Supported Nucleus Tissue enriched 67 cerebral cortex: 20.4 testis: 0.3 TTC9B FLJ30373 ENSG00000174521 Tetratricopeptide repeat domain 9B 19 40216058-40218399 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042496 Uncertain Tissue enriched 66 cerebral cortex: 57.7 adrenal gland: 0.8 SLC17A6 DNPI, VGLUT2 ENSG00000091664 Solute carrier family 17 (vesicular glutamate transporter), member 6 11 22338097-22379503 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037130, HPA039226 Supported Supported Tissue enriched 65 cerebral cortex: 6.5 epididymis: 0.0 GPR37L1 ETBR-LP-2 ENSG00000170075 G protein-coupled receptor 37 like 1 1 202122858-202133592 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064454 Supported Tissue enriched 61 cerebral cortex: 34.2 seminal vesicle: 0.5 ZDHHC22 C14orf59 ENSG00000177108 Zinc finger, DHHC-type containing 22 14 77131270-77142734 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA072213 Approved Plasma membrane Tissue enriched 57 cerebral cortex: 64.4 epididymis: 1.1 CSPG5 NGC ENSG00000114646 Chondroitin sulfate proteoglycan 5 (neuroglycan C) 3 47562239-47580792 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049529, HPA067818, HPA071779 Supported Approved Nucleoplasm
Mitochondria Tissue enriched 56 cerebral cortex: 157.1 testis: 2.8 CAMKV MGC8407, VACAMKL ENSG00000164076 CaM kinase-like vesicle-associated 3 49857988-49870222 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA007656, CAB034931 Supported Approved Nucleoplasm
Cytokinetic bridge Tissue enriched 55 cerebral cortex: 86.5 testis: 1.5 PMP2 FABP8, M-FABP, MP2 ENSG00000147588 Peripheral myelin protein 2 8 81440326-81447523 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 55 cerebral cortex: 289.4 seminal vesicle: 5.2 AMER2 FAM123A, FLJ25477 ENSG00000165566 APC membrane recruitment protein 2 13 25161684-25172288 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039458 Supported Tissue enriched 53 cerebral cortex: 72.6 testis: 1.3 MCHR2 GPR145, MCH2, MCH2R, SLT ENSG00000152034 Melanin-concentrating hormone receptor 2 6 99919910-99994247 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 53 cerebral cortex: 8.6;testis: 6.2 colon: 0.1 POU3F3 BRN1, OTF8 ENSG00000198914 POU class 3 homeobox 3 2 104855511-104860471 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA052792, HPA056039, HPA067151 Supported Supported Nucleus Group enriched 51 cerebral cortex: 36.6;epididymis: 34.9;kidney: 28.3;seminal vesicle: 17.2 skin: 0.5 SEZ6 ENSG00000063015 Seizure related 6 homolog (mouse) 17 28954901-29006440 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011777 Supported Uncertain Intermediate filaments Tissue enriched 51 cerebral cortex: 54.1 duodenum: 1.0 DLL3 SCDO1 ENSG00000090932 Delta-like 3 (Drosophila) 19 39498895-39508481 Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056533 Approved Nucleoplasm
Cytosol Tissue enriched 49 cerebral cortex: 51.5 testis: 1.0 HPCA ENSG00000121905 Hippocalcin 1 32885994-32898441 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012340, HPA043245 Supported Tissue enriched 47 cerebral cortex: 153.6 testis: 3.2 LRTM2 ENSG00000166159 Leucine-rich repeats and transmembrane domains 2 12 1820267-1836752 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA055094 Uncertain Tissue enriched 47 cerebral cortex: 8.3 testis: 0.1 HAPLN2 BRAL1 ENSG00000132702 Hyaluronan and proteoglycan link protein 2 1 156619294-156625725 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA045765 Supported Tissue enriched 46 cerebral cortex: 42.2 duodenum: 0.9 NR2E1 TLL, TLX, XTLL ENSG00000112333 Nuclear receptor subfamily 2, group E, member 1 6 108166058-108188809 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA036954, HPA055642 Approved Approved Nuclear bodies Tissue enriched 46 cerebral cortex: 11.5 parathyroid gland: 0.2 ELAVL3 DKFZp547J036, HUC, HUCL, MGC20653, PLE21 ENSG00000196361 ELAV like neuron-specific RNA binding protein 3 19 11451326-11481046 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB013066, HPA045610 Supported Approved Vesicles Tissue enriched 45 cerebral cortex: 73.0 adrenal gland: 1.6 ZIC5 ENSG00000139800 Zic family member 5 13 99962964-99971909 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA074045 Uncertain Nucleoplasm
Vesicles Group enriched 45 cerebral cortex: 2.3;testis: 6.6 adipose tissue: 0.0 GABRA1 EJM5 ENSG00000022355 Gamma-aminobutyric acid (GABA) A receptor, alpha 1 5 161847191-161899981 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022502, HPA055746 Supported Tissue enriched 44 cerebral cortex: 109.1 adrenal gland: 2.4 NKAIN2 FAM77B, TCBA1 ENSG00000188580 Na+/K+ transporting ATPase interacting 2 6 123804141-124825657 Disease related genes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045860 Approved Cytosol Tissue enriched 44 cerebral cortex: 48.0 skeletal muscle: 1.0 PCDHGC5 PCDH-GAMMA-C5 ENSG00000240764 Protocadherin gamma subfamily C, 5 5 141489121-141512979 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA008755, HPA051540 Uncertain Approved Nucleoplasm Tissue enriched 44 cerebral cortex: 50.8 smooth muscle: 1.1 GABRA5 ENSG00000186297 Gamma-aminobutyric acid (GABA) A receptor, alpha 5 15 26866363-26949207 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA077031 Supported Cell Junctions Tissue enriched 43 cerebral cortex: 82.0 esophagus: 1.8 MEPE ENSG00000152595 Matrix extracellular phosphoglycoprotein 4 87821411-87846817 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038003, HPA038004 Uncertain Tissue enriched 41 cerebral cortex: 4.0 epididymis: 0.0 KIAA1549L C11orf41, C11orf69, G2, MGC34830 ENSG00000110427 KIAA1549-like 11 33542072-33674102 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051594 Approved Nucleoplasm Group enriched 40 cerebral cortex: 35.0;parathyroid gland: 143.5 skin: 2.2 TNR ENSG00000116147 Tenascin R 1 175315194-175743770 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022343, HPA027134, HPA027150, HPA029859 Supported Tissue enriched 38 cerebral cortex: 70.8 adrenal gland: 1.8 GAP43 B-50, PP46 ENSG00000172020 Growth associated protein 43 3 115623324-115721490 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004417, HPA013392, HPA015600 Supported Validated Plasma membrane Tissue enriched 37 cerebral cortex: 346.9 appendix: 9.4 GPM6A GPM6 ENSG00000150625 Glycoprotein M6A 4 175632934-176002664 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017338 Supported Tissue enriched 36 cerebral cortex: 1107.6 lung: 30.7 PHF24 KIAA1045 ENSG00000122733 PHD finger protein 24 9 34957608-34982544 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020974 Approved Group enriched 36 cerebral cortex: 58.7;testis: 25.8 skin: 1.1 SULT4A1 hBR-STL-1, SULTX3 ENSG00000130540 Sulfotransferase family 4A, member 1 22 43824509-43862503 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003129 Supported Tissue enriched 35 cerebral cortex: 144.1 adrenal gland: 4.1 CASKIN1 ANKS5A, KIAA1306 ENSG00000167971 CASK interacting protein 1 16 2177180-2196525 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055990 Supported Approved Nucleus
Cytosol Tissue enriched 34 cerebral cortex: 20.3 testis: 0.6 FXYD7 ENSG00000221946 FXYD domain containing ion transport regulator 7 19 35143250-35154301 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026916 Approved Tissue enriched 34 cerebral cortex: 106.1 lymph node: 3.1 GRM3 GPRC1C, mGlu3, MGLUR3 ENSG00000198822 Glutamate receptor, metabotropic 3 7 86643914-86864884 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 34 cerebral cortex: 62.5 testis: 1.8 SLC32A1 bA122O1.1, VGAT, VIAAT ENSG00000101438 Solute carrier family 32 (GABA vesicular transporter), member 1 20 38724462-38729372 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB037156, HPA058859, HPA059985 Supported Tissue enriched 34 cerebral cortex: 15.9 testis: 0.4 CACNG8 ENSG00000142408 Calcium channel, voltage-dependent, gamma subunit 8 19 53963040-53990215 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041351 Supported Tissue enriched 32 cerebral cortex: 23.8 testis: 0.7 ELAVL2 HEL-N1, HuB ENSG00000107105 ELAV like neuron-specific RNA binding protein 2 9 23690104-23826337 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022222, HPA063001 Supported Approved Nucleoplasm
Cytosol Group enriched 32 cerebral cortex: 38.1;testis: 80.2 adrenal gland: 1.8 FRMPD4 KIAA0316, PDZD10, PDZK10 ENSG00000169933 FERM and PDZ domain containing 4 X 12138466-12724523 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035580 Uncertain Group enriched 32 cerebral cortex: 15.5;parathyroid gland: 23.8 heart muscle: 0.6 KCNF1 IK8, KCNF, kH1, Kv5.1 ENSG00000162975 Potassium channel, voltage gated modifier subfamily F, member 1 2 10911937-10914225 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level CAB004678, HPA014738 Supported Approved Golgi apparatus Tissue enriched 32 cerebral cortex: 37.6 endometrium: 1.1 PACSIN1 SDPI ENSG00000124507 Protein kinase C and casein kinase substrate in neurons 1 6 34466061-34535231 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009929, HPA028852, HPA055491 Supported Approved Nucleus
Vesicles Tissue enriched 32 cerebral cortex: 134.1 lymph node: 4.2 SNAP25 bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25 ENSG00000132639 Synaptosomal-associated protein, 25kDa 20 10218830-10307418 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000360, HPA001830 Supported Supported Tissue enriched 31 cerebral cortex: 1764.2 adrenal gland: 57.4 SYN1 ENSG00000008056 Synapsin I X 47571898-47619853 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000397, CAB021929 Supported Tissue enriched 31 cerebral cortex: 236.8 adrenal gland: 7.7 VWC2L ENSG00000174453 Von Willebrand factor C domain containing protein 2-like 2 214411065-214578959 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044815, HPA059414 Uncertain Tissue enriched 31 cerebral cortex: 3.1 epididymis: 0.0 HS3ST2 3OST2 ENSG00000122254 Heparan sulfate (glucosamine) 3-O-sulfotransferase 2 16 22814177-22916338 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA017736 Approved Tissue enriched 30 cerebral cortex: 35.8 lung: 1.1 MBP ENSG00000197971 Myelin basic protein 18 76978827-77133683 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002300, HPA049222, HPA064368 Supported Supported Approved Plasma membrane Tissue enriched 30 cerebral cortex: 2938.8 parathyroid gland: 97.8 PLP1 GPM6C, PLP, SPG2 ENSG00000123560 Proteolipid protein 1 X 103773718-103792619 Cancer-related genes, Disease related genes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004128 Supported Tissue enriched 30 cerebral cortex: 3225.1 parathyroid gland: 106.1 SLC1A2 EAAT2, GLT-1 ENSG00000110436 Solute carrier family 1 (glial high affinity glutamate transporter), member 2 11 35251206-35420063 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002574, HPA009172 Supported Tissue enriched 30 cerebral cortex: 367.1 liver: 12.2 EGR4 NGFI-C, PAT133 ENSG00000135625 Early growth response 4 2 73290929-73293705 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028983 Approved Group enriched 29 cerebral cortex: 9.7;testis: 3.2 appendix: 0.2 FEZF2 FEZL, FKSG36, FLJ10142, TOF, Zfp312, ZNF312 ENSG00000153266 FEZ family zinc finger 2 3 62369681-62374324 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 29 cerebral cortex: 11.8 colon: 0.4 PSD2 DKFZp761B0514, EFA6C ENSG00000146005 Pleckstrin and Sec7 domain containing 2 5 139795821-139844466 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 29 cerebral cortex: 58.7 epididymis: 2.0 SOX8 ENSG00000005513 SRY (sex determining region Y)-box 8 16 981808-986979 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA041640, HPA058665 Approved Supported Nucleus Tissue enriched 29 cerebral cortex: 110.2 salivary gland: 3.8 TBR1 ENSG00000136535 T-box, brain, 1 2 161416094-161425870 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051256 Approved Tissue enriched 29 cerebral cortex: 30.7 testis: 1.0 CACNG3 ENSG00000006116 Calcium channel, voltage-dependent, gamma subunit 3 16 24255553-24362801 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059010 Approved Tissue enriched 28 cerebral cortex: 42.6 adrenal gland: 1.5 KIF5A D12S1889, MY050, NKHC, SPG10 ENSG00000155980 Kinesin family member 5A 12 57549998-57586632 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004469, CAB015157, HPA073448 Approved Approved Approved Nucleoplasm
Mitotic spindle
Cytosol Tissue enriched 28 cerebral cortex: 326.6 adrenal gland: 11.5 NPTX1 ENSG00000171246 Neuronal pentraxin I 17 80467148-80477843 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 28 cerebral cortex: 122.8 adrenal gland: 4.3 SLC39A12 FLJ30499 ENSG00000148482 Solute carrier family 39 (zinc transporter), member 12 10 17951839-18043292 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 28 cerebral cortex: 25.4 breast: 0.8 SYN2 SYNII, SYNIIa, SYNIIb ENSG00000157152 Synapsin II 3 12004402-12191400 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA037012 Supported Nucleoplasm Tissue enriched 28 cerebral cortex: 200.6 adipose tissue: 7.0 TRIM67 TNL ENSG00000119283 Tripartite motif containing 67 1 231162112-231221556 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA034776 Uncertain Tissue enriched 28 cerebral cortex: 10.3 testis: 0.3 C2orf80 GONDA1, LOC389073 ENSG00000188674 Chromosome 2 open reading frame 80 2 208165343-208190073 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042639 Approved Golgi apparatus Tissue enriched 27 cerebral cortex: 37.7 testis: 1.4 ERMN ERMIN, JN, KIAA1189 ENSG00000136541 Ermin, ERM-like protein 2 157318625-157327713 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA038295, HPA038296 Supported Tissue enriched 27 cerebral cortex: 228.3 bone marrow: 8.4 SOHLH1 bA100C15.3, bHLHe80, C9orf157, NOHLH, SPATA27, TEB2 ENSG00000165643 Spermatogenesis and oogenesis specific basic helix-loop-helix 1 9 135693407-135699528 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA059439 Approved Nuclear speckles Group enriched 27 cerebral cortex: 6.4;testis: 13.4 skin: 0.3 TTYH1 ENSG00000167614 Tweety family member 1 19 54415219-54436900 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA023617, HPA050655 Approved Tissue enriched 27 cerebral cortex: 57.9 testis: 2.1 NKX6-2 GTX, NKX6.1, NKX6B ENSG00000148826 NK6 homeobox 2 10 132783179-132786052 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 26 cerebral cortex: 15.8;stomach: 17.1 testis: 0.6 GRIN2B GluN2B, NMDAR2B ENSG00000273079 Glutamate receptor, ionotropic, N-methyl D-aspartate 2B 12 13537337-13981957 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069762 Approved Tissue enriched 25 cerebral cortex: 13.2 adipose tissue: 0.5 KCNJ4 HIR, hIRK2, HRK1, IRK3, Kir2.3 ENSG00000168135 Potassium channel, inwardly rectifying subfamily J, member 4 22 38426327-38455199 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 25 cerebral cortex: 41.0;heart muscle: 11.7 gallbladder: 1.0 NTSR2 NTR2 ENSG00000169006 Neurotensin receptor 2 2 11658178-11670164 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 25 cerebral cortex: 25.1 ovary: 1.0 STMN4 RB3 ENSG00000015592 Stathmin-like 4 8 27235323-27258420 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA027765 Uncertain Golgi apparatus
Vesicles Tissue enriched 25 cerebral cortex: 339.4 adrenal gland: 13.4 BCAN BEHAB, CSPG7, MGC13038 ENSG00000132692 Brevican 1 156641390-156659532 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007865, CAB025862 Supported Tissue enriched 24 cerebral cortex: 429.4 epididymis: 17.9 SHANK1 SPANK-1, SSTRIP, synamon ENSG00000161681 SH3 and multiple ankyrin repeat domains 1 19 50661827-50719450 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032129, HPA032130 Uncertain Supported Plasma membrane Tissue enriched 24 cerebral cortex: 35.9 adrenal gland: 1.5 TMEM151A MGC33486, TMEM151 ENSG00000179292 Transmembrane protein 151A 11 66291870-66296664 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041035 Uncertain Approved Nucleoli
Cytosol Tissue enriched 24 cerebral cortex: 45.4 adrenal gland: 1.8 CORT MGC32686 ENSG00000241563 Cortistatin 1 10449719-10451902 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 23 cerebral cortex: 24.9 placenta: 1.1 FBXL16 C16orf22, Fbl16, MGC33974 ENSG00000127585 F-box and leucine-rich repeat protein 16 16 692498-705829 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039504, HPA056354 Supported Tissue enriched 23 cerebral cortex: 187.0 testis: 8.0 KCNV1 Kv8.1 ENSG00000164794 Potassium channel, voltage gated modifier subfamily V, member 1 8 109963645-109975847 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 23 cerebral cortex: 21.9 epididymis: 0.9 SLC7A10 asc-1 ENSG00000130876 Solute carrier family 7 (neutral amino acid transporter light chain, asc system), member 10 19 33208664-33225850 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041884, HPA057036 Uncertain Uncertain Nucleus
Nucleoli Group enriched 23 adipose tissue: 31.5;cerebral cortex: 6.6 breast: 0.8 SV2B HsT19680, KIAA0735 ENSG00000185518 Synaptic vesicle glycoprotein 2B 15 91099950-91301309 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046247 Approved Tissue enriched 23 cerebral cortex: 48.1 adipose tissue: 2.1 SYNPR MGC26651, SPO ENSG00000163630 Synaptoporin 3 63228315-63616921 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051368, HPA061671 Supported Tissue enriched 23 cerebral cortex: 78.4 heart muscle: 3.3 HIPK4 FLJ32818 ENSG00000160396 Homeodomain interacting protein kinase 4 19 40379271-40390187 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA027733 Uncertain Group enriched 22 cerebral cortex: 4.7;testis: 14.7 seminal vesicle: 0.4 JPH3 CAGL237, HDL2, JP-3, JP3, TNRC22 ENSG00000154118 Junctophilin 3 16 87601835-87698156 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA076304 Approved Nucleoplasm
Cytosol Tissue enriched 22 cerebral cortex: 43.4 adrenal gland: 2.0 SCN2A HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2 ENSG00000136531 Sodium channel, voltage gated, type II alpha subunit 2 165239402-165392310 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022567 Supported Tissue enriched 22 cerebral cortex: 58.5 kidney: 2.7 SLC4A10 NBCn2, NCBE ENSG00000144290 Solute carrier family 4, sodium bicarbonate transporter, member 10 2 161424332-161985282 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA034755 Supported Tissue enriched 22 cerebral cortex: 57.7 adrenal gland: 2.6 UNC5A KIAA1976, UNC5H1 ENSG00000113763 Unc-5 netrin receptor A 5 176810477-176880895 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071450 Approved Plasma membrane
Cytosol Group enriched 22 adrenal gland: 10.4;cerebral cortex: 35.5 lymph node: 1.0 VGF SCG7, SgVII ENSG00000128564 VGF nerve growth factor inducible 7 101162509-101165593 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055177, HPA072505 Supported Supported Vesicles Tissue enriched 22 cerebral cortex: 46.2 adipose tissue: 2.0 APC2 APCL ENSG00000115266 Adenomatosis polyposis coli 2 19 1446302-1473244 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA078002 Approved Cytokinetic bridge
Midbody ring
Cytosol Tissue enriched 21 cerebral cortex: 70.7 adrenal gland: 3.3 C11orf87 LOC399947, LOH11CR1A, NEURIM1 ENSG00000185742 Chromosome 11 open reading frame 87 11 109422120-109429114 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA034656 Approved Tissue enriched 21 cerebral cortex: 30.9 endometrium: 1.5 CNTNAP4 CASPR4, KIAA1763 ENSG00000152910 Contactin associated protein-like 4 16 76277278-76559238 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031859, HPA057342 Supported Tissue enriched 21 cerebral cortex: 36.0 testis: 1.6 STX1B STX1B1, STX1B2 ENSG00000099365 Syntaxin 1B 16 30989256-31010628 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069176 Supported Tissue enriched 21 cerebral cortex: 89.7 testis: 4.3 C1QL3 C1ql, C1QTNF13, CTRP13, K100 ENSG00000165985 Complement component 1, q subcomponent-like 3 10 16513743-16522005 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 20 cerebral cortex: 43.5 kidney: 2.2 CMTM5 CKLFSF5, FLJ37521 ENSG00000166091 CKLF-like MARVEL transmembrane domain containing 5 14 23376808-23379772 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052338 Supported Tissue enriched 20 cerebral cortex: 81.5 bone marrow: 4.0 FAM181B LOC220382, MGC33846 ENSG00000182103 Family with sequence similarity 181, member B 11 82729941-82733864 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA066861 Approved Approved Nuclear membrane
Mitochondria Tissue enriched 20 cerebral cortex: 17.5 fallopian tube: 0.8 GDAP1L1 ENSG00000124194 Ganglioside induced differentiation associated protein 1-like 1 20 44247099-44280917 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054182, HPA063265 Approved Approved Endoplasmic reticulum Tissue enriched 20 cerebral cortex: 55.7 adrenal gland: 2.8 PNMA5 KIAA1934 ENSG00000198883 Paraneoplastic Ma antigen family member 5 X 152988824-152994127 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044690 Supported Group enriched 20 cerebral cortex: 8.1;testis: 16.2 spleen: 0.6 VSTM2B ENSG00000187135 V-set and transmembrane domain containing 2B 19 29526499-29564479 Predicted secreted proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enriched 20 cerebral cortex: 42.5 cervix: 2.0 ACTL6B ACTL6, BAF53B ENSG00000077080 Actin-like 6B 7 100643097-100656461 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045126 Uncertain Approved Nucleoli Tissue enriched 19 cerebral cortex: 45.7 adrenal gland: 2.4 BTBD17 BTBD17A, LGALS3BPL, TANGO10A ENSG00000204347 BTB (POZ) domain containing 17 17 74356416-74361946 Predicted secreted proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA025022 Approved Tissue enriched 19 cerebral cortex: 12.9 adrenal gland: 0.6 CDH10 ENSG00000040731 Cadherin 10, type 2 (T2-cadherin) 5 24487100-24644978 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010651 Approved Group enriched 19 cerebral cortex: 32.7;prostate: 6.8 adrenal gland: 1.0 CYP46A1 CYP46 ENSG00000036530 Cytochrome P450, family 46, subfamily A, polypeptide 1 14 99684304-99727301 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040702 Uncertain Tissue enriched 19 cerebral cortex: 64.3 heart muscle: 3.3 GABBR2 GABABR2, GPR51, GPRC3B, HG20 ENSG00000136928 Gamma-aminobutyric acid (GABA) B receptor, 2 9 98288082-98709197 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013820, HPA031684 Supported Tissue enriched 19 cerebral cortex: 88.4 adrenal gland: 4.6 CTNND2 GT24, NPRAP ENSG00000169862 Catenin (cadherin-associated protein), delta 2 5 10971840-11904043 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015077, CAB037339 Supported Approved Nucleoplasm
Golgi apparatus
Cell Junctions Tissue enriched 18 cerebral cortex: 103.5 spleen: 5.7 AQP4 MIWC ENSG00000171885 Aquaporin 4 18 26852038-26865818 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005079, HPA014784, CAB058689 Supported Supported Supported Plasma membrane
Cell Junctions Group enriched 17 cerebral cortex: 631.8;lung: 172.2 thyroid gland: 24.3 C1QL2 C1QTNF10, CTRP10 ENSG00000144119 Complement component 1, q subcomponent-like 2 2 119156243-119158889 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA057934 Uncertain Tissue enriched 17 cerebral cortex: 2.5 testis: 0.1 FNDC9 C5orf40, MGC27121 ENSG00000172568 Fibronectin type III domain containing 9 5 157341600-157345721 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA011115, HPA017291 Approved Group enriched 17 adrenal gland: 6.3;cerebral cortex: 20.7 appendix: 0.7 GABRG1 ENSG00000163285 Gamma-aminobutyric acid (GABA) A receptor, gamma 1 4 46035769-46124081 FDA approved drug targets, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035622 Approved Tissue enriched 17 cerebral cortex: 26.1 ovary: 1.5 GAD2 GAD65 ENSG00000136750 Glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) 10 26216307-26304558 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044637, CAB078177 Supported Tissue enriched 17 cerebral cortex: 23.0 pancreas: 1.3 GPM6B M6B, MGC17150, MGC54284 ENSG00000046653 Glycoprotein M6B X 13771031-13938638 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002913 Approved Tissue enriched 17 cerebral cortex: 838.3 seminal vesicle: 48.9 GPR158 KIAA1136 ENSG00000151025 G protein-coupled receptor 158 10 25175062-25602226 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013185 Uncertain Approved Cytosol Tissue enriched 17 cerebral cortex: 17.9 testis: 1.0 HRH3 GPCR97 ENSG00000101180 Histamine receptor H3 20 62214970-62220267 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 17 cerebral cortex: 11.1 adrenal gland: 0.6 LYPD1 LYPDC1, MGC29643 ENSG00000150551 LY6/PLAUR domain containing 1 2 132644853-132671579 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 17 cerebral cortex: 27.3;fallopian tube: 125.8 salivary gland: 4.5 MT3 GIF ENSG00000087250 Metallothionein 3 16 56589074-56591088 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004011, CAB017779 Supported Tissue enriched 17 cerebral cortex: 740.5 adrenal gland: 43.0 NRGN RC3 ENSG00000154146 Neurogranin (protein kinase C substrate, RC3) 11 124739846-124747210 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006908, HPA038171 Supported Tissue enriched 17 cerebral cortex: 964.6 lung: 56.4 BAALC ENSG00000164929 Brain and acute leukemia, cytoplasmic 8 103140710-103230305 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA027132, HPA068307 Approved Supported Nucleus
Cytosol Tissue enriched 16 cerebral cortex: 248.4 adrenal gland: 15.7 CEND1 BM88, FLJ90066 ENSG00000184524 Cell cycle exit and neuronal differentiation 1 11 787104-790123 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA042527 Supported Approved Mitochondria Tissue enriched 16 cerebral cortex: 114.3 adrenal gland: 7.1 ERC2 CAST, CAST1, ELKSL, KIAA0378, SPBC110, Spc110 ENSG00000187672 ELKS/RAB6-interacting/CAST family member 2 3 55508308-56468363 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 16 cerebral cortex: 24.6 seminal vesicle: 1.4 GNG3 ENSG00000162188 Guanine nucleotide binding protein (G protein), gamma 3 11 62707658-62709201 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level Tissue enriched 16 cerebral cortex: 316.2 adrenal gland: 19.1 GPR6 ENSG00000146360 G protein-coupled receptor 6 6 109978256-109980718 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 16 cerebral cortex: 1.5 epididymis: 0.0 KCNK12 K2p12.1, THIK-2, THIK2 ENSG00000184261 Potassium channel, two pore domain subfamily K, member 12 2 47516581-47570939 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 16 cerebral cortex: 5.3 testis: 0.3 NPY PYY4 ENSG00000122585 Neuropeptide Y 7 24284163-24291865 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009978, CAB016733, CAB034368, HPA044572, HPA056798 Supported Supported Validated Golgi apparatus Group enriched 16 adrenal gland: 154.2;cerebral cortex: 212.3;prostate: 448.9 appendix: 16.6 RAB3C ENSG00000152932 RAB3C, member RAS oncogene family 5 58582221-58859394 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA003160, HPA048156 Supported Approved Cytosol Group enriched 16 adrenal gland: 12.1;cerebral cortex: 55.5 small intestine: 2.0 SLC1A3 EA6, EAAT1, GLAST ENSG00000079215 Solute carrier family 1 (glial high affinity glutamate transporter), member 3 5 36606355-36688334 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002573, HPA037467, HPA037468 Supported Approved Nucleoli
Mitochondria Tissue enriched 16 cerebral cortex: 519.6 adipose tissue: 31.7 TMEM59L BSMAP, C19orf4 ENSG00000105696 Transmembrane protein 59-like 19 18607430-18621039 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA010661, HPA070701 Approved Approved Nucleoplasm
Actin filaments Tissue enriched 16 cerebral cortex: 367.2 adrenal gland: 22.3 UNC13A KIAA1032, Munc13-1 ENSG00000130477 Unc-13 homolog A (C. elegans) 19 17601328-17688365 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041418 Uncertain Tissue enriched 16 cerebral cortex: 53.7 adrenal gland: 3.4 C1QL1 C1QRF, C1QTNF14, CRF ENSG00000131094 Complement component 1, q subcomponent-like 1 17 44959693-44968071 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 15 cerebral cortex: 38.5 duodenum: 2.5 C8orf46 MGC33510 ENSG00000169085 Chromosome 8 open reading frame 46 8 66460003-66518524 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA075134 Approved Nuclear speckles Tissue enriched 15 cerebral cortex: 65.3 seminal vesicle: 4.4 DPF1 BAF45b, NEUD4, neuro-d4 ENSG00000011332 D4, zinc and double PHD fingers family 1 19 38211006-38229714 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA049148 Supported Approved Nucleoplasm
Mitochondria
Cytosol Tissue enriched 15 cerebral cortex: 27.5 testis: 1.8 ELMOD1 DKFZp547C176 ENSG00000110675 ELMO/CED-12 domain containing 1 11 107591091-107666779 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA038434, HPA038435 Supported Nucleoplasm
Cytosol Group enriched 15 cerebral cortex: 71.6;skin: 36.8 fallopian tube: 3.5 ENC1 ENC-1, KLHL37, NRPB, PIG10, TP53I10 ENSG00000171617 Ectodermal-neural cortex 1 (with BTB domain) 5 74627406-74641424 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA078061 Uncertain Plasma membrane
Cytoplasmic bodies Tissue enriched 15 cerebral cortex: 462.7 gallbladder: 30.9 GABRB1 ENSG00000163288 Gamma-aminobutyric acid (GABA) A receptor, beta 1 4 46993723-47426444 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051297 Uncertain Tissue enriched 15 cerebral cortex: 19.8 heart muscle: 1.3 GPR26 ENSG00000154478 G protein-coupled receptor 26 10 123666355-123694607 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA062736 Supported Tissue enriched 15 cerebral cortex: 4.3 testis: 0.2 MDGA2 MAMDC1 ENSG00000139915 MAM domain containing glycosylphosphatidylinositol anchor 2 14 46839629-47674954 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003084 Uncertain Group enriched 15 cerebral cortex: 6.3;testis: 6.9 skin: 0.4 NETO1 BCTL1, BTCL1 ENSG00000166342 Neuropilin (NRP) and tolloid (TLL)-like 1 18 72742314-72868146 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA064630 Approved Golgi apparatus Tissue enriched 15 cerebral cortex: 64.1 spleen: 4.1 OLFM3 NOE3 ENSG00000118733 Olfactomedin 3 1 101802574-101997030 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050297 Uncertain Vesicles Tissue enriched 15 cerebral cortex: 26.8 adrenal gland: 1.8 PTPN5 PTPSTEP, STEP ENSG00000110786 Protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) 11 18727928-18792721 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031014, HPA072091 Supported Approved Endoplasmic reticulum Tissue enriched 15 cerebral cortex: 58.9 testis: 3.8 RASL10A RRP22 ENSG00000100276 RAS-like, family 10, member A 22 29312933-29319679 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA056169 Approved Tissue enriched 15 cerebral cortex: 33.6 breast: 2.2 SHD ENSG00000105251 Src homology 2 domain containing transforming protein D 19 4278601-4290724 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA017955 Approved Uncertain Microtubule organizing center
Cytosol Group enriched 15 cerebral cortex: 22.2;heart muscle: 4.5 appendix: 0.9 STX1A HPC-1, p35-1, STX1 ENSG00000106089 Syntaxin 1A (brain) 7 73699206-73719672 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008372, HPA069176 Supported Tissue enriched 15 cerebral cortex: 167.1 gallbladder: 10.8 SVOP DKFZp761H039 ENSG00000166111 SV2 related protein 12 108907741-109021240 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA016573 Uncertain Tissue enriched 15 cerebral cortex: 32.4 adrenal gland: 2.1 UNC13C DKFZp547H074, Munc13-3 ENSG00000137766 Unc-13 homolog C (C. elegans) 15 54012904-54633414 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041516 Uncertain Group enriched 15 cerebral cortex: 17.4;testis: 15.2 thyroid gland: 1.1 ADGRB2 BAI2 ENSG00000121753 Adhesion G protein-coupled receptor B2 1 31727117-31764893 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052612, HPA054617 Supported Centrosome Tissue enriched 14 cerebral cortex: 72.5 adrenal gland: 5.1 CADM2 IGSF4D, Necl-3, NECL3, SynCAM2 ENSG00000175161 Cell adhesion molecule 2 3 84958981-86074429 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA010024 Supported Tissue enriched 14 cerebral cortex: 86.4 seminal vesicle: 6.2 CCKBR ENSG00000110148 Cholecystokinin B receptor 11 6259736-6272127 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 14 cerebral cortex: 13.7;pancreas: 5.4;stomach: 16.1 prostate: 0.8 CHRNB2 ENSG00000160716 Cholinergic receptor, nicotinic, beta 2 (neuronal) 1 154567781-154580026 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 14 cerebral cortex: 22.0 adrenal gland: 1.5 DNM1 DNM ENSG00000106976 Dynamin 1 9 128203352-128255248 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005920, HPA049910, HPA061801 Supported Supported Nucleoplasm Tissue enriched 14 cerebral cortex: 365.7 cervix: 25.2 GSG1L2 ENSG00000214978 GSG1-like 2 17 9802386-9822071 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA059428 Uncertain Group enriched 14 cerebral cortex: 1.5;testis: 1.1 epididymis: 0.0 KCNQ3 EBN2, Kv7.3 ENSG00000184156 Potassium channel, voltage gated KQT-like subfamily Q, member 3 8 132120859-132480953 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 14 cerebral cortex: 26.9 adrenal gland: 1.9 LY6H NMLY6 ENSG00000176956 Lymphocyte antigen 6 complex, locus H 8 143157914-143160711 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 14 cerebral cortex: 38.1 duodenum: 2.6 MGAT5B FLJ25132, GnT-IX, GnT-VB ENSG00000167889 Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase, isozyme B 17 76868456-76950393 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011082 Approved Nucleoplasm
Mitotic spindle Tissue enriched 14 cerebral cortex: 23.2 testis: 1.6 NPTXR ENSG00000221890 Neuronal pentraxin receptor 22 38818452-38843982 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level No evidence Evidence at protein level HPA001079 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 14 cerebral cortex: 177.0 fallopian tube: 13.0 NRSN1 p24, VMP ENSG00000152954 Neurensin 1 6 24126122-24154900 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA061006 Approved Approved Nucleus
Vesicles Tissue enriched 14 cerebral cortex: 96.7 adrenal gland: 6.7 PTCHD2 DISP3, KIAA1337 ENSG00000204624 Patched domain containing 2 1 11479166-11537584 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA054579 Uncertain Uncertain Nucleoplasm
Cytosol Group enriched 14 cerebral cortex: 8.7;testis: 4.3 adrenal gland: 0.4 RASGRF1 CDC25, CDC25L, GNRP, GRF1, GRF55, H-GRF55, PP13187 ENSG00000058335 Ras protein-specific guanine nucleotide-releasing factor 1 15 78959947-79090773 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010413, HPA041965 Approved Supported Golgi apparatus Group enriched 14 cerebral cortex: 30.6;lung: 11.7 lymph node: 1.5 SLC30A3 ZNT3 ENSG00000115194 Solute carrier family 30 (zinc transporter), member 3 2 27253684-27275817 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060505, HPA067637 Approved Approved Nucleus
Nucleoli
Vesicles
Cytosol Group enriched 14 cerebral cortex: 36.7;epididymis: 65.2;testis: 43.6 heart muscle: 3.4 SLIT1 MEGF4, SLIL1, Slit-1, slit1, SLIT3 ENSG00000187122 Slit guidance ligand 1 10 96998038-97185920 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 14 cerebral cortex: 60.2 thyroid gland: 4.1 SOX11 ENSG00000176887 SRY (sex determining region Y)-box 11 2 5692667-5701385 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000536, CAB056152, CAB056153 Approved Tissue enriched 14 cerebral cortex: 5.4 smooth muscle: 0.3 SYT11 DKFZp781D015, KIAA0080, MGC10881, MGC17226 ENSG00000132718 Synaptotagmin XI 1 155859509-155885199 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064091 Supported Tissue enriched 14 cerebral cortex: 403.4 endometrium: 28.3 VSNL1 HLP3, HPCAL3, HUVISL1, VILIP, VILIP-1 ENSG00000163032 Visinin-like 1 2 17539126-17657018 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053808 Approved Cytosol Tissue enriched 14 cerebral cortex: 625.9 esophagus: 44.2 APLP1 APLP ENSG00000105290 Amyloid beta (A4) precursor-like protein 1 19 35867899-35879791 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028970, HPA028971 Supported Tissue enriched 13 cerebral cortex: 441.8 adrenal gland: 34.6 C10orf90 bA422P15.2, FATS, FLJ32938 ENSG00000154493 Chromosome 10 open reading frame 90 10 126424997-126670446 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038648, HPA057599 Uncertain Uncertain Nucleoplasm
Plasma membrane
Cytosol Group enriched 13 breast: 5.6;cerebral cortex: 15.3;salivary gland: 4.4;testis: 12.4 tonsil: 0.7 CACNG2 MGC138502, MGC138504, stargazin ENSG00000166862 Calcium channel, voltage-dependent, gamma subunit 2 22 36563921-36703558 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 13 cerebral cortex: 15.4 adrenal gland: 1.2 CALY CALCYON, DRD1IP, NSG3 ENSG00000130643 Calcyon neuron-specific vesicular protein 10 133324072-133336935 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042283 Uncertain Group enriched 13 adrenal gland: 23.6;cerebral cortex: 77.3 testis: 3.8 CERS1 LAG1, LASS1, UOG1 ENSG00000223802 Ceramide synthase 1 19 18868545-18896727 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045724 Approved Approved Endoplasmic reticulum Group enriched 13 cerebral cortex: 136.6;testis: 28.0 skeletal muscle: 6.5 FABP7 B-FABP, BLBP ENSG00000164434 Fatty acid binding protein 7, brain 6 122779475-122784074 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025488, HPA028825, CAB058697 Supported Supported Nucleoplasm
Cytosol Group enriched 13 breast: 32.9;cerebral cortex: 102.5 skin: 5.2 GPR22 ENSG00000172209 G protein-coupled receptor 22 7 107470018-107475659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 13 adrenal gland: 2.4;cerebral cortex: 9.5;cervix, uterine: 6.3;endometrium: 5.0;heart muscle: 11.9 smooth muscle: 0.5 GPR62 ENSG00000180929 G protein-coupled receptor 62 3 51955314-51957504 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 13 cerebral cortex: 8.0 ovary: 0.6 KIF1A ATSV, C2orf20, SPG30, UNC104 ENSG00000130294 Kinesin family member 1A 2 240713764-240820308 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005442 Approved Approved Cytosol Tissue enriched 13 cerebral cortex: 308.0 adrenal gland: 23.1 KIF3C ENSG00000084731 Kinesin family member 3C 2 25926596-25982749 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035755 Approved Nuclear membrane
Nuclear bodies
Intermediate filaments Tissue enriched 13 cerebral cortex: 133.6 adrenal gland: 10.0 LINGO1 FLJ14594, LERN1, LRRN6A ENSG00000169783 Leucine rich repeat and Ig domain containing 1 15 77613027-77820900 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA074653 Approved Plasma membrane Tissue enriched 13 cerebral cortex: 131.2 heart muscle: 9.7 NKAIN4 bA261N11.2, C20orf58, FAM77A ENSG00000101198 Na+/K+ transporting ATPase interacting 4 20 63240784-63272694 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029876 Approved Tissue enriched 13 cerebral cortex: 71.9 kidney: 5.5 PNMA3 MA3, MA5, MGC132756, MGC132758 ENSG00000183837 Paraneoplastic Ma antigen 3 X 153056409-153060467 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA047920 Approved Group enriched 13 cerebral cortex: 15.4;epididymis: 44.8;testis: 12.3 fallopian tube: 1.8 SCG3 FLJ90833, SgIII ENSG00000104112 Secretogranin III 15 51681353-51721031 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006880, CAB033274, HPA053715 Supported Approved Validated Vesicles Tissue enriched 13 cerebral cortex: 279.1 adrenal gland: 22.0 SYT1 P65, SVP65, SYT ENSG00000067715 Synaptotagmin I 12 78863993-79452008 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008394, HPA064788 Supported Tissue enriched 13 cerebral cortex: 477.9 smooth muscle: 36.4 TMEM88B ENSG00000205116 Transmembrane protein 88B 1 1426128-1427787 Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence HPA065743 Supported Tissue enriched 13 cerebral cortex: 11.9 testis: 0.9 ATCAY BNIP-H ENSG00000167654 Ataxia, cerebellar, Cayman type 19 3879864-3928079 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017755 Supported Tissue enriched 12 cerebral cortex: 109.9 adrenal gland: 8.9 ATP6V1G2 ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10 ENSG00000213760 ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 6 31544462-31548427 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB004616 Supported Tissue enriched 12 cerebral cortex: 16.8 lymph node: 1.4 CNDP1 CN1, CPGL2, HsT2308, MGC10825 ENSG00000150656 Carnosine dipeptidase 1 (metallopeptidase M20 family) 18 74534440-74587212 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008933 Supported Group enriched 12 cerebral cortex: 102.0;liver: 23.0 duodenum: 5.2 CNP ENSG00000173786 2',3'-cyclic nucleotide 3' phosphodiesterase 17 41966741-41977731 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002672, HPA023266, HPA023278, HPA023280, HPA023338 Supported Validated Nucleus
Cytosol Tissue enriched 12 cerebral cortex: 616.5 prostate: 52.3 CNTN2 AXT, TAG-1, TAX, TAX1 ENSG00000184144 Contactin 2 (axonal) 1 205043197-205078499 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001397, HPA012497 Approved Tissue enriched 12 cerebral cortex: 79.8 testis: 6.9 CTNNA2 CAP-R, CT114 ENSG00000066032 Catenin (cadherin-associated protein), alpha 2 2 79185231-80648861 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB037175 Approved Group enriched 12 cerebral cortex: 111.9;epididymis: 80.2;testis: 32.0 adrenal gland: 6.4 ENHO C9orf165, UNQ470 ENSG00000168913 Energy homeostasis associated 9 34521040-34523041 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042575 Approved Tissue enriched 12 cerebral cortex: 140.7 testis: 11.6 FAM57B DKFZP434I2117 ENSG00000149926 Family with sequence similarity 57, member B 16 30024427-30052978 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030837 Uncertain Group enriched 12 cerebral cortex: 18.7;testis: 77.3 skeletal muscle: 3.9 FSD1 MGC3213, MIR1 ENSG00000105255 Fibronectin type III and SPRY domain containing 1 19 4304600-4323843 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043141 Supported Group enriched 12 cerebral cortex: 25.5;testis: 9.1 lymph node: 1.4 FUT9 Fuc-TIX ENSG00000172461 Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) 6 96015984-96215612 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA070923 Approved Nucleoplasm
Microtubules
Cytokinetic bridge
Cytosol Group enriched 12 cerebral cortex: 28.2;stomach: 22.2 duodenum: 2.1 GABRA4 ENSG00000109158 Gamma-aminobutyric acid (GABA) A receptor, alpha 4 4 46918900-46994407 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 12 cerebral cortex: 15.1 heart muscle: 1.2 GPR88 ENSG00000181656 G protein-coupled receptor 88 1 100538137-100542018 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007488 Uncertain Approved Group enriched 12 breast: 9.7;cerebral cortex: 3.1;liver: 5.1;ovary: 3.4;parathyroid gland: 7.9;spleen: 14.7 adipose tissue: 0.6 IL1RAPL1 IL1R8, IL1RAPL, MRX10, MRX21, MRX34, OPHN4, TIGIRR-2 ENSG00000169306 Interleukin 1 receptor accessory protein-like 1 X 28587399-29956723 Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 12 cerebral cortex: 5.1 seminal vesicle: 0.4 KCNH1 eag, eag1, h-eag, Kv10.1 ENSG00000143473 Potassium channel, voltage gated eag related subfamily H, member 1 1 210678315-211134115 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014551, HPA019445 Supported Approved Vesicles Tissue enriched 12 cerebral cortex: 11.5 testis: 0.9 KCNK4 K2p4.1, TRAAK ENSG00000182450 Potassium channel, two pore domain subfamily K, member 4 11 64291302-64300031 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 12 cerebral cortex: 4.3 cervix: 0.3 MAST1 KIAA0973, SAST ENSG00000105613 Microtubule associated serine/threonine kinase 1 19 12833951-12874951 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028181 Approved Vesicles Tissue enriched 12 cerebral cortex: 35.3 testis: 3.0 NCDN NCDN-1, NCDN-2 ENSG00000020129 Neurochondrin 1 35557473-35567274 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023676 Supported Supported Supported Cytosol Tissue enriched 12 cerebral cortex: 285.2 adrenal gland: 22.8 PCDHGB1 PCDH-GAMMA-B1 ENSG00000254221 Protocadherin gamma subfamily B, 1 5 141350102-141512979 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA008755, HPA076182 Uncertain Approved Plasma membrane
Focal adhesion sites
Midbody Tissue enriched 12 cerebral cortex: 23.8 endometrium: 2.0 PNMA2 MA2, RGAG2 ENSG00000240694 Paraneoplastic Ma antigen 2 8 26504686-26514092 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001936 Supported Tissue enriched 12 cerebral cortex: 163.9 adrenal gland: 13.6 RAB3A ENSG00000105649 RAB3A, member RAS oncogene family 19 18196784-18204074 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003160, CAB009949 Supported Approved Nucleoplasm
Centrosome
Cytosol Tissue enriched 12 cerebral cortex: 251.3 adrenal gland: 20.7 SH3GL3 CNSA3, EEN-B2, HsT19371, SH3D2C, SH3P13 ENSG00000140600 SH3-domain GRB2-like 3 15 83447228-83618743 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039381, HPA077877 Supported Approved Cytosol Group enriched 12 cerebral cortex: 30.0;testis: 38.3 lung: 2.9 SLC35F1 C6orf169, dJ230I3.1 ENSG00000196376 Solute carrier family 35, member F1 6 117907526-118317676 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA019576 Approved Approved Nucleoplasm
Microtubule organizing center
Cytosol Tissue enriched 12 cerebral cortex: 45.6 epididymis: 3.7 B3GAT1 CD57, GlcAT-P, HNK-1, LEU7, NK-1 ENSG00000109956 Beta-1,3-glucuronyltransferase 1 11 134378504-134411918 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB002500, CAB010893, HPA069468 Supported Validated Vesicles Tissue enriched 11 cerebral cortex: 115.7 thyroid gland: 10.3 CNIH2 CNIH-2, Cnil, MGC50896 ENSG00000174871 Cornichon family AMPA receptor auxiliary protein 2 11 66278190-66285301 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 11 cerebral cortex: 53.0 adrenal gland: 4.6 CNTNAP2 Caspr2, KIAA0868, NRXN4 ENSG00000174469 Contactin associated protein-like 2 7 146116002-148420998 Disease related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002739 Supported Group enriched 11 cerebral cortex: 20.2;prostate: 5.7 breast: 1.2 CPLX1 CPX-I ENSG00000168993 Complexin 1 4 784957-826198 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071191 Uncertain Vesicles Tissue enriched 11 cerebral cortex: 60.4 adipose tissue: 5.3 DCLK2 DCAMKL2, DCDC3, DCDC3B, DCK2, MGC45428 ENSG00000170390 Doublecortin-like kinase 2 4 150078274-150257457 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA015770 Supported Tissue enriched 11 cerebral cortex: 82.8 heart muscle: 7.4 DLGAP3 DAP3, SAPAP3 ENSG00000116544 Discs, large (Drosophila) homolog-associated protein 3 1 34865436-34929585 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026445 Supported Group enriched 11 cerebral cortex: 21.9;testis: 5.7 spleen: 1.2 DSCAM CHD2-42, CHD2-52 ENSG00000171587 Down syndrome cell adhesion molecule 21 40010999-40847139 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019324 Supported Approved Nucleoplasm
Cytosol Tissue enriched 11 cerebral cortex: 12.5 spleen: 1.1 GABRB2 ENSG00000145864 Gamma-aminobutyric acid (GABA) A receptor, beta 2 5 161288429-161549044 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001964, HPA067632 Supported Tissue enriched 11 cerebral cortex: 63.0 epididymis: 5.5 HPCAL4 DKFZp761G122, HLP4 ENSG00000116983 Hippocalcin like 4 1 39678648-39691689 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053808 Approved Cytosol Tissue enriched 11 cerebral cortex: 146.1 adrenal gland: 13.3 HTR5A 5-HT5A ENSG00000157219 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 7 155070324-155085749 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB017467 Approved Tissue enriched 11 cerebral cortex: 8.6 testis: 0.7 KCNC2 Kv3.2 ENSG00000166006 Potassium channel, voltage gated Shaw related subfamily C, member 2 12 75040077-75209868 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019664, CAB022571 Uncertain Supported Plasma membrane
Cytosol Tissue enriched 11 cerebral cortex: 46.5 prostate: 4.2 KIRREL3 KIAA1867, KIRRE, NEPH2 ENSG00000149571 Kin of IRRE like 3 (Drosophila) 11 126423359-127003460 Disease related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053324, HPA056320 Supported Tissue enriched 11 cerebral cortex: 20.5 adrenal gland: 1.9 LGI1 EPITEMPIN, EPT, ETL1, IB1099 ENSG00000108231 Leucine-rich, glioma inactivated 1 10 93757809-93798174 Cancer-related genes, Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 11 cerebral cortex: 51.3 esophagus: 4.7 LHFPL3 LHFPL4 ENSG00000187416 Lipoma HMGIC fusion partner-like 3 7 104328656-104907232 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA069691 Approved Vesicles Tissue enriched 11 cerebral cortex: 48.9 cervix: 4.6 LHX2 hLhx2, LH-2 ENSG00000106689 LIM homeobox 2 9 124001670-124033301 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA000838 Supported Approved Nucleoplasm Tissue enriched 11 cerebral cortex: 56.4 placenta: 5.1 MAP2 MAP2A, MAP2B, MAP2C ENSG00000078018 Microtubule-associated protein 2 2 209424058-209734118 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001984, HPA008273, HPA012828 Supported Supported Supported Nucleoli
Cytosol Tissue enriched 11 cerebral cortex: 297.4 thyroid gland: 27.8 MYT1L KIAA1106, NZF1, ZC2HC4B ENSG00000186487 Myelin transcription factor 1-like 2 1789113-2331260 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 11 cerebral cortex: 60.2 testis: 5.3 PCDH9 ENSG00000184226 Protocadherin 9 13 66302834-67230445 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015581 Approved Nucleoplasm
Centrosome Tissue enriched 11 cerebral cortex: 69.0 seminal vesicle: 6.0 PCDHGC4 PCDH-GAMMA-C4 ENSG00000242419 Protocadherin gamma subfamily C, 4 5 141484997-141512979 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA008755, HPA078024 Uncertain Approved Golgi apparatus Tissue enriched 11 cerebral cortex: 16.4 adrenal gland: 1.4 PDYN ADCA, PENKB, SCA23 ENSG00000101327 Prodynorphin 20 1978757-1994285 Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049841, HPA053342 Approved Tissue enriched 11 cerebral cortex: 63.5 testis: 5.5 PLPPR5 LPPR5, PAP2, PAP2D, PRG5 ENSG00000117598 Phospholipid phosphatase related 5 1 98890245-99005032 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018072 Uncertain Approved Nucleus
Plasma membrane
Centrosome Group enriched 11 cerebral cortex: 12.0;testis: 4.0 adrenal gland: 0.7 POU3F4 BRN4, DFN3, DFNX2, OTF9 ENSG00000196767 POU class 3 homeobox 4 X 83508250-83512127 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA031984 Uncertain Tissue enriched 11 cerebral cortex: 8.0 kidney: 0.7 RGR RP44 ENSG00000148604 Retinal G protein coupled receptor 10 84245053-84259960 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 11 cerebral cortex: 16.1 epididymis: 1.4 RPRML MGC43894 ENSG00000179673 Reprimo-like 17 46978156-46979248 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062668 Uncertain Tissue enriched 11 cerebral cortex: 8.4 epididymis: 0.7 SCN3B HSA243396 ENSG00000166257 Sodium channel, voltage gated, type III beta subunit 11 123629187-123655244 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042518 Approved Nuclear membrane
Cytokinetic bridge Tissue enriched 11 cerebral cortex: 132.5 adrenal gland: 11.6 SEPT3 SEP3 ENSG00000100167 Septin 3 22 41976272-41998221 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003548, CAB017633 Supported Approved Nucleoplasm
Plasma membrane
Actin filaments Tissue enriched 11 cerebral cortex: 235.5 parathyroid gland: 21.5 SHISA7 ENSG00000187902 Shisa family member 7 19 55428740-55442863 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA058935 Uncertain Tissue enriched 11 cerebral cortex: 18.3 testis: 1.7 SLC8A2 KIAA1087, NCX2 ENSG00000118160 Solute carrier family 8 (sodium/calcium exchanger), member 2 19 47428017-47472168 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA050818, HPA054671 Supported Tissue enriched 11 cerebral cortex: 68.4 endometrium: 6.2 SYP MRX96 ENSG00000102003 Synaptophysin X 49187804-49200259 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000076, HPA002858, CAB055505 Supported Tissue enriched 11 cerebral cortex: 573.3 adrenal gland: 51.4 TRIM9 RNF91, SPRING ENSG00000100505 Tripartite motif containing 9 14 50975262-51096061 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041489 Supported Cytosol Tissue enriched 11 cerebral cortex: 79.4 gallbladder: 6.9 ADD2 ADDB ENSG00000075340 Adducin 2 (beta) 2 70607618-70768225 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009796, HPA034509, HPA034510 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 10 bone marrow: 40.3;cerebral cortex: 44.8 testis: 4.1 ADGRB3 BAI3, KIAA0550 ENSG00000135298 Adhesion G protein-coupled receptor B3 6 68635367-69389511 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 10 cerebral cortex: 53.2 adrenal gland: 5.2 ASIC1 ACCN2, BNaC2, hBNaC2 ENSG00000110881 Acid sensing (proton gated) ion channel 1 12 50057548-50083611 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA058870 Approved Golgi apparatus
Plasma membrane Tissue enriched 10 cerebral cortex: 57.0 parathyroid gland: 5.5 B3GAT2 GlcAT-S ENSG00000112309 Beta-1,3-glucuronyltransferase 2 6 70856679-70957038 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012059 Uncertain Tissue enriched 10 cerebral cortex: 19.6 testis: 1.9 C4orf50 FLJ46481 ENSG00000181215 Chromosome 4 open reading frame 50 4 5897591-5989818 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA058292 Uncertain Tissue enriched 10 cerebral cortex: 3.6 prostate: 0.3 CDK5R2 NCK5AI, P39, p39nck5ai ENSG00000171450 Cyclin-dependent kinase 5, regulatory subunit 2 (p39) 2 218959655-218962162 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 10 cerebral cortex: 52.3 adrenal gland: 5.1 CRB1 LCA8, RP12 ENSG00000134376 Crumbs family member 1, photoreceptor morphogenesis associated 1 197268204-197478455 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA061250, HPA063127 Approved Uncertain Vesicles Group enriched 10 cerebral cortex: 12.1;testis: 4.9 ovary: 0.8 DDN KIAA0749 ENSG00000181418 Dendrin 12 48995149-48999309 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA060952 Uncertain Approved Nucleoplasm
Cytosol Group enriched 10 cerebral cortex: 96.3;skeletal muscle: 46.6 kidney: 6.9 DGKI DGK-IOTA ENSG00000157680 Diacylglycerol kinase, iota 7 137381037-137847092 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021924 Uncertain Approved Nucleoplasm Group enriched 10 cerebral cortex: 9.3;thyroid gland: 32.8 heart muscle: 2.0 DLGAP2 DAP-2 ENSG00000198010 Discs, large (Drosophila) homolog-associated protein 2 8 1501366-1708476 Nuclear receptors, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030320 Uncertain Group enriched 10 cerebral cortex: 1.9;testis: 5.5 kidney: 0.3 DNAJC6 KIAA0473, PARK19 ENSG00000116675 DnaJ (Hsp40) homolog, subfamily C, member 6 1 65248219-65415869 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031182, HPA054917 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enriched 10 cerebral cortex: 163.3 adrenal gland: 15.7 FEZ1 ENSG00000149557 Fasciculation and elongation protein zeta 1 (zygin I) 11 125445745-125496317 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038490 Supported Microtubules
Cytosol Tissue enriched 10 cerebral cortex: 412.6 urinary bladder: 43.0 FSTL5 DKFZp566D234, KIAA1263 ENSG00000168843 Follistatin-like 5 4 161383897-162164035 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045909, HPA046724 Uncertain Group enriched 10 adrenal gland: 7.8;cerebral cortex: 16.3 testis: 1.1 GABRD ENSG00000187730 Gamma-aminobutyric acid (GABA) A receptor, delta 1 2019324-2030751 Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044371 Supported Uncertain Golgi apparatus
Vesicles Tissue enriched 10 cerebral cortex: 47.4 testis: 4.5 GLRA2 GLR ENSG00000101958 Glycine receptor, alpha 2 X 14529298-14731812 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB070422 Approved Group enriched 10 cerebral cortex: 6.2;colon: 1.4;rectum: 4.3 testis: 0.3 GRIA4 GluA4, GLUR4, GLURD ENSG00000152578 Glutamate receptor, ionotropic, AMPA 4 11 105609994-105982092 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 10 cerebral cortex: 73.4 adrenal gland: 7.4 GRM2 GPRC1B, mGlu2, MGLUR2 ENSG00000164082 Glutamate receptor, metabotropic 2 3 51707070-51718613 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065166 Approved Tissue enriched 10 cerebral cortex: 4.4 testis: 0.4 HTR1A 5-HT1A, ADRB2RL1, ADRBRL1 ENSG00000178394 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 5 63960356-63962507 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA018073 Uncertain Group enriched 10 cerebral cortex: 1.9;ovary: 3.9 testis: 0.2 ICAM5 TLCN, TLN ENSG00000105376 Intercellular adhesion molecule 5, telencephalin 19 10289981-10296778 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008943, HPA009083, CAB025178 Supported Approved Nucleoplasm Tissue enriched 10 cerebral cortex: 21.6 lung: 2.0 KCNN1 hSK1, KCa2.1 ENSG00000105642 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 1 19 17951293-18000080 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA065938 Approved Actin filaments
Cytosol Tissue enriched 10 cerebral cortex: 21.5 testis: 2.0 KCTD4 bA321C24.3 ENSG00000180332 Potassium channel tetramerization domain containing 4 13 45192853-45194717 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA040734 Uncertain Approved Microtubule organizing center Group enriched 10 cerebral cortex: 17.7;skin: 3.7 gallbladder: 1.1 LRRTM2 KIAA0416 ENSG00000146006 Leucine rich repeat transmembrane neuronal 2 5 138868923-138875368 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 10 cerebral cortex: 29.1 placenta: 3.0 MC4R ENSG00000166603 Melanocortin 4 receptor 18 60371110-60372775 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA016719 Uncertain Group enriched 10 cerebral cortex: 3.0;fallopian tube: 5.0 epididymis: 0.4 MCF2 ARHGEF21, DBL ENSG00000101977 MCF.2 cell line derived transforming sequence X 139581770-139708227 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 10 adrenal gland: 38.5;cerebral cortex: 8.7;epididymis: 14.7;ovary: 12.8;seminal vesicle: 23.7;testis: 34.4 prostate: 2.1 NEFL CMT1F, CMT2E, NF68, NFL, PPP1R110 ENSG00000277586 Neurofilament, light polypeptide 8 24950955-24957110 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014850, HPA015021 Supported Supported Approved Nuclear speckles
Intermediate filaments Tissue enriched 10 cerebral cortex: 282.9 adrenal gland: 27.5 PCDHA5 CNR6, CNRN6, CNRS6, CRNR6, PCDH-ALPHA5 ENSG00000204965 Protocadherin alpha 5 5 140821604-141012344 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044557 Approved Tissue enriched 10 cerebral cortex: 4.1 endometrium: 0.4 PLPPR4 KIAA0455, LPPR4, PHP1, PRG-1 ENSG00000117600 Phospholipid phosphatase related 4 1 99263953-99309590 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 10 cerebral cortex: 88.9 testis: 8.9 PRR18 MGC35308 ENSG00000176381 Proline rich 18 6 166305300-166308448 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 10 cerebral cortex: 32.7 fallopian tube: 3.4 PRR36 ENSG00000183248 Proline rich 36 19 7868719-7874379 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062741 Uncertain Approved Nucleus
Golgi apparatus Tissue enriched 10 cerebral cortex: 18.0 prostate: 1.7 SERPINI1 neuroserpin, PI12 ENSG00000163536 Serpin peptidase inhibitor, clade I (neuroserpin), member 1 3 167735243-167825568 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001565, CAB026059, HPA056092 Supported Approved Cytosol Tissue enriched 10 cerebral cortex: 323.2 kidney: 31.1 SH3GL2 CNSA2, EEN-B1, SH3D2A, SH3P4 ENSG00000107295 SH3-domain GRB2-like 2 9 17579082-17797129 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010056, HPA026685, HPA063573 Supported Supported Approved Microtubules
Cytokinetic bridge Tissue enriched 10 cerebral cortex: 170.6 kidney: 17.3 SLC6A17 ENSG00000197106 Solute carrier family 6 (neutral amino acid transporter), member 17 1 110150486-110202202 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007663, HPA008044 Approved Approved Nucleus
Golgi apparatus Tissue enriched 10 cerebral cortex: 75.6 adrenal gland: 7.9 SLCO1C1 OATP-F, OATP1, OATP1C1, SLC21A14 ENSG00000139155 Solute carrier organic anion transporter family, member 1C1 12 20695355-20753386 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 10 cerebral cortex: 27.6 testis: 2.6 SRRM3 FLJ37078 ENSG00000177679 Serine/arginine repetitive matrix 3 7 76201900-76287288 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA019337 Uncertain Approved Plasma membrane
Intermediate filaments
Microtubules Group enriched 10 adrenal gland: 2.7;cerebral cortex: 8.5;testis: 1.8 stomach: 0.4 SYT3 ENSG00000213023 Synaptotagmin III 19 50621307-50668394 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 10 cerebral cortex: 17.1 testis: 1.7 SYT5 ENSG00000129990 Synaptotagmin V 19 55171199-55180441 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 10 cerebral cortex: 131.7 adrenal gland: 12.8 TMEM151B bA444E17.5, C6orf137, TMEM193 ENSG00000178233 Transmembrane protein 151B 6 44270466-44307506 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055167 Uncertain Tissue enriched 10 cerebral cortex: 40.1 adrenal gland: 4.0 TMEM257 CXorf1 ENSG00000221870 Transmembrane protein 257 X 145827410-145829850 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 10 cerebral cortex: 4.2 seminal vesicle: 0.4 TMOD2 NTMOD ENSG00000128872 Tropomodulin 2 (neuronal) 15 51751561-51816368 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041365 Supported Approved Nucleus
Nucleoli fibrillar center Tissue enriched 10 cerebral cortex: 111.3 seminal vesicle: 11.6 TPPP p25, p25alpha, TPPP/p25, TPPP1 ENSG00000171368 Tubulin polymerization promoting protein 5 659862-693395 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036575, HPA036576 Supported Supported Mitochondria
Cytosol Tissue enriched 10 cerebral cortex: 167.1 fallopian tube: 16.8 XKR7 C20orf159, dJ310O13.4 ENSG00000260903 XK, Kell blood group complex subunit-related family, member 7 20 31968002-32003387 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA040854 Uncertain Tissue enriched 10 cerebral cortex: 3.6 testis: 0.3 ADGRB1 BAI1 ENSG00000181790 Adhesion G protein-coupled receptor B1 8 142449430-142545009 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 9 cerebral cortex: 22.0 spleen: 2.3 AK5 ENSG00000154027 Adenylate kinase 5 1 77282051-77559969 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019128, HPA057255 Supported Supported Microtubule organizing center
Cytosol Tissue enriched 9 cerebral cortex: 221.4 breast: 23.3 AMER3 FAM123C, FLJ38377 ENSG00000178171 APC membrane recruitment protein 3 2 130755435-130768134 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045593, HPA054230 Uncertain Approved Nucleoplasm
Nuclear bodies
Cytosol Tissue enriched 9 cerebral cortex: 7.0 adrenal gland: 0.8 AMPH ENSG00000078053 Amphiphysin 7 38383704-38631567 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008559, HPA019828, HPA019829 Supported Supported Plasma membrane
Cytosol Tissue enriched 9 cerebral cortex: 84.0 cervix: 8.9 ATP1B2 AMOG ENSG00000129244 ATPase, Na+/K+ transporting, beta 2 polypeptide 17 7646627-7657768 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010698 Supported Tissue enriched 9 cerebral cortex: 340.3 ovary: 36.6 BRINP2 DBCCR1L2, FAM5B ENSG00000198797 Bone morphogenetic protein/retinoic acid inducible neural-specific 2 1 177171497-177282422 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA050681, HPA061920 Uncertain Approved Nucleoli
Vesicles Group enriched 9 adrenal gland: 11.5;cerebral cortex: 35.5 testis: 2.4 CAMK2A CAMKA, CaMKIINalpha, KIAA0968 ENSG00000070808 Calcium/calmodulin-dependent protein kinase II alpha 5 150219491-150290291 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004330, HPA051783, HPA051785, HPA053973 Supported Supported Plasma membrane
Cell Junctions Tissue enriched 9 cerebral cortex: 284.4 skeletal muscle: 33.3 CARNS1 ATPGD1, KIAA1394 ENSG00000172508 Carnosine synthase 1 11 67414968-67425607 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038569 Approved Group enriched 9 cerebral cortex: 37.2;skeletal muscle: 25.9 heart muscle: 3.4 CELF4 BRUNOL4 ENSG00000101489 CUGBP, Elav-like family member 4 18 37243047-37566037 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037986 Approved Tissue enriched 9 cerebral cortex: 127.3 adrenal gland: 14.7 CLEC2L FLJ32986 ENSG00000236279 C-type lectin domain family 2, member L 7 139523856-139544984 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence Evidence at protein level HPA045050 Supported Group enriched 9 cerebral cortex: 21.0;parathyroid gland: 13.4 endometrium: 1.9 CNKSR2 CNK2, KIAA0902, KSR2 ENSG00000149970 Connector enhancer of kinase suppressor of Ras 2 X 21374418-21654695 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001502 Approved Golgi apparatus
Plasma membrane Tissue enriched 9 cerebral cortex: 54.1 adrenal gland: 5.8 CRHR1 ENSG00000263715 Corticotropin releasing hormone receptor 1 17 45620344-45835826 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enriched 9 cerebral cortex: 1.1 fallopian tube: 0.1 DIRAS2 Di-Ras2, DKFZp761C07121 ENSG00000165023 DIRAS family, GTP-binding RAS-like 2 9 90609832-90643104 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043758 Uncertain Tissue enriched 9 cerebral cortex: 124.9 cervix: 13.6 DOC2A ENSG00000149927 Double C2-like domains, alpha 16 30005509-30023270 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065676 Uncertain Nucleus
Nucleoli
Cell Junctions Group enriched 9 cerebral cortex: 69.9;testis: 21.0 ovary: 5.2 FAM131B KIAA0773 ENSG00000159784 Family with sequence similarity 131, member B 7 143353400-143362770 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021371, HPA029992 Validated Nucleoplasm
Cytosol Tissue enriched 9 cerebral cortex: 64.0 parathyroid gland: 7.4 GABRG2 ENSG00000113327 Gamma-aminobutyric acid (GABA) A receptor, gamma 2 5 162067540-162155536 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 9 cerebral cortex: 74.3 adrenal gland: 8.2 GNAO1 G-ALPHA-o ENSG00000087258 Guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O 16 56191390-56357444 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008387, HPA040878 Supported Tissue enriched 9 cerebral cortex: 324.2 seminal vesicle: 36.8 GRM5 GPRC1E, mGlu5, MGLUR5, PPP1R86 ENSG00000168959 Glutamate receptor, metabotropic 5 11 88504576-89065945 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 9 cerebral cortex: 27.3 testis: 3.1 HRK DP5 ENSG00000135116 Harakiri, BCL2 interacting protein 12 116856144-116881441 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB025973 Uncertain Group enriched 9 cerebral cortex: 13.4;thyroid gland: 6.4 testis: 1.1 LHFPL4 ENSG00000156959 Lipoma HMGIC fusion partner-like 4 3 9498361-9553802 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041421 Uncertain Approved Nucleus
Golgi apparatus Tissue enriched 9 cerebral cortex: 23.1 adrenal gland: 2.6 MAP1A MAP1L ENSG00000166963 Microtubule-associated protein 1A 15 43510958-43531620 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039063, HPA039064, HPA066488 Supported Approved Cytosol Tissue enriched 9 cerebral cortex: 166.1 smooth muscle: 18.7 MPPED1 239AB, C22orf1, FAM1A ENSG00000186732 Metallophosphoesterase domain containing 1 22 43411196-43507848 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 9 cerebral cortex: 39.5 liver: 4.2 NAPB SNAP-BETA, SNAPB ENSG00000125814 N-ethylmaleimide-sensitive factor attachment protein, beta 20 23374519-23421519 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037225, CAB037227, HPA046149, HPA050196 Approved Uncertain Cytosol Tissue enriched 9 cerebral cortex: 304.1 adrenal gland: 32.3 NXPH2 NPH2 ENSG00000144227 Neurexophilin 2 2 138670772-138780348 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034759 Approved Group enriched 9 cerebral cortex: 5.7;kidney: 5.0;ovary: 13.9 endometrium: 0.9 OLFM1 AMY, NOE1, NOELIN, OlfA ENSG00000130558 Olfactomedin 1 9 135075243-135121179 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057444 Uncertain Approved Nucleus
Nucleoli
Cytosol Tissue enriched 9 cerebral cortex: 732.4 epididymis: 85.0 OPCML IGLON1, OBCAM, OPCM ENSG00000183715 Opioid binding protein/cell adhesion molecule-like 11 132414977-133532519 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 9 cerebral cortex: 63.2 parathyroid gland: 7.4 PAQR6 FLJ22672, PRdelta ENSG00000160781 Progestin and adipoQ receptor family member VI 1 156243321-156248117 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA073505 Approved Nucleus
Nucleoli Tissue enriched 9 cerebral cortex: 97.8 skin: 10.8 PDZD4 FLJ34125, KIAA1444, LU1, PDZK4, PDZRN4L ENSG00000067840 PDZ domain containing 4 X 153802166-153830565 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003878 Approved Tissue enriched 9 cerebral cortex: 123.9 seminal vesicle: 13.6 PEX5L PEX5R, PXR2, TRIP8b ENSG00000114757 Peroxisomal biogenesis factor 5-like 3 179794958-180037053 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058026 Approved Group enriched 9 cerebral cortex: 67.7;parathyroid gland: 93.0 testis: 8.8 PGM2L1 BM32A, FLJ32029 ENSG00000165434 Phosphoglucomutase 2-like 1 11 74330318-74398473 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA056995, HPA060948 Supported Approved Mitochondria Tissue enriched 9 cerebral cortex: 64.3 endometrium: 7.3 PHACTR3 C20orf101, PPP1R123 ENSG00000087495 Phosphatase and actin regulator 3 20 59577509-59847711 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051834, HPA054847 Validated Nucleoplasm Tissue enriched 9 cerebral cortex: 65.0 spleen: 7.5 PRKAR1B ENSG00000188191 Protein kinase, cAMP-dependent, regulatory, type I, beta 7 549197-727650 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026719 Approved Tissue enriched 9 cerebral cortex: 239.8 ovary: 26.4 PRKCG MGC57564, PKCC, PKCG, SCA14 ENSG00000126583 Protein kinase C, gamma 19 53879190-53907652 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013051, HPA047870, HPA054560 Supported Tissue enriched 9 cerebral cortex: 41.1 testis: 4.7 PTPRZ1 phosphacan, PTP18, PTPRZ, PTPZ, RPTPB ENSG00000106278 Protein tyrosine phosphatase, receptor-type, Z polypeptide 1 7 121873089-122062036 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015103, CAB025106 Supported Approved Vesicles Tissue enriched 9 cerebral cortex: 258.6 skin: 30.2 RLBP1 CRALBP ENSG00000140522 Retinaldehyde binding protein 1 15 89209869-89221751 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042051, HPA044083 Approved Approved Nucleoplasm
Centrosome
Cytosol Tissue enriched 9 cerebral cortex: 6.2 testis: 0.6 RTP5 C2orf85, CXXC11, FLJ33590, Z3CXXC5 ENSG00000188011 Receptor (chemosensory) transporter protein 5 (putative) 2 241869600-241873823 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA050902 Uncertain Tissue enriched 9 cerebral cortex: 5.3 lymph node: 0.5 RUNDC3A RAP2IP, RPIP8 ENSG00000108309 RUN domain containing 3A 17 44308413-44318671 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023548 Uncertain Approved Vesicles Tissue enriched 9 cerebral cortex: 191.3 adrenal gland: 21.4 S100B S100beta ENSG00000160307 S100 calcium binding protein B 21 46598962-46605208 Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000073, HPA015768, CAB078196 Supported Approved Nucleus
Vesicles Group enriched 9 adipose tissue: 208.2;cerebral cortex: 628.0 seminal vesicle: 49.1 SMIM18 ENSG00000253457 Small integral membrane protein 18 8 30638600-30646064 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence Evidence at protein level HPA066648 Supported Uncertain Nucleus
Centrosome Tissue enriched 9 cerebral cortex: 11.1 adrenal gland: 1.3 SRRM4 KIAA1853, nSR100 ENSG00000139767 Serine/arginine repetitive matrix 4 12 118981495-119163051 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052783 Uncertain Tissue enriched 9 cerebral cortex: 13.5 adrenal gland: 1.5 TMEM130 DKFZp761L1417, FLJ42643 ENSG00000166448 Transmembrane protein 130 7 98846488-98870771 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA012928 Uncertain Supported Golgi apparatus Group enriched 9 adrenal gland: 49.3;cerebral cortex: 183.7;testis: 70.8 epididymis: 11.5 TMEM132D KIAA1944, MOLT, PPP1R153 ENSG00000151952 Transmembrane protein 132D 12 129071725-129903666 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA010739 Approved Tissue enriched 9 cerebral cortex: 12.8 testis: 1.4 TUBB2A dJ40E16.7, TUBB, TUBB2 ENSG00000137267 Tubulin, beta 2A class IIa 6 3153669-3157526 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015339, HPA043640, HPA046280 Supported Validated Microtubules Tissue enriched 9 cerebral cortex: 624.8 skin: 72.1 ZFR2 KIAA1086 ENSG00000105278 Zinc finger RNA binding protein 2 19 3804024-3869032 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043275, HPA055678 Uncertain Uncertain Nucleoplasm Group enriched 9 adrenal gland: 3.8;cerebral cortex: 12.7;testis: 19.0 fallopian tube: 1.3 ZIC1 ZIC, ZNF201 ENSG00000152977 Zic family member 1 3 147393422-147510293 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA004098 Supported Supported Nucleoplasm Tissue enriched 9 cerebral cortex: 23.8 skin: 2.5 ADCY8 AC8, ADCY3, HBAC1 ENSG00000155897 Adenylate cyclase 8 (brain) 8 130780301-131042426 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018652, HPA024291 Supported Group enriched 8 cerebral cortex: 12.9;epididymis: 27.3;fallopian tube: 6.2 seminal vesicle: 1.9 ANKS1B AIDA-1, ANKS2, cajalin-2, EB-1 ENSG00000185046 Ankyrin repeat and sterile alpha motif domain containing 1B 12 98726457-99984654 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044628 Approved Vesicles
Plasma membrane
Cytosol Tissue enriched 8 cerebral cortex: 112.3 testis: 14.0 ARNT2 bHLHe1, KIAA0307 ENSG00000172379 Aryl-hydrocarbon receptor nuclear translocator 2 15 80404350-80597937 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001056, CAB005081 Approved Approved Nucleus
Mitochondria Tissue enriched 8 cerebral cortex: 154.5 testis: 19.3 ASCL1 ASH1, bHLHa46, HASH1 ENSG00000139352 Achaete-scute family bHLH transcription factor 1 12 102957686-102960516 Predicted secreted proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA029217 Supported Group enriched 8 cerebral cortex: 16.3;liver: 6.5 adrenal gland: 1.4 ASIC4 ACCN4, BNAC4 ENSG00000072182 Acid sensing (proton gated) ion channel family member 4 2 219514170-219538772 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA036042 Approved Golgi apparatus Tissue enriched 8 cerebral cortex: 10.6 adrenal gland: 1.3 ATP2B3 CFAP39, CLA2, PMCA3, SCAX1 ENSG00000067842 ATPase, Ca++ transporting, plasma membrane 3 X 153517676-153582939 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001583 Supported Uncertain Golgi apparatus
Plasma membrane Group enriched 8 adrenal gland: 12.2;cerebral cortex: 19.1 fallopian tube: 2.0 BRINP1 DBC1, DBCCR1, FAM5A ENSG00000078725 Bone morphogenetic protein/retinoic acid inducible neural-specific 1 9 119153458-119369467 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038828 Approved Approved Microtubules Tissue enriched 8 cerebral cortex: 59.7 seminal vesicle: 7.1 CACNA1B CACNL1A5, CACNN, Cav2.2 ENSG00000148408 Calcium channel, voltage-dependent, N type, alpha 1B subunit 9 137877789-138124624 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044347 Uncertain Group enriched 8 adrenal gland: 3.7;cerebral cortex: 14.9;fallopian tube: 4.8;testis: 7.6 prostate: 1.0 CDH8 ENSG00000150394 Cadherin 8, type 2 16 61647242-62037035 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014908, HPA058444 Approved Supported Plasma membrane Group enriched 8 cerebral cortex: 27.9;seminal vesicle: 6.9 ovary: 2.1 CTXN2 ENSG00000233932 Cortexin 2 15 48191539-48203756 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA053168 Uncertain Group enriched 8 cerebral cortex: 1.9;testis: 1.5 fallopian tube: 0.2 DACH2 ENSG00000126733 Dachshund family transcription factor 2 X 86148458-86832604 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA000258 Uncertain Group enriched 8 cerebral cortex: 11.9;epididymis: 4.4;fallopian tube: 5.0 kidney: 0.8 DDX25 GRTH ENSG00000109832 DEAD (Asp-Glu-Ala-Asp) box helicase 25 11 125903376-125928829 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020137 Supported Group enriched 8 cerebral cortex: 10.0;testis: 22.3 fallopian tube: 2.1 DPYSL5 CRAM, CRMP-5, CRMP5, Ulip6 ENSG00000157851 Dihydropyrimidinase-like 5 2 26847747-26950351 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA034544, HPA072387 Supported Approved Nucleoplasm
Cytosol Group enriched 8 cerebral cortex: 31.4;testis: 10.0 adrenal gland: 2.5 ELAVL4 HUD, PNEM ENSG00000162374 ELAV like neuron-specific RNA binding protein 4 1 50048014-50203786 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004442 Supported Group enriched 8 adrenal gland: 10.8;cerebral cortex: 53.5;testis: 10.8 appendix: 2.9 ETNPPL AGXT2L1 ENSG00000164089 Ethanolamine-phosphate phospho-lyase 4 108742040-108763054 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044546, HPA072938 Approved Approved Nucleus Group enriched 8 cerebral cortex: 141.6;liver: 98.5 stomach: 14.7 FGFBP3 C10orf13, MGC39320 ENSG00000174721 Fibroblast growth factor binding protein 3 10 91906589-91909483 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053943 Uncertain Tissue enriched 8 cerebral cortex: 19.6 thyroid gland: 2.5 GRIA2 GluA2, GLUR2, GLURB ENSG00000120251 Glutamate receptor, ionotropic, AMPA 2 4 157204182-157366075 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006830, CAB007812, HPA008441, CAB012981 Supported Tissue enriched 8 cerebral cortex: 207.2 endometrium: 27.2 HBQ1 HBQ ENSG00000086506 Hemoglobin, theta 1 16 180453-181181 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062473 Supported Approved Lipid droplets Group enriched 8 bone marrow: 14.7;cerebral cortex: 3.0 placenta: 1.1 HTR2A 5-HT2A, HTR2 ENSG00000102468 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13 46831550-46897076 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014011 Supported Tissue enriched 8 cerebral cortex: 32.3 smooth muscle: 3.8 KCNC1 Kv3.1 ENSG00000129159 Potassium channel, voltage gated Shaw related subfamily C, member 1 11 17734812-17783055 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047634, HPA048249 Supported Approved Nucleus
Nuclear membrane
Vesicles
Cytosol Tissue enriched 8 cerebral cortex: 16.5 testis: 1.9 KCNMB4 ENSG00000135643 Potassium channel subfamily M regulatory beta subunit 4 12 70366276-70434292 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA072287 Approved Cytosol Group enriched 8 adrenal gland: 19.6;cerebral cortex: 38.2 placenta: 3.7 MAPK8IP2 IB2, JIP2, PRKM8IPL ENSG00000008735 Mitogen-activated protein kinase 8 interacting protein 2 22 50600685-50613981 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034780 Uncertain Tissue enriched 8 cerebral cortex: 78.5 adrenal gland: 10.1 MAPT DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau ENSG00000186868 Microtubule-associated protein tau 17 45894382-46028334 Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000151, HPA048895, HPA069524, HPA069570 Supported Supported Nuclear speckles
Plasma membrane Tissue enriched 8 cerebral cortex: 116.6 skeletal muscle: 13.7 MCF2L2 ARHGEF22, KIAA0861 ENSG00000053524 MCF.2 cell line derived transforming sequence-like 2 3 183178043-183428778 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038946, HPA038947 Uncertain Approved Plasma membrane
Cytosol Group enriched 8 adrenal gland: 10.3;cerebral cortex: 17.1;parathyroid gland: 7.4;spleen: 3.5;testis: 4.6 prostate: 1.0 MLC1 KIAA0027, LVM, MLC, VL ENSG00000100427 Megalencephalic leukoencephalopathy with subcortical cysts 1 22 50059391-50085902 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003040, HPA067533 Supported Tissue enriched 8 cerebral cortex: 181.4 bone marrow: 23.1 MOBP ENSG00000168314 Myelin-associated oligodendrocyte basic protein 3 39467198-39529479 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035152 Supported Tissue enriched 8 cerebral cortex: 176.4 parathyroid gland: 21.9 NAT16 C7orf52, FLJ39237 ENSG00000167011 N-acetyltransferase 16 (GCN5-related, putative) 7 101170493-101180276 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA021918 Uncertain Uncertain Nucleus Group enriched 8 cerebral cortex: 5.1;thyroid gland: 3.0 pancreas: 0.5 NIM1K MGC42105, NIM1 ENSG00000177453 NIM1 serine/threonine protein kinase 5 43192071-43280850 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA007695 Uncertain Approved Cytosol Tissue enriched 8 cerebral cortex: 16.4 lung: 2.0 NRXN2 ENSG00000110076 Neurexin 2 11 64606174-64723188 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051470 Approved Nucleus
Nuclear membrane
Cytosol Tissue enriched 8 cerebral cortex: 143.0 testis: 17.0 PCDH8 ARCADLIN, PAPC ENSG00000136099 Protocadherin 8 13 52842889-52848641 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA010509 Uncertain Tissue enriched 8 cerebral cortex: 5.7 testis: 0.7 PRMT8 HRMT1L3, HRMT1L4 ENSG00000111218 Protein arginine methyltransferase 8 12 3381349-3593973 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039747, HPA069769 Approved Tissue enriched 8 cerebral cortex: 20.0 testis: 2.4 PRRT1 C6orf31, IFITMD7, NG5 ENSG00000204314 Proline-rich transmembrane protein 1 6 32148359-32154373 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055149 Approved Tissue enriched 8 cerebral cortex: 4.5 ovary: 0.6 RASGEF1C FLJ35841 ENSG00000146090 RasGEF domain family, member 1C 5 180100791-180209153 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028242 Uncertain Approved Mitochondria Group enriched 8 cerebral cortex: 16.5;testis: 6.1 seminal vesicle: 1.3 RGS7 ENSG00000182901 Regulator of G-protein signaling 7 1 240775514-241357230 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000688, CAB017561 Supported Approved Nucleus Group enriched 8 adrenal gland: 10.8;cerebral cortex: 47.0;testis: 13.4 stomach: 2.9 RIPPLY2 C6orf159, dJ237I15.1 ENSG00000203877 Ripply transcriptional repressor 2 6 83853266-83857515 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA047454 Uncertain Tissue enriched 8 cerebral cortex: 14.9 adrenal gland: 1.8 RS1 RS, XLRS1 ENSG00000102104 Retinoschisin 1 X 18639910-18672109 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059546 Supported Group enriched 8 cerebral cortex: 1.1;lung: 1.7 thyroid gland: 0.1 RTN1 NSP ENSG00000139970 Reticulon 1 14 59595976-59870966 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002745, HPA040945, HPA044249 Supported Validated Endoplasmic reticulum Tissue enriched 8 cerebral cortex: 412.9 parathyroid gland: 48.8 SLC12A5 KCC2, KIAA1176 ENSG00000124140 Solute carrier family 12 (potassium/chloride transporter), member 5 20 46021690-46060152 FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA072058 Supported Tissue enriched 8 cerebral cortex: 94.5 adrenal gland: 12.0 SLC7A14 KIAA1613, PPP1R142 ENSG00000013293 Solute carrier family 7, member 14 3 170459584-170586074 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045929 Approved Tissue enriched 8 cerebral cortex: 26.8 adrenal gland: 3.1 SOX1 ENSG00000182968 SRY (sex determining region Y)-box 1 13 112067647-112070488 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 cerebral cortex: 3.6;testis: 1.5 skin: 0.3 SOX2 ENSG00000181449 SRY (sex determining region Y)-box 2 3 181711924-181714436 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010648, HPA045725 Approved Supported Nucleoplasm Tissue enriched 8 cerebral cortex: 118.3 esophagus: 14.9 SPRN bA108K14.1, FLJ41197, Shadoo, Sprn ENSG00000203772 Shadow of prion protein homolog (zebrafish) 10 133420666-133424572 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 8 cerebral cortex: 24.9 testis: 3.0 STXBP1 hUNC18, MUNC18-1, rbSec1, UNC18 ENSG00000136854 Syntaxin binding protein 1 9 127611760-127692936 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008209, HPA023483, CAB034434 Supported Approved Nucleoplasm
Cytosol Tissue enriched 8 cerebral cortex: 401.8 fallopian tube: 51.7 TAGLN3 NP22, NP25 ENSG00000144834 Transgelin 3 3 111998664-112013887 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062620 Supported Tissue enriched 8 cerebral cortex: 357.2 adrenal gland: 42.7 TMEM179 C14orf90, FLJ42486, TMEM179A ENSG00000258986 Transmembrane protein 179 14 104474678-104605647 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA002942 Uncertain Mitochondria Group enriched 8 adrenal gland: 14.7;cerebral cortex: 28.0 testis: 2.5 ZMAT4 FLJ13842 ENSG00000165061 Zinc finger, matrin-type 4 8 40530590-40897833 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069813, HPA071585 Supported Supported Nucleus
Nucleoli Group enriched 8 cerebral cortex: 10.1;thyroid gland: 27.5 testis: 2.3 AGAP2 CENTG1 ENSG00000135439 ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 12 57723761-57742157 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023474 Approved Supported Nucleus
Nucleoli
Mitochondria Tissue enriched 7 cerebral cortex: 145.0 lymph node: 20.1 ALDOC ENSG00000109107 Aldolase C, fructose-bisphosphate 17 28573115-28577264 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003282, CAB020828, HPA067442 Supported Supported Approved Nucleus
Nucleoli fibrillar center
Vesicles
Cytosol Tissue enriched 7 cerebral cortex: 768.7 heart muscle: 110.6 ARC Arg3.1, KIAA0278 ENSG00000198576 Activity-regulated cytoskeleton-associated protein 8 142611044-142614472 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056430 Approved Vesicles
Microtubules Group enriched 7 adipose tissue: 14.1;adrenal gland: 13.4;cerebral cortex: 14.4;gallbladder: 3.3;seminal vesicle: 5.5 placenta: 1.4 ASPDH ENSG00000204653 Aspartate dehydrogenase domain containing 19 50511600-50514690 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042631, HPA042654 Approved Group enriched 7 cerebral cortex: 17.9;duodenum: 7.1;kidney: 27.9;liver: 34.6 adrenal gland: 3.3 ATP2B2 PMCA2 ENSG00000157087 ATPase, Ca++ transporting, plasma membrane 2 3 10324023-10708031 Enzymes, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005606 Supported Tissue enriched 7 cerebral cortex: 63.0 salivary gland: 9.2 B4GALNT1 beta1-4GalNAc-T, GALGT, SPG26 ENSG00000135454 Beta-1,4-N-acetyl-galactosaminyl transferase 1 12 57623410-57633355 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008968, HPA015128 Supported Tissue enriched 7 cerebral cortex: 26.3 seminal vesicle: 3.7 BIN1 AMPH2, AMPHL, SH3P9 ENSG00000136717 Bridging integrator 1 2 127048027-127107355 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001945, HPA003894, HPA005437 Supported Supported Cytosol Group enriched 7 cerebral cortex: 156.9;skeletal muscle: 724.3 adrenal gland: 61.7 C9orf129 bA165J3.3 ENSG00000204352 Chromosome 9 open reading frame 129 9 93318199-93346414 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA071515 Uncertain Mitochondria Group enriched 7 cerebral cortex: 4.1;testis: 1.7 epididymis: 0.4 CABP1 ENSG00000157782 Calcium binding protein 1 12 120640552-120667324 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051438 Uncertain Tissue enriched 7 cerebral cortex: 77.6 adipose tissue: 11.2 CACNA1E BII, CACH6, CACNL1A6, Cav2.3 ENSG00000198216 Calcium channel, voltage-dependent, R type, alpha 1E subunit 1 181413102-181808084 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042515 Approved Plasma membrane
Actin filaments
Cytosol Tissue enriched 7 cerebral cortex: 10.3 adrenal gland: 1.3 CADPS CAPS, CAPS1, KIAA1121 ENSG00000163618 Ca++-dependent secretion activator 3 62398346-62875389 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059328 Supported Approved Vesicles Group enriched 7 adrenal gland: 21.7;cerebral cortex: 94.3 heart muscle: 8.4 CBLN2 ENSG00000141668 Cerebellin 2 precursor 18 72536680-72638521 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056335 Uncertain Endoplasmic reticulum Group enriched 7 cerebral cortex: 30.3;seminal vesicle: 7.2 small intestine: 2.8 CDK5R1 Nck5a, p35nck5a ENSG00000176749 Cyclin-dependent kinase 5, regulatory subunit 1 (p35) 17 32486619-32491256 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000252 Supported Nucleoplasm
Vesicles Tissue enriched 7 cerebral cortex: 98.7 lymph node: 14.9 CECR6 ENSG00000183307 Cat eye syndrome chromosome region, candidate 6 22 17116299-17121367 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA068790 Approved Nucleoplasm
Vesicles
Plasma membrane Group enriched 7 cerebral cortex: 15.0;prostate: 10.9 testis: 1.9 CELF5 BRUNOL5 ENSG00000161082 CUGBP, Elav-like family member 5 19 3224703-3297076 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA042012, HPA060336 Supported Tissue enriched 7 cerebral cortex: 38.2 ovary: 5.1 CHD5 ENSG00000116254 Chromodomain helicase DNA binding protein 5 1 6101793-6180123 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015809, HPA055477 Supported Supported Nucleoplasm
Nuclear speckles
Cytosol Tissue enriched 7 cerebral cortex: 42.2 testis: 6.1 CHN1 ARHGAP2, CHN, DURS2, n-chimerin, RhoGAP2 ENSG00000128656 Chimerin 1 2 174799363-175005369 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036111 Approved Cytosol Group enriched 7 cerebral cortex: 640.9;parathyroid gland: 131.0 placenta: 55.5 COL20A1 KIAA1510 ENSG00000101203 Collagen, type XX, alpha 1 20 63293186-63334851 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051962 Uncertain Tissue enriched 7 cerebral cortex: 16.2 testis: 2.3 CSMD3 ENSG00000164796 CUB and Sushi multiple domains 3 8 112222928-113437099 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029007 Uncertain Group enriched 7 cerebral cortex: 4.9;testis: 1.8 spleen: 0.4 DNER bet, UNQ26 ENSG00000187957 Delta/notch-like EGF repeat containing 2 229357629-229714558 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017320 Approved Group enriched 7 adrenal gland: 74.9;cerebral cortex: 176.5 salivary gland: 17.4 DPP10 DPRP3 ENSG00000175497 Dipeptidyl-peptidase 10 (non-functional) 2 114442299-115845752 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048767 Uncertain Approved Nucleus
Vesicles
Cytosol Group enriched 7 adrenal gland: 14.2;cerebral cortex: 34.8 pancreas: 3.6 ELFN2 dJ63G5.3, KIAA1904, LRRC62, PPP1R29 ENSG00000166897 Extracellular leucine-rich repeat and fibronectin type III domain containing 2 22 37367960-37427470 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000781 Approved Approved Nucleoplasm
Vesicles Tissue enriched 7 cerebral cortex: 24.3 testis: 3.7 ENO2 ENSG00000111674 Enolase 2 (gamma, neuronal) 12 6913745-6923698 Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000063, HPA068284, CAB073539 Supported Approved Nucleus
Plasma membrane
Cytosol Tissue enriched 7 cerebral cortex: 432.2 parathyroid gland: 64.5 FAIM2 KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2 ENSG00000135472 Fas apoptotic inhibitory molecule 2 12 49866896-49904217 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018790, HPA048800 Supported Approved Intermediate filaments Tissue enriched 7 cerebral cortex: 370.8 adrenal gland: 56.0 FAM135B C8ORFK32 ENSG00000147724 Family with sequence similarity 135, member B 8 138130023-138496822 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA023911, HPA023950, HPA024815 Uncertain Approved Nucleoplasm
Nuclear membrane Group enriched 7 adrenal gland: 3.6;cerebral cortex: 8.3;testis: 7.2 colon: 0.8 FAM216A C12orf24, HSU79274 ENSG00000204856 Family with sequence similarity 216, member A 12 110468364-110490385 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038286 Approved Approved Actin filaments Group enriched 7 cerebral cortex: 16.2;testis: 60.9 appendix: 5.7 GABRA3 ENSG00000011677 Gamma-aminobutyric acid (GABA) A receptor, alpha 3 X 152166234-152451358 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA000839 Approved Supported Tissue enriched 7 cerebral cortex: 28.9 placenta: 4.1 GALNT8 GALNAC-T8 ENSG00000130035 Polypeptide N-acetylgalactosaminyltransferase 8 12 4720341-4851927 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA012638, HPA014418, HPA073461 Approved Approved Vesicles Group enriched 7 cerebral cortex: 19.5;colon: 18.0;duodenum: 8.4;rectum: 41.3;small intestine: 19.3;testis: 26.3 appendix: 3.3 GALNT9 GALNAC-T9 ENSG00000182870 Polypeptide N-acetylgalactosaminyltransferase 9 12 132196372-132329349 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA075016 Approved Vesicles Group enriched 7 cerebral cortex: 29.5;epididymis: 7.8;thyroid gland: 6.4 kidney: 1.9 GDF1 ENSG00000130283 Growth differentiation factor 1 19 18868545-18896096 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 7 cerebral cortex: 12.3 testis: 1.7 GOLGA7B bA451M19.3, bA459F3.4, C10orf132, C10orf133 ENSG00000155265 Golgin A7 family, member B 10 97850239-97871580 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA046878 Uncertain Group enriched 7 cerebral cortex: 18.4;epididymis: 28.1;skin: 17.4 adrenal gland: 3.1 GPR52 ENSG00000203737 G protein-coupled receptor 52 1 174448111-174449198 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028575 Uncertain Tissue enriched 7 cerebral cortex: 2.7 bone marrow: 0.3 GPRIN1 GRIN1, KIAA1893 ENSG00000169258 G protein regulated inducer of neurite outgrowth 1 5 176595802-176610133 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA036478, HPA070892 Supported Supported Vesicles
Plasma membrane Tissue enriched 7 cerebral cortex: 27.9 duodenum: 3.9 HAPLN4 BRAL2, KIAA1926 ENSG00000187664 Hyaluronan and proteoglycan link protein 4 19 19255641-19262796 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055856 Approved Group enriched 7 cerebral cortex: 8.5;duodenum: 15.7;small intestine: 21.7 cervix: 2.1 HCN1 BCNG-1, BCNG1, HAC-2 ENSG00000164588 Hyperpolarization activated cyclic nucleotide gated potassium channel 1 5 45254950-45696498 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019195 Supported Tissue enriched 7 cerebral cortex: 11.5 heart muscle: 1.7 HCN2 BCNG-2, BCNG2, HAC-1 ENSG00000099822 Hyperpolarization activated cyclic nucleotide gated potassium channel 2 19 589893-617159 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 cerebral cortex: 38.5;heart muscle: 8.1 testis: 3.4 HMP19 ENSG00000170091 HMP19 protein 5 174045604-174243501 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA056191 Supported Approved Golgi apparatus Tissue enriched 7 cerebral cortex: 289.3 adrenal gland: 42.2 HS3ST4 3OST4 ENSG00000182601 Heparan sulfate (glucosamine) 3-O-sulfotransferase 4 16 25692026-26137688 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 7 cerebral cortex: 18.7 breast: 2.7 IGLON5 LOC402665 ENSG00000142549 IgLON family member 5 19 51311848-51330354 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041994 Approved Uncertain Nucleus Group enriched 7 adrenal gland: 2.3;cerebral cortex: 11.1;testis: 9.5 seminal vesicle: 1.1 KCNIP2 KCHIP2 ENSG00000120049 Kv channel interacting protein 2 10 101825974-101843920 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA066717 Uncertain Vesicles Group enriched 7 adipose tissue: 238.4;cerebral cortex: 81.6;heart muscle: 150.4 testis: 23.9 KCNJ6 BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2 ENSG00000157542 Potassium channel, inwardly rectifying subfamily J, member 6 21 37607376-37916446 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 7 cerebral cortex: 2.6 epididymis: 0.3 KCNK9 K2p9.1, TASK-3, TASK3 ENSG00000169427 Potassium channel, two pore domain subfamily K, member 9 8 139600838-139703056 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 adrenal gland: 4.8;cerebral cortex: 4.8 cervix: 0.7 KCNQ2 BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2 ENSG00000075043 Potassium channel, voltage gated KQT-like subfamily Q, member 2 20 63400210-63472677 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016642, HPA057112 Approved Approved Endoplasmic reticulum Tissue enriched 7 cerebral cortex: 56.3 adrenal gland: 8.2 KCTD16 KIAA1317 ENSG00000183775 Potassium channel tetramerization domain containing 16 5 144170832-144485686 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044590, HPA050154 Approved Approved Nuclear speckles Group enriched 7 cerebral cortex: 12.3;testis: 3.0 lung: 1.1 KHDRBS3 Etle, etoile, SALP, SLM-2, SLM2, T-STAR ENSG00000131773 KH domain containing, RNA binding, signal transduction associated 3 8 135457457-135656722 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000275, HPA000500, HPA000981 Supported Supported Nucleoplasm Group enriched 7 cerebral cortex: 89.3;testis: 284.7 epididymis: 27.4 KIAA0513 ENSG00000135709 KIAA0513 16 85027751-85094230 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA012866, HPA014431 Supported Uncertain Nucleoplasm
Cytosol Tissue enriched 7 cerebral cortex: 102.9 adrenal gland: 14.9 LGI3 ENSG00000168481 Leucine-rich repeat LGI family, member 3 8 22146825-22157084 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA024826 Approved Cytosol Group enriched 7 cerebral cortex: 76.2;lung: 23.9;skin: 17.4;thyroid gland: 21.5 esophagus: 5.2 LRP8 APOER2, HSZ75190, LRP-8, MCI1 ENSG00000157193 Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor 1 53242364-53328070 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 cerebral cortex: 25.2;testis: 47.4;thyroid gland: 87.3 appendix: 7.9 LRRC3B LRP15 ENSG00000179796 Leucine rich repeat containing 3B 3 26622806-26710776 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015568 Approved Group enriched 7 cerebral cortex: 19.2;skeletal muscle: 3.9;testis: 13.0 ovary: 1.6 LRRC4C KIAA1580, NGL-1 ENSG00000148948 Leucine rich repeat containing 4C 11 40114203-41459773 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051335, HPA054800 Approved Approved Cytosol Tissue enriched 7 cerebral cortex: 34.5 cervix: 4.7 MAP6D1 FLJ12748, SL21 ENSG00000180834 MAP6 domain containing 1 3 183815876-183825594 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037991 Approved Cytosol Group enriched 7 cerebral cortex: 43.2;skeletal muscle: 11.0 skin: 4.1 MEGF10 KIAA1780 ENSG00000145794 Multiple EGF-like-domains 10 5 127290831-127465737 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 cerebral cortex: 15.8 adrenal gland: 2.2 MSANTD1 C4orf44, LOC345222 ENSG00000188981 Myb/SANT-like DNA-binding domain containing 1 4 3244369-3271738 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 7 cerebral cortex: 1.9;testis: 2.5 epididymis: 0.3 MYT1 MTF1, MYTI, NZF2, PLPB1, ZC2HC4A ENSG00000196132 Myelin transcription factor 1 20 64151791-64242253 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006303 Uncertain Supported Nucleoplasm
Cytosol Group enriched 7 adrenal gland: 2.5;cerebral cortex: 5.7 testis: 0.6 NAT8L FLJ37478, Hcml3 ENSG00000185818 N-acetyltransferase 8-like (GCN5-related, putative) 4 2059512-2069089 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040677 Supported Mitochondria Group enriched 7 adipose tissue: 48.6;cerebral cortex: 65.1;testis: 19.0 kidney: 6.7 NECAB1 EFCBP1 ENSG00000123119 N-terminal EF-hand calcium binding protein 1 8 90791550-90959408 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023252, HPA023629, HPA025963, HPA031262, CAB068208, CAB068209, CAB068210 Supported Supported Supported Nucleoplasm
Cytosol Tissue enriched 7 cerebral cortex: 79.9 testis: 12.2 NEU4 ENSG00000204099 Sialidase 4 2 241808825-241817413 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA037394, HPA037395 Uncertain Group enriched 7 bone marrow: 2.4;cerebral cortex: 6.4;colon: 8.5;duodenum: 5.7;liver: 4.1;rectum: 3.9;small intestine: 5.4 gallbladder: 0.8 NOL4 CT125, HRIHFB2255, NOLP ENSG00000101746 Nucleolar protein 4 18 33851100-34224952 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA046740 Supported Nucleus Group enriched 7 cerebral cortex: 16.0;testis: 22.7 thyroid gland: 2.9 NRXN1 Hs.22998, KIAA0578 ENSG00000179915 Neurexin 1 2 49918505-51225564 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 cerebral cortex: 83.7 testis: 12.1 NWD1 ENSG00000188039 NACHT and WD repeat domain containing 1 19 16719976-16817963 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 cerebral cortex: 1.9;fallopian tube: 7.6;prostate: 5.8;seminal vesicle: 1.6 lung: 0.6 OPRK1 KOR, OPRK ENSG00000082556 Opioid receptor, kappa 1 8 53225716-53251697 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB022595 Uncertain Group enriched 7 cerebral cortex: 3.6;prostate: 3.2;testis: 1.8 skeletal muscle: 0.3 PAX7 Hup1 ENSG00000009709 Paired box 7 1 18631006-18748866 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 7 cerebral cortex: 1.4;skeletal muscle: 2.2 testis: 0.2 PLEKHB1 KPL1, PHR1, PHRET1 ENSG00000021300 Pleckstrin homology domain containing, family B (evectins) member 1 11 73646178-73662819 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 7 cerebral cortex: 496.1;parathyroid gland: 145.9 thyroid gland: 48.2 PRLHR GPR10, PrRPR ENSG00000119973 Prolactin releasing hormone receptor 10 118589989-118595699 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA039361 Supported Group enriched 7 adrenal gland: 6.5;cerebral cortex: 3.5;endometrium: 3.9;smooth muscle: 5.4 seminal vesicle: 0.7 RIMS3 NIM3, RIM3 ENSG00000117016 Regulating synaptic membrane exocytosis 3 1 40620679-40665657 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055285 Approved Nucleoli
Mitochondria Tissue enriched 7 cerebral cortex: 60.6 adrenal gland: 8.3 RP11-277P12.6 ENSG00000255641 12 10412312-10436001 Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA062570 Uncertain Group enriched 7 cerebral cortex: 8.2;spleen: 6.2 bone marrow: 1.0 RPH3A exophilin-1, KIAA0985, rabphilin ENSG00000089169 Rabphilin 3A 12 112570380-112898881 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002475 Supported Tissue enriched 7 cerebral cortex: 95.5 bone marrow: 13.9 SCG2 CHGC, SgII, SN ENSG00000171951 Secretogranin II 2 223596940-223602503 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002519, HPA011893 Approved Supported Group enriched 7 adrenal gland: 449.0;cerebral cortex: 232.7 duodenum: 46.3 SCRT1 DKFZp547F072, ZNF898 ENSG00000261678 Scratch family zinc finger 1 8 144330565-144336281 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA045265 Uncertain Approved Nuclear bodies Tissue enriched 7 cerebral cortex: 10.9 adrenal gland: 1.5 SEC14L5 KIAA0420, PRELID4B ENSG00000103184 SEC14-like lipid binding 5 16 4958317-5019158 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041492, HPA041825 Uncertain Uncertain Golgi apparatus
Cytosol Tissue enriched 7 cerebral cortex: 17.2 heart muscle: 2.4 SH2D5 ENSG00000189410 SH2 domain containing 5 1 20719732-20732837 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030182 Supported Cytosol Group enriched 7 cerebral cortex: 16.6;placenta: 5.1;testis: 10.5 thyroid gland: 1.5 SHC4 RaLP ENSG00000185634 SHC (Src homology 2 domain containing) family, member 4 15 48823735-48963444 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA074146 Approved Cytosol Group enriched 7 cerebral cortex: 13.2;testis: 20.4 gallbladder: 2.3 SLC24A2 NCKX2 ENSG00000155886 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 9 19507452-19786928 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 7 cerebral cortex: 51.8 adrenal gland: 7.9 SNAP91 AP180, CALM, KIAA0656 ENSG00000065609 Synaptosomal-associated protein, 91kDa 6 83552880-83709691 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009745, HPA029632, HPA029633 Supported Uncertain Centrosome
Cytosol Tissue enriched 7 cerebral cortex: 152.6 testis: 22.4 SPHKAP SKIP ENSG00000153820 SPHK1 interactor, AKAP domain containing 2 227979950-228181645 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042499, HPA048168 Supported Group enriched 7 cerebral cortex: 19.5;heart muscle: 20.3 ovary: 2.7 ST18 KIAA0535, NZF3, ZC2HC10, ZNF387 ENSG00000147488 Suppression of tumorigenicity 18, zinc finger 8 52110839-52460959 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044919 Uncertain Tissue enriched 7 cerebral cortex: 11.6 stomach: 1.5 ST8SIA3 SIAT8C ENSG00000177511 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 3 18 57350813-57371731 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA063398, HPA066783 Supported Supported Golgi apparatus Tissue enriched 7 cerebral cortex: 31.9 adrenal gland: 4.8 SYNGR3 ENSG00000127561 Synaptogyrin 3 16 1989660-1994275 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034278, HPA042842 Supported Approved Plasma membrane Tissue enriched 7 cerebral cortex: 82.8 adrenal gland: 12.5 TCEAL5 WEX4 ENSG00000204065 Transcription elongation factor A (SII)-like 5 X 103273691-103276872 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045564, HPA058982, HPA072199 Uncertain Uncertain Nucleoplasm
Cytosol Group enriched 7 cerebral cortex: 82.7;testis: 82.5 adrenal gland: 11.9 TMEM132B KIAA1786, KIAA1906 ENSG00000139364 Transmembrane protein 132B 12 125186836-125662377 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035661, HPA035662 Uncertain Tissue enriched 7 cerebral cortex: 21.9 thyroid gland: 3.1 UCHL1 PARK5, PGP9.5, Uch-L1 ENSG00000154277 Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) 4 41256413-41268455 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002580, HPA005993 Supported Validated Nucleoplasm
Cytosol Tissue enriched 7 cerebral cortex: 788.3 adrenal gland: 108.6 YWHAH YWHA1 ENSG00000128245 Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta 22 31944461-31957603 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025918 Uncertain Tissue enriched 7 cerebral cortex: 899.0 lung: 138.0 ZNF488 FLJ32104 ENSG00000265763 Zinc finger protein 488 10 47365496-47384273 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA035957, HPA035958, HPA044867 Uncertain Supported Nucleoplasm
Cytosol Group enriched 7 cerebral cortex: 19.1;duodenum: 23.2;placenta: 4.7;small intestine: 12.4 skin: 2.0 ABCA2 ABC2 ENSG00000107331 ATP-binding cassette, sub-family A (ABC1), member 2 9 137007227-137028922 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042886 Approved Tissue enriched 6 cerebral cortex: 98.2 thyroid gland: 17.0 ABCG4 WHITE2 ENSG00000172350 ATP-binding cassette, sub-family G (WHITE), member 4 11 119149012-119162653 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040312 Uncertain Group enriched 6 cerebral cortex: 6.6;parathyroid gland: 4.0;testis: 5.1 seminal vesicle: 0.8 ACSL6 ACS2, FACL6, KIAA0837, LACS2, LACS5 ENSG00000164398 Acyl-CoA synthetase long-chain family member 6 5 131949973-132012243 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA040470 Uncertain Group enriched 6 bone marrow: 18.0;cerebral cortex: 62.1;parathyroid gland: 22.1;seminal vesicle: 28.7;testis: 51.2 adrenal gland: 6.5 ADAM23 MDC3 ENSG00000114948 ADAM metallopeptidase domain 23 2 206443539-206621130 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012130, CAB033276 Uncertain Group enriched 6 cerebral cortex: 55.7;parathyroid gland: 132.9 heart muscle: 16.4 ADARB2 ADAR3, hRED2, RED2 ENSG00000185736 Adenosine deaminase, RNA-specific, B2 (non-functional) 10 1177318-1737476 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031333 Uncertain Tissue enriched 6 cerebral cortex: 13.1 testis: 2.1 ADGRV1 DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1 ENSG00000164199 Adhesion G protein-coupled receptor V1 5 90529344-91164221 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067503 Approved Group enriched 6 adrenal gland: 56.5;cerebral cortex: 29.1 thyroid gland: 6.6 ANKRD63 ENSG00000230778 Ankyrin repeat domain 63 15 40281444-40282586 Predicted intracellular proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level Tissue enriched 6 cerebral cortex: 1.0 spleen: 0.1 ANO4 FLJ34221, FLJ34272, FLJ35277, TMEM16D ENSG00000151572 Anoctamin 4 12 100717526-101128641 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053412 Uncertain Group enriched 6 adrenal gland: 17.6;cerebral cortex: 10.0;cervix, uterine: 12.5;endometrium: 8.3;ovary: 10.9;prostate: 10.9;seminal vesicle: 11.3 testis: 2.0 AP3B2 NAPTB ENSG00000103723 Adaptor-related protein complex 3, beta 2 subunit 15 82659281-82709914 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039467, HPA039818 Supported Uncertain Nucleoplasm
Golgi apparatus
Cytosol Group enriched 6 cerebral cortex: 36.3;parathyroid gland: 7.5 adrenal gland: 3.8 ARPP21 ARPP-21, R3HDM3, TARPP ENSG00000172995 CAMP-regulated phosphoprotein, 21kDa 3 35638945-35794496 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017303 Supported Approved Nucleoli
Cytosol Tissue enriched 6 cerebral cortex: 127.5 skeletal muscle: 20.2 ARSF ENSG00000062096 Arylsulfatase F X 3041471-3112726 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000549 Uncertain Cytosol Group enriched 6 adrenal gland: 4.0;cerebral cortex: 2.1;epididymis: 2.1;esophagus: 2.3;kidney: 8.0;skin: 6.7 urinary bladder: 0.6 ASIC2 ACCN, ACCN1, ASIC2a, BNaC1, BNC1, hBNaC1, MDEG ENSG00000108684 Acid sensing (proton gated) ion channel 2 17 33013087-34174964 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052112 Approved Group enriched 6 cerebral cortex: 8.7;cervix, uterine: 3.9;endometrium: 6.4;smooth muscle: 2.1 adrenal gland: 0.8 ASTN1 ASTN ENSG00000152092 Astrotactin 1 1 176857302-177164973 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA074112 Approved Golgi apparatus
Vesicles Group enriched 6 adrenal gland: 19.7;cerebral cortex: 67.0 ovary: 7.4 ATOH7 bHLHa13, Math5 ENSG00000179774 Atonal bHLH transcription factor 7 10 68230624-68232103 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA027008 Uncertain Tissue enriched 6 cerebral cortex: 2.2 small intestine: 0.3 ATP1A2 FHM2, MHP2 ENSG00000018625 ATPase, Na+/K+ transporting, alpha 2 polypeptide 1 160115759-160143591 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022230 Approved Group enriched 6 cerebral cortex: 435.6;skeletal muscle: 307.1 heart muscle: 59.1 ATP8A2 ATPIB, ML-1 ENSG00000132932 ATPase, aminophospholipid transporter, class I, type 8A, member 2 13 25372071-26025851 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039926, HPA040033 Approved Supported Nucleoplasm
Plasma membrane Group enriched 6 cerebral cortex: 26.5;testis: 10.6 adrenal gland: 2.9 BEND6 bA203B9.1, C6orf65, FLJ30162 ENSG00000151917 BEN domain containing 6 6 56955126-57027342 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA052973 Approved Nucleus
Plasma membrane Tissue enriched 6 cerebral cortex: 39.3 cervix: 6.7 BRSK1 KIAA1811 ENSG00000160469 BR serine/threonine kinase 1 19 55282072-55312533 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021212, HPA061719 Supported Supported Nucleoplasm Tissue enriched 6 cerebral cortex: 138.2 parathyroid gland: 23.8 BSN ZNF231 ENSG00000164061 Bassoon presynaptic cytomatrix protein 3 49554489-49671545 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA034757 Approved Tissue enriched 6 cerebral cortex: 28.3 epididymis: 4.7 C1QTNF4 CTRP4, ZACRP4 ENSG00000172247 C1q and tumor necrosis factor related protein 4 11 47589664-47594659 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041032 Approved Tissue enriched 6 cerebral cortex: 28.3 parathyroid gland: 5.1 C2CD4C FAM148C, KIAA1957, NLF3 ENSG00000183186 C2 calcium-dependent domain containing 4C 19 405438-409170 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055915 Uncertain Approved Vesicles Group enriched 6 adipose tissue: 2.5;cerebral cortex: 10.7;gallbladder: 4.4 endometrium: 0.9 CACNB1 CACNLB1 ENSG00000067191 Calcium channel, voltage-dependent, beta 1 subunit 17 39173456-39197703 FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA023343 Approved Group enriched 6 cerebral cortex: 46.9;skeletal muscle: 108.5 skin: 12.3 CDH22 C20orf25, dJ998H6.1 ENSG00000149654 Cadherin 22, type 2 20 46173733-46308498 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA012164 Uncertain Group enriched 6 adrenal gland: 2.0;cerebral cortex: 10.3;fallopian tube: 2.3;skin: 5.2 testis: 0.8 CELF3 BRUNOL1, CAGH4, ERDA4, MGC57297, TNRC4 ENSG00000159409 CUGBP, Elav-like family member 3 1 151702404-151716814 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006292 Uncertain Approved Nucleoplasm Group enriched 6 adrenal gland: 15.3;cerebral cortex: 51.8 stomach: 5.6 CELSR3 ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2 ENSG00000008300 Cadherin, EGF LAG seven-pass G-type receptor 3 3 48636469-48662915 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062866 Approved Group enriched 6 adrenal gland: 1.6;cerebral cortex: 6.0;testis: 3.6 parathyroid gland: 0.6 CHRM1 ENSG00000168539 Cholinergic receptor, muscarinic 1 11 62908679-62921807 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014101, CAB022366 Supported Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 40.0;prostate: 40.1;salivary gland: 11.1 breast: 4.7 CLASP2 KIAA0627 ENSG00000163539 Cytoplasmic linker associated protein 2 3 33496245-33718356 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA067071 Supported Golgi apparatus
Cytosol Tissue enriched 6 cerebral cortex: 193.7 endometrium: 33.9 CLEC19A ENSG00000261210 C-type lectin domain family 19, member A 16 19285739-19322145 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042113 Uncertain Tissue enriched 6 cerebral cortex: 2.6 skin: 0.4 CLVS2 bA160A10.4, C6orf212, C6orf213, RLBP1L2 ENSG00000146352 Clavesin 2 6 122995971-123072927 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043764 Uncertain Group enriched 6 cerebral cortex: 15.5;prostate: 4.4 endometrium: 1.6 COL9A3 DJ885L7.4.1, EDM3, FLJ90759, IDD, MED ENSG00000092758 Collagen, type IX, alpha 3 20 62816244-62841159 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040125, HPA058323 Uncertain Approved Nucleoplasm
Intermediate filaments Group enriched 6 cerebral cortex: 7.5;salivary gland: 10.5;testis: 6.4;thyroid gland: 19.3 seminal vesicle: 1.8 CPNE6 ENSG00000100884 Copine VI (neuronal) 14 24070837-24078100 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031636 Approved Group enriched 6 cerebral cortex: 88.2;seminal vesicle: 34.7 kidney: 9.6 CRYM DFNA40 ENSG00000103316 Crystallin, mu 16 21238874-21303083 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019086, HPA030619 Supported Supported Cytosol Group enriched 6 cerebral cortex: 102.6;heart muscle: 98.1;kidney: 56.5;prostate: 52.7;urinary bladder: 30.8 lung: 11.5 DAGLA C11orf11, DAGLALPHA, KIAA0659, NSDDR ENSG00000134780 Diacylglycerol lipase, alpha 11 61680433-61747001 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA062497 Approved Tissue enriched 6 cerebral cortex: 18.6 colon: 3.1 DGKB DAGK2, DGK, DGK-BETA, KIAA0718 ENSG00000136267 Diacylglycerol kinase, beta 90kDa 7 14145049-14974777 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA020321 Supported Tissue enriched 6 cerebral cortex: 34.3 endometrium: 5.6 DLEU7 FLJ44882 ENSG00000186047 Deleted in lymphocytic leukemia, 7 13 50711008-50843939 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053750 Uncertain Tissue enriched 6 cerebral cortex: 6.3 epididymis: 1.0 DLG4 PSD-95, PSD95, SAP-90, SAP90 ENSG00000132535 Discs, large homolog 4 (Drosophila) 17 7189890-7219702 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001999, CAB002000, HPA010122 Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 179.1 endometrium: 28.9 DLGAP1 DAP-1, GKAP, SAPAP1 ENSG00000170579 Discs, large (Drosophila) homolog-associated protein 1 18 3496032-4455335 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 90.3 seminal vesicle: 14.4 DOCK3 KIAA0299, MOCA, PBP ENSG00000088538 Dedicator of cytokinesis 3 3 50675241-51384198 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037543, HPA037544 Approved Validated Cytosol Group enriched 6 cerebral cortex: 33.8;parathyroid gland: 12.5;testis: 8.5;thyroid gland: 15.1 adrenal gland: 3.0 DRP2 ENSG00000102385 Dystrophin related protein 2 X 101219769-101264497 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA002949 Supported Tissue enriched 6 cerebral cortex: 12.3 prostate: 2.1 EEF1A2 EEF1AL, HS1, STN, STNL ENSG00000101210 Eukaryotic translation elongation factor 1 alpha 2 20 63488013-63499315 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB034019, HPA051759, HPA053862, HPA056990 Approved Validated Nucleoli
Cytosol Group enriched 6 cerebral cortex: 410.5;heart muscle: 413.7;skeletal muscle: 1373.0 adrenal gland: 128.3 FAM133A CT115, FLJ37659, RP1-32F7.2 ENSG00000179083 Family with sequence similarity 133, member A X 93674013-93712274 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA066175, HPA069513 Approved Nucleus
Nucleoli Group enriched 6 cerebral cortex: 5.3;testis: 14.0 adrenal gland: 1.5 FAM155A ENSG00000204442 Family with sequence similarity 155, member A 13 107163510-107866735 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039453, HPA058768 Supported Approved Nucleus
Vesicles
Centrosome Tissue enriched 6 cerebral cortex: 15.6 seminal vesicle: 2.4 FAM163B C9orf166 ENSG00000196990 Family with sequence similarity 163, member B 9 133578415-133586197 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA067336 Approved Approved Nuclear bodies
Plasma membrane
Cytosol Tissue enriched 6 cerebral cortex: 103.9 adrenal gland: 16.5 FAM171B FLJ34104, KIAA1946 ENSG00000144369 Family with sequence similarity 171, member B 2 186693971-186765965 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA010639, HPA013434 Approved Approved Nucleus
Mitochondria Tissue enriched 6 cerebral cortex: 114.9 parathyroid gland: 19.0 FAM19A1 TAFA-1 ENSG00000183662 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1 3 68004216-68545625 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013407 Approved Tissue enriched 6 cerebral cortex: 30.9 seminal vesicle: 5.5 FMN2 ENSG00000155816 Formin 2 1 240014348-240475189 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050649 Approved Plasma membrane
Actin filaments Group enriched 6 cerebral cortex: 54.0;parathyroid gland: 32.9 adrenal gland: 7.0 FOXG1 BF1, FKH2, FKHL1, FKHL2, FKHL3, FKHL4, FOXG1A, FOXG1B, FOXG1C, HBF-3, HFK1, HFK2, HFK3, QIN ENSG00000176165 Forkhead box G1 14 28765388-28770277 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 29.7 testis: 5.3 FRMD5 MGC14161 ENSG00000171877 FERM domain containing 5 15 43870761-44195252 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011746, HPA013961 Uncertain Uncertain Golgi apparatus
Centrosome Group enriched 6 adrenal gland: 7.1;cerebral cortex: 20.1;heart muscle: 7.1;testis: 5.5 fallopian tube: 1.6 FRMPD2 MGC35285, PDZD5C, PDZK5C ENSG00000170324 FERM and PDZ domain containing 2 10 48156558-48274870 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045059 Uncertain Group enriched 6 cerebral cortex: 3.9;fallopian tube: 5.3;testis: 2.9 thyroid gland: 0.7 GABRA2 ENSG00000151834 Gamma-aminobutyric acid (GABA) A receptor, alpha 2 4 46248427-46475230 FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 6 cerebral cortex: 74.5 epididymis: 13.3 GAD1 GAD ENSG00000128683 Glutamate decarboxylase 1 (brain, 67kDa) 2 170813213-170861151 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004415, HPA031949, HPA058412, CAB078176 Supported Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 75.5 parathyroid gland: 11.7 GALNT13 GalNAc-T13, KIAA1918 ENSG00000144278 Polypeptide N-acetylgalactosaminyltransferase 13 2 153871913-154453849 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA060775 Approved Group enriched 6 adrenal gland: 6.6;cerebral cortex: 32.8 lung: 3.2 GAREML FAM59B, FLJ00375, KIAA2038 ENSG00000157833 GRB2 associated, regulator of MAPK1-like 2 26173091-26189663 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA071575 Approved Cytosol Group enriched 6 cerebral cortex: 23.1;parathyroid gland: 17.5 smooth muscle: 3.4 GJD2 CX36, GJA9 ENSG00000159248 Gap junction protein, delta 2, 36kDa 15 34751032-34754965 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014355 Uncertain Group enriched 6 adrenal gland: 8.0;cerebral cortex: 1.9 pancreas: 0.8 GLRA3 ENSG00000145451 Glycine receptor, alpha 3 4 174636914-174829314 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 breast: 2.6;cerebral cortex: 9.1 adrenal gland: 1.0 GPR162 A-2, GRCA ENSG00000250510 G protein-coupled receptor 162 12 6821545-6829972 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA055135 Supported Approved Microtubule organizing center Group enriched 6 cerebral cortex: 84.5;fallopian tube: 29.1 lung: 9.6 GRIA1 GluA1, GLUR1, GLURA ENSG00000155511 Glutamate receptor, ionotropic, AMPA 1 5 153489615-153813869 FDA approved drug targets, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001965, HPA035202 Supported Tissue enriched 6 cerebral cortex: 67.3 lung: 10.6 GRIK3 GluK3, GLUR7 ENSG00000163873 Glutamate receptor, ionotropic, kainate 3 1 36795527-37034129 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 6 cerebral cortex: 19.8 seminal vesicle: 3.5 HCN4 ENSG00000138622 Hyperpolarization activated cyclic nucleotide gated potassium channel 4 15 73319859-73369264 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 1.4;heart muscle: 1.9;testis: 6.7 adrenal gland: 0.5 HEPACAM FLJ25530, GLIALCAM, hepaCAM ENSG00000165478 Hepatic and glial cell adhesion molecule 11 124919193-124936412 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017613, CAB025486 Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 80.9 adipose tissue: 14.4 HEPN1 ENSG00000221932 Hepatocellular carcinoma, down-regulated 1 11 124919244-124920677 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA043768, HPA063054 Uncertain Approved Golgi apparatus Tissue enriched 6 cerebral cortex: 79.7 adipose tissue: 12.9 INA NEF5, NF-66 ENSG00000148798 Internexin neuronal intermediate filament protein, alpha 10 103277163-103290351 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002059, HPA008057 Supported Supported Supported Nucleoplasm
Nuclear membrane
Intermediate filaments Tissue enriched 6 cerebral cortex: 89.2 adrenal gland: 16.1 JAKMIP2 JAMIP2, KIAA0555 ENSG00000176049 Janus kinase and microtubule interacting protein 2 5 147585439-147782848 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046929, HPA065023 Approved Supported Golgi apparatus Tissue enriched 6 cerebral cortex: 32.8 testis: 5.2 KCNA1 AEMK, HUK1, Kv1.1, MBK1, RBK1 ENSG00000111262 Potassium channel, voltage gated shaker related subfamily A, member 1 12 4909905-4931361 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022365 Uncertain Tissue enriched 6 cerebral cortex: 13.5 parathyroid gland: 2.0 KCNH7 erg3, HERG3, Kv11.3 ENSG00000184611 Potassium channel, voltage gated eag related subfamily H, member 7 2 162371407-162838730 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA018039 Uncertain Tissue enriched 6 cerebral cortex: 4.7 testis: 0.7 KCNJ10 Kir1.2, Kir4.1 ENSG00000177807 Potassium channel, inwardly rectifying subfamily J, member 10 1 160037467-160070248 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 120.1;kidney: 27.8 spleen: 13.3 KIAA0319 NMIG ENSG00000137261 KIAA0319 6 24544104-24646155 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 15.8 fallopian tube: 2.8 KIF6 C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317 ENSG00000164627 Kinesin family member 6 6 39329990-39725405 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA038811, HPA058624 Supported Approved Centrosome Group enriched 6 cerebral cortex: 7.1;fallopian tube: 6.0;testis: 9.7 lung: 1.2 KLHL32 BKLHD5, KIAA1900 ENSG00000186231 Kelch-like family member 32 6 96924620-97140754 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039150 Approved Group enriched 6 cerebral cortex: 25.4;fallopian tube: 10.2 testis: 3.1 KLRC2 CD159c, NKG2-C ENSG00000205809 Killer cell lectin-like receptor subfamily C, member 2 12 10426854-10442300 CD markers, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA058052 Approved Plasma membrane Group enriched 6 cerebral cortex: 17.4;spleen: 8.3 stomach: 2.0 LIX1 C5orf11, Lft ENSG00000145721 Limb and CNS expressed 1 5 97091867-97142872 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA058426 Uncertain Tissue enriched 6 cerebral cortex: 32.9 seminal vesicle: 5.6 LRRTM4 FLJ12568 ENSG00000176204 Leucine rich repeat transmembrane neuronal 4 2 76747719-77593319 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 6 cerebral cortex: 21.4 epididymis: 3.8 LUZP2 ENSG00000187398 Leucine zipper protein 2 11 24496970-25082631 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039007, HPA046161 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Group enriched 6 adrenal gland: 8.5;cerebral cortex: 33.1 prostate: 3.3 MAG GMA, S-MAG, SIGLEC-4A, SIGLEC4A ENSG00000105695 Myelin associated glycoprotein 19 35292125-35313804 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009345, HPA012499 Supported Tissue enriched 6 cerebral cortex: 164.0 ovary: 27.5 MARCH4 KIAA1399, MARCH-IV, RNF174 ENSG00000144583 Membrane-associated ring finger (C3HC4) 4, E3 ubiquitin protein ligase 2 216257865-216372027 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014348 Approved Tissue enriched 6 cerebral cortex: 9.1 stomach: 1.6 MEGF11 DKFZp434L121, KIAA1781 ENSG00000157890 Multiple EGF-like-domains 11 15 65895079-66253747 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA017982 Uncertain Group enriched 6 cerebral cortex: 13.0;fallopian tube: 12.2 testis: 1.9 NACAD KIAA0363 ENSG00000136274 NAC alpha domain containing 7 45080438-45088914 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020981 Approved Approved Nucleus
Cytosol Tissue enriched 6 cerebral cortex: 48.9 ovary: 7.6 NOS1AP CAPON, KIAA0464 ENSG00000198929 Nitric oxide synthase 1 (neuronal) adaptor protein 1 162069774-162370475 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018582, HPA030066, HPA055561 Approved Approved Nucleus
Vesicles Tissue enriched 6 cerebral cortex: 23.5 adrenal gland: 3.8 NYAP2 KIAA1486 ENSG00000144460 Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 2 2 225400648-225654018 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045531 Uncertain Approved Nucleoplasm
Intermediate filaments Tissue enriched 6 cerebral cortex: 1.9 lung: 0.3 OLR1 CLEC8A, LOX-1, SCARE1 ENSG00000173391 Oxidized low density lipoprotein (lectin-like) receptor 1 12 10158301-10172138 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050798 Supported Nucleoplasm
Vesicles
Plasma membrane Group enriched 6 appendix: 42.1;cerebral cortex: 32.8;lung: 146.2;placenta: 159.6 bone marrow: 15.8 OR14I1 OR5BU1, OR5BU1P ENSG00000189181 Olfactory receptor, family 14, subfamily I, member 1 1 248681369-248682304 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level Tissue enriched 6 cerebral cortex: 3.4 prostate: 0.6 P2RY12 HORK3, P2Y12, SP1999 ENSG00000169313 Purinergic receptor P2Y, G-protein coupled, 12 3 151337380-151384812 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013796, HPA014518 Supported Tissue enriched 6 cerebral cortex: 84.0 lymph node: 13.3 PAPL ENSG00000183760 Iron/zinc purple acid phosphatase-like protein 19 39083913-39111493 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042005, HPA042613 Uncertain Group enriched 6 cerebral cortex: 1.8;skin: 6.9;tonsil: 2.5 epididymis: 0.6 PAX6 AN, AN2, D11S812E, WAGR ENSG00000007372 Paired box 6 11 31784792-31817961 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030775, CAB034143 Supported Validated Nucleoplasm Group enriched 6 cerebral cortex: 24.4;stomach: 12.1 testis: 2.9 PCDH11Y PCDH22, PCDHY ENSG00000099715 Protocadherin 11 Y-linked Y 5000226-5742224 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA000432 Uncertain Tissue enriched 6 cerebral cortex: 4.4 seminal vesicle: 0.7 PLPPR1 FLJ20300, LPPR1, MGC26189, PRG-3 ENSG00000148123 Phospholipid phosphatase related 1 9 101028709-101325135 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014760, HPA014968, HPA014979 Supported Approved Nucleoplasm Group enriched 6 cerebral cortex: 23.9;kidney: 15.7 epididymis: 3.2 POPDC3 bA355M14.1, MGC22671, POP3 ENSG00000132429 Popeye domain containing 3 6 105158280-105179995 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA012514 Uncertain Approved Nucleoli
Cytosol Group enriched 6 cerebral cortex: 8.8;heart muscle: 18.4;skeletal muscle: 41.8;testis: 9.7 epididymis: 3.4 RAB6B ENSG00000154917 RAB6B, member RAS oncogene family 3 133824239-133895836 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017713, HPA059131 Uncertain Approved Golgi apparatus Group enriched 6 cerebral cortex: 211.9;parathyroid gland: 75.7 fallopian tube: 25.9 RFPL1 RNF78 ENSG00000128250 Ret finger protein-like 1 22 29438583-29442455 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA048320, HPA072380 Approved Nuclear speckles
Plasma membrane Tissue enriched 6 cerebral cortex: 27.3 ovary: 4.4 RIT2 RIBA, RIN ENSG00000152214 Ras-like without CAAX 2 18 42743227-43115691 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 18.3 adrenal gland: 2.8 RTBDN FLJ36353 ENSG00000132026 Retbindin 19 12825478-12835428 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052511 Approved Endoplasmic reticulum Group enriched 6 adrenal gland: 4.6;cerebral cortex: 14.7;testis: 3.5 stomach: 1.2 RTN4RL2 NgR2, NGRH1 ENSG00000186907 Reticulon 4 receptor-like 2 11 57460549-57477534 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 48.9;thyroid gland: 36.1 liver: 6.6 SATB2 FLJ21474, KIAA1034 ENSG00000119042 SATB homeobox 2 2 199269500-199471266 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231 Supported Supported Nucleoplasm Group enriched 6 cerebral cortex: 22.8;colon: 37.7;rectum: 48.3 small intestine: 6.5 SCN3A Nav1.3 ENSG00000153253 Sodium channel, voltage gated, type III alpha subunit 2 165087522-165204067 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035396 Approved Tissue enriched 6 cerebral cortex: 18.0 adrenal gland: 3.0 SCN8A CerIII, MED, NaCh6, Nav1.6, PN4 ENSG00000196876 Sodium channel, voltage gated, type VIII alpha subunit 12 51590266-51812864 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022169 Supported Vesicles
Cell Junctions Tissue enriched 6 cerebral cortex: 22.1 testis: 3.5 SEZ6L ENSG00000100095 Seizure related 6 homolog (mouse)-like 22 26169474-26383597 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 89.4 adrenal gland: 13.7 SH3TC2 CMT4C, KIAA1985 ENSG00000169247 SH3 domain and tetratricopeptide repeats 2 5 148923639-149063163 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037683, HPA037684 Uncertain Approved Nucleoplasm
Cytosol Group enriched 6 cerebral cortex: 3.0;placenta: 2.8;testis: 8.7 heart muscle: 0.8 SLC1A6 EAAT4 ENSG00000105143 Solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 19 14950034-15022990 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041505, HPA044066 Supported Uncertain Intermediate filaments Group enriched 6 cerebral cortex: 16.2;skin: 8.9;testis: 36.8 epididymis: 3.7 SLC22A17 BOCT, BOIT, NGALR ENSG00000092096 Solute carrier family 22, member 17 14 23346306-23352912 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA002728 Uncertain Tissue enriched 6 cerebral cortex: 229.2 prostate: 38.6 SLC25A22 EIEE3, FLJ13044, GC1, NET44 ENSG00000177542 Solute carrier family 25 (mitochondrial carrier: glutamate), member 22 11 790475-798333 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014662 Approved Validated Nucleoplasm
Mitochondria Tissue enriched 6 cerebral cortex: 89.9 testis: 15.2 SLC4A3 AE3, SLC2C ENSG00000114923 Solute carrier family 4 (anion exchanger), member 3 2 219627327-219641980 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA063498 Approved Nucleoplasm Group enriched 6 cerebral cortex: 30.1;heart muscle: 125.7;ovary: 47.6 testis: 10.9 SLC5A11 KST1, SGLT6, SMIT2 ENSG00000158865 Solute carrier family 5 (sodium/inositol cotransporter), member 11 16 24845841-24911628 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035331 Uncertain Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 10.5;duodenum: 6.8;kidney: 6.0;small intestine: 15.5 breast: 1.7 SLC8A3 NCX3 ENSG00000100678 Solute carrier family 8 (sodium/calcium exchanger), member 3 14 70044217-70189070 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 cerebral cortex: 16.3;skeletal muscle: 6.1 adrenal gland: 1.7 SOX21 SOX25 ENSG00000125285 SRY (sex determining region Y)-box 21 13 94709622-94712399 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA064084 Approved Nucleus Group enriched 6 cerebral cortex: 18.0;esophagus: 6.9;skin: 19.4;stomach: 33.9 tonsil: 3.2 SPTBN4 KIAA1642, SPTBN3 ENSG00000160460 Spectrin, beta, non-erythrocytic 4 19 40466241-40576464 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054481 Approved Approved Nucleus
Nucleoli Tissue enriched 6 cerebral cortex: 18.7 adrenal gland: 2.9 SRSF12 SFRS13B, SFRS19, SRrp35 ENSG00000154548 Serine/arginine-rich splicing factor 12 6 89095959-89118081 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA049782 Approved Group enriched 6 cerebral cortex: 6.9;testis: 20.9 thyroid gland: 2.2 STAC2 24b2 ENSG00000141750 SH3 and cysteine rich domain 2 17 39210536-39225872 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017288 Approved Nucleoplasm
Vesicles Group enriched 6 breast: 31.7;cerebral cortex: 30.2;epididymis: 14.8;seminal vesicle: 35.5 skin: 4.5 STMN2 SCG10, SCGN10 ENSG00000104435 Stathmin 2 8 79610814-79666175 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA026922 Supported Approved Endoplasmic reticulum
Vesicles Tissue enriched 6 cerebral cortex: 490.7 adrenal gland: 88.6 SYT16 CHR14SYT, Strep14, SYT14L, yt14r ENSG00000139973 Synaptotagmin XVI 14 61995823-62112550 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA004199 Uncertain Tissue enriched 6 cerebral cortex: 13.9 prostate: 2.2 TCEAL6 WEX2 ENSG00000204071 Transcription elongation factor A (SII)-like 6 X 102140476-102142970 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045564, HPA058982 Uncertain Group enriched 6 adrenal gland: 15.0;cerebral cortex: 65.3;testis: 35.6 endometrium: 6.2 TMEM145 FLJ90805 ENSG00000167619 Transmembrane protein 145 19 42313325-42325062 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA060462 Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 38.4 adrenal gland: 6.0 TSPAN7 A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2 ENSG00000156298 Tetraspanin 7 X 38561370-38688920 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003140, CAB062566, CAB068245 Supported Tissue enriched 6 cerebral cortex: 576.3 adrenal gland: 99.7 TTBK1 KIAA1855 ENSG00000146216 Tau tubulin kinase 1 6 43243680-43288259 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031735, HPA031736 Supported Supported Nucleoplasm
Cytosol Tissue enriched 6 cerebral cortex: 19.0 small intestine: 3.2 TTYH2 C17orf29 ENSG00000141540 Tweety family member 2 17 74213514-74262020 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 6 cerebral cortex: 129.6 testis: 21.8 TUBA8 TUBAL2 ENSG00000183785 Tubulin, alpha 8 22 18110331-18146554 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043684, CAB046031, HPA063394 Approved Supported Microtubules Group enriched 6 cerebral cortex: 28.7;heart muscle: 85.0;skeletal muscle: 121.8;testis: 47.4 thyroid gland: 11.2 TUBB2B bA506K6.1, DKFZp566F223, MGC8685 ENSG00000137285 Tubulin, beta 2B class IIb 6 3224261-3231730 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043640, HPA046280 Supported Approved Microtubules Tissue enriched 6 cerebral cortex: 309.5 epididymis: 51.0 TUBB3 beta-4, CFEOM3, CFEOM3A, FEOM3 ENSG00000258947 Tubulin, beta 3 class III 16 89921392-89938761 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043640, HPA046280 Approved Supported Microtubules Tissue enriched 6 cerebral cortex: 196.2 adrenal gland: 34.7 VAT1L KIAA1576 ENSG00000171724 Vesicle amine transport 1-like 16 77788530-77980107 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044061, CAB046032 Approved Approved Cytosol Group enriched 6 adrenal gland: 91.0;cerebral cortex: 38.9 heart muscle: 10.6 XKR4 KIAA1889 ENSG00000206579 XK, Kell blood group complex subunit-related family, member 4 8 55102389-55542054 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA025072, HPA028083 Uncertain Tissue enriched 6 cerebral cortex: 4.7 seminal vesicle: 0.8 ZIC2 HPE5 ENSG00000043355 Zic family member 2 13 99981772-99986773 Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055031 Approved Nuclear bodies Tissue enriched 6 cerebral cortex: 7.4 testis: 1.2 ZIM2 ZNF656 ENSG00000269699 Zinc finger, imprinted 2 19 56774552-56840729 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA071856 Approved Nuclear speckles
Cytosol Group enriched 6 adrenal gland: 5.8;cerebral cortex: 5.1;ovary: 10.0;placenta: 6.8;testis: 7.8 endometrium: 1.1 ACBD7 bA455B2.2, FLJ38219 ENSG00000176244 Acyl-CoA binding domain containing 7 10 15077523-15088776 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043326, HPA062478 Uncertain Approved Vesicles
Cytosol Tissue enriched 5 cerebral cortex: 40.8 testis: 7.9 AKAP5 AKAP75, AKAP79 ENSG00000179841 A kinase (PRKA) anchor protein 5 14 64465499-64474503 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004308, HPA053891 Supported Approved Nucleoplasm Tissue enriched 5 cerebral cortex: 22.6 rectum: 4.4 AL008723.1 ENSG00000279219 22 32191094-32191452 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enriched 5 cerebral cortex: 11.7 prostate: 2.3 ANKRD34A ANKRD34 ENSG00000272031 Ankyrin repeat domain 34A 1 145959442-145964582 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029642, HPA029643 Uncertain Validated Cytosol Tissue enriched 5 cerebral cortex: 12.7 parathyroid gland: 2.4 ANOS1 ADMLX, KAL, KAL1, KALIG-1, WFDC19 ENSG00000011201 Anosmin 1 X 8528874-8732187 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 cerebral cortex: 32.5;lung: 66.1;parathyroid gland: 47.6;thyroid gland: 15.7 testis: 7.4 APLNR AGTRL1, APJ, APJR, FLJ90771 ENSG00000134817 Apelin receptor 11 57233577-57237314 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025842 Approved Group enriched 5 cerebral cortex: 82.9;placenta: 145.6;spleen: 164.2 adipose tissue: 24.9 CALN1 ENSG00000183166 Calneuron 1 7 71779491-72447151 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036278, HPA036708 Approved Uncertain Vesicles
Plasma membrane Group enriched 5 adrenal gland: 14.8;cerebral cortex: 46.5 testis: 6.0 CCK ENSG00000187094 Cholecystokinin 3 42257825-42266207 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002308, HPA045039 Supported Supported Group enriched 5 cerebral cortex: 134.1;duodenum: 119.6;prostate: 32.8 small intestine: 18.1 CDH12 Br-cadherin, CDHB ENSG00000154162 Cadherin 12, type 2 (N-cadherin 2) 5 21750673-22853622 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029325 Uncertain Approved Vesicles Group enriched 5 adrenal gland: 2.5;cerebral cortex: 3.8;cervix, uterine: 5.3;fallopian tube: 4.0;skin: 1.1;testis: 2.7 breast: 0.6 CDH20 Cdh7, CDH7L3 ENSG00000101542 Cadherin 20, type 2 18 61333582-61555773 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015490 Uncertain Tissue enriched 5 cerebral cortex: 26.9 adipose tissue: 4.9 CHL1 CALL, FLJ44930, L1CAM2, MGC132578 ENSG00000134121 Cell adhesion molecule L1-like 3 196596-409417 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003345, CAB026120 Supported Tissue enriched 5 cerebral cortex: 112.2 ovary: 20.9 COLGALT2 C1orf17, GLT25D2, KIAA0584 ENSG00000198756 Collagen beta(1-O)galactosyltransferase 2 1 183929854-184037729 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031749, HPA031750 Approved Approved Nucleus
Vesicles Tissue enriched 5 cerebral cortex: 46.5 adrenal gland: 8.5 CPNE9 KIAA4217 ENSG00000144550 Copine family member IX 3 9703807-9729908 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 5 cerebral cortex: 12.6 testis: 2.4 CRMP1 DPYSL1, DRP-1 ENSG00000072832 Collapsin response mediator protein 1 4 5748084-5893058 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035640, CAB037313 Approved Supported Cytosol Tissue enriched 5 cerebral cortex: 134.1 endometrium: 26.8 DBX2 FLJ16139 ENSG00000185610 Developing brain homeobox 2 12 45014672-45051099 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA066053 Uncertain Group enriched 5 cerebral cortex: 4.1;testis: 1.2 skin: 0.5 DCLK1 DCAMKL1, DCDC3A, DCLK, KIAA0369 ENSG00000133083 Doublecortin-like kinase 1 13 35768652-36131306 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012405, HPA015040, HPA015655 Supported Approved Nucleus
Cytosol Tissue enriched 5 cerebral cortex: 140.9 smooth muscle: 27.0 DNAJC18 MGC29463 ENSG00000170464 DnaJ (Hsp40) homolog, subfamily C, member 18 5 139408588-139444491 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA036538, HPA060154 Approved Supported Cell Junctions Group enriched 5 cerebral cortex: 30.2;testis: 115.2 ovary: 13.8 EPHA5 CEK7, EHK1, Hek7, TYRO4 ENSG00000145242 EPH receptor A5 4 65319563-65670495 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 5 cerebral cortex: 18.0 cervix: 3.3 FAM107A DRR1, TU3A ENSG00000168309 Family with sequence similarity 107, member A 3 58564117-58627610 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055888 Approved Approved Nuclear speckles Group enriched 5 cerebral cortex: 487.1;fallopian tube: 123.9 epididymis: 56.9 FAM181A C14orf152 ENSG00000140067 Family with sequence similarity 181, member A 14 93918894-93929608 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA001603 Supported Group enriched 5 cerebral cortex: 3.4;fallopian tube: 3.2;testis: 13.9 thyroid gland: 1.3 GDI1 FLJ41411, GDIL, MRX41, MRX48, OPHN2, RABGDIA, XAP-4 ENSG00000203879 GDP dissociation inhibitor 1 X 154436913-154443467 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012979, HPA049290, HPA057668 Supported Approved Vesicles Tissue enriched 5 cerebral cortex: 533.6 smooth muscle: 99.9 GJB6 CX30, DFNA3, ED2, EDH, HED ENSG00000121742 Gap junction protein, beta 6, 30kDa 13 20221971-20232395 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014846 Supported Cell Junctions Group enriched 5 bone marrow: 47.6;cerebral cortex: 39.6;esophagus: 150.3;skin: 32.0 tonsil: 12.7 GPR83 GPR72 ENSG00000123901 G protein-coupled receptor 83 11 94377311-94401419 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 adrenal gland: 1.0;cerebral cortex: 4.6;thyroid gland: 5.2 epididymis: 0.6 GRIN2A GluN2A, NMDAR2A ENSG00000183454 Glutamate receptor, ionotropic, N-methyl D-aspartate 2A 16 9753404-10182754 Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022725 Supported Tissue enriched 5 cerebral cortex: 25.0 testis: 4.7 GRIN3A GluN3A ENSG00000198785 Glutamate receptor, ionotropic, N-methyl-D-aspartate 3A 9 101569353-101738580 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 cerebral cortex: 12.4;cervix, uterine: 2.5 seminal vesicle: 1.4 HS3ST5 3-OST-5 ENSG00000249853 Heparan sulfate (glucosamine) 3-O-sulfotransferase 5 6 114055586-114343045 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021823, HPA064677 Approved Group enriched 5 cerebral cortex: 6.2;seminal vesicle: 2.2;skeletal muscle: 1.3 adrenal gland: 0.6 HTR2C 5-HT2C, 5HTR2C, HTR1C ENSG00000147246 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled X 114584078-114910061 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 5 cerebral cortex: 3.1 cervix: 0.5 IGDCC3 HsT18880, PUNC ENSG00000174498 Immunoglobulin superfamily, DCC subclass, member 3 15 65327127-65378040 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA015246 Approved Group enriched 5 cerebral cortex: 3.3;parathyroid gland: 14.4;placenta: 8.5;testis: 5.2 thyroid gland: 1.5 ISLR2 KIAA1465 ENSG00000167178 Immunoglobulin superfamily containing leucine-rich repeat 2 15 74100311-74138540 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA012930, HPA067333 Uncertain Group enriched 5 cerebral cortex: 31.2;testis: 15.2 endometrium: 4.5 JAKMIP1 FLJ31564, Gababrbp, JAMIP1, MARLIN1 ENSG00000152969 Janus kinase and microtubule interacting protein 1 4 6026199-6200591 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044570 Uncertain Tissue enriched 5 cerebral cortex: 38.5 prostate: 7.4 KCNA2 HK4, Kv1.2 ENSG00000177301 Potassium channel, voltage gated shaker related subfamily A, member 2 1 110593580-110631474 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001976 Supported Tissue enriched 5 cerebral cortex: 20.7 thyroid gland: 3.8 KCNH3 BEC1, elk2, Kv12.2 ENSG00000135519 Potassium channel, voltage gated eag related subfamily H, member 3 12 49539157-49558308 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051088 Uncertain Approved Nucleus
Mitochondria Group enriched 5 cerebral cortex: 24.3;fallopian tube: 7.1;parathyroid gland: 4.9 adrenal gland: 2.2 KCNT1 KCa4.1, KIAA1422, SLACK, Slo2.2 ENSG00000107147 Potassium channel, sodium activated subfamily T, member 1 9 135702185-135795508 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059880 Uncertain Group enriched 5 cerebral cortex: 11.7;ovary: 3.9;skeletal muscle: 3.9;spleen: 6.7 testis: 1.2 KISS1R AXOR12, GPR54, HOT7T175 ENSG00000116014 KISS1 receptor 19 917287-921015 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA071913 Supported Vesicles
Plasma membrane Tissue enriched 5 cerebral cortex: 1.2 placenta: 0.2 KLK6 Bssp, Klk7, neurosin, PRSS18, PRSS9 ENSG00000167755 Kallikrein-related peptidase 6 19 50958631-50969673 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051837 Supported Nucleoplasm
Nuclear membrane
Cytokinetic bridge Group enriched 5 cerebral cortex: 79.0;esophagus: 63.2;fallopian tube: 44.3;tonsil: 32.5 kidney: 10.1 LMTK3 KIAA1883, LMR3, PPP1R101, TYKLM3 ENSG00000142235 Lemur tyrosine kinase 3 19 48485271-48513189 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040203 Approved Nucleoplasm
Cell Junctions Group enriched 5 cerebral cortex: 20.4;parathyroid gland: 4.8 duodenum: 2.3 LRFN2 FIGLER2, KIAA1246, SALM1 ENSG00000156564 Leucine rich repeat and fibronectin type III domain containing 2 6 40391586-40587465 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA013653, HPA076660 Uncertain Supported Vesicles Tissue enriched 5 cerebral cortex: 6.9 spleen: 1.3 LRRTM3 ENSG00000198739 Leucine rich repeat transmembrane neuronal 3 10 66926006-67099830 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 5 cerebral cortex: 22.7 ovary: 4.2 MAP1B MAP5, PPP1R102 ENSG00000131711 Microtubule-associated protein 1B 5 72107234-72209570 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009792, HPA022275 Supported Validated Cytosol Tissue enriched 5 cerebral cortex: 188.2 smooth muscle: 36.3 MAPK8IP1 IB1, JIP-1, JIP1, PRKM8IP ENSG00000121653 Mitogen-activated protein kinase 8 interacting protein 1 11 45885651-45906465 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA058921, HPA070332 Supported Plasma membrane Tissue enriched 5 cerebral cortex: 177.7 parathyroid gland: 32.6 MGAT4C HGNT-IV-H ENSG00000182050 MGAT4 family, member C 12 85955666-86838904 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 cerebral cortex: 11.9;epididymis: 13.6;testis: 11.1;thyroid gland: 31.8 adrenal gland: 3.3 NAP1L2 BPX, MGC26243 ENSG00000186462 Nucleosome assembly protein 1-like 2 X 73212299-73214848 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA054050, HPA057065 Validated Vesicles
Plasma membrane
Cytosol Tissue enriched 5 cerebral cortex: 90.3 parathyroid gland: 17.6 NGB ENSG00000165553 Neuroglobin 14 77265483-77271312 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042615, HPA058596 Supported Group enriched 5 adrenal gland: 10.2;cerebral cortex: 4.8;fallopian tube: 2.1 pancreas: 1.0 NMNAT2 C1orf15, KIAA0479, PNAT2 ENSG00000157064 Nicotinamide nucleotide adenylyltransferase 2 1 183248237-183418602 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 5 cerebral cortex: 73.8 heart muscle: 13.7 NNAT Peg5 ENSG00000053438 Neuronatin 20 37521215-37523693 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 cerebral cortex: 158.1;placenta: 148.0 adipose tissue: 28.1 NOG SYM1, SYNS1 ENSG00000183691 Noggin 17 56593699-56595590 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA061318 Approved Group enriched 5 cerebral cortex: 7.3;placenta: 15.8 lymph node: 2.2 NPAS1 bHLHe11, MOP5, PASD5 ENSG00000130751 Neuronal PAS domain protein 1 19 47019820-47045775 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043364, HPA072259 Approved Approved Nucleoplasm Group enriched 5 cerebral cortex: 3.9;skin: 4.4;spleen: 1.9;stomach: 2.7 lymph node: 0.6 NSF SKD2 ENSG00000073969 N-ethylmaleimide-sensitive factor 17 46590669-46757464 Enzymes, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003154, CAB009324, CAB013645, HPA071089 Approved Supported Cytosol Tissue enriched 5 cerebral cortex: 134.7 parathyroid gland: 25.1 NTNG2 KIAA1857, Lmnt2, NTNG1 ENSG00000196358 Netrin G2 9 132161676-132244534 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071290 Approved Group enriched 5 bone marrow: 26.5;cerebral cortex: 18.5;parathyroid gland: 16.0;prostate: 8.6 spleen: 3.2 PABPC1L2A RBM32A ENSG00000186288 Poly(A) binding protein, cytoplasmic 1-like 2A X 73077276-73079512 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041573 Approved Group enriched 5 adrenal gland: 2.0;cerebral cortex: 6.7;prostate: 3.7;testis: 2.8 epididymis: 0.7 PABPC1L2B RBM32B ENSG00000184388 Poly(A) binding protein, cytoplasmic 1-like 2B X 73003517-73005713 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041573 Approved Group enriched 5 cerebral cortex: 8.8;prostate: 4.5 testis: 1.2 PAK7 KIAA1264, PAK5 ENSG00000101349 P21 protein (Cdc42/Rac)-activated kinase 7 20 9537389-9839041 Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA020444 Approved Approved Nucleoplasm Tissue enriched 5 cerebral cortex: 13.4 adrenal gland: 2.6 PCDH10 KIAA1400, OL-PCDH ENSG00000138650 Protocadherin 10 4 133149315-133208606 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA011220, HPA073462 Approved Approved Nucleus
Golgi apparatus
Vesicles Group enriched 5 cerebral cortex: 62.2;placenta: 36.4;prostate: 17.0;seminal vesicle: 24.4 adrenal gland: 6.9 PCDHGA10 PCDH-GAMMA-A10 ENSG00000253846 Protocadherin gamma subfamily A, 10 5 141412987-141512979 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA008755 Uncertain Tissue enriched 5 cerebral cortex: 28.1 placenta: 5.1 PNMAL2 KIAA1183 ENSG00000204851 Paraneoplastic Ma antigen family-like 2 19 46486906-46496498 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA054810 Approved Group enriched 5 adrenal gland: 12.2;cerebral cortex: 33.0 ovary: 4.3 PPFIA2 ENSG00000139220 Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2 12 81257975-81759553 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 5 cerebral cortex: 61.2 testis: 11.4 PPFIA3 KIAA0654, LPNA3, MGC126567, MGC126569 ENSG00000177380 Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 19 49119389-49151026 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043567, HPA050340 Supported Uncertain Nucleoli fibrillar center
Vesicles Group enriched 5 cerebral cortex: 21.6;skin: 20.2 parathyroid gland: 3.9 PPM1E CaMKP-N, KIAA1072, POPX1, PP2CH ENSG00000175175 Protein phosphatase, Mg2+/Mn2+ dependent, 1E 17 58755869-58985176 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018462, HPA019263 Approved Supported Nucleus
Nucleoli Group enriched 5 adrenal gland: 7.3;cerebral cortex: 20.5;testis: 12.1 fallopian tube: 2.4 PPP1R17 C7orf16, GSBS ENSG00000106341 Protein phosphatase 1, regulatory subunit 17 7 31686715-31708455 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047819 Supported Group enriched 5 adrenal gland: 4.9;cerebral cortex: 2.6;testis: 1.1 lung: 0.5 PRKACB PKACb ENSG00000142875 Protein kinase, cAMP-dependent, catalytic, beta 1 84078062-84238498 Enzymes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010363, HPA029754, HPA071185 Approved Approved Cytosol Tissue enriched 5 cerebral cortex: 317.2 adrenal gland: 63.4 PTPRN IA-2 ENSG00000054356 Protein tyrosine phosphatase, receptor type, N 2 219289623-219309648 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007152, HPA007179 Supported Approved Endoplasmic reticulum Tissue enriched 5 cerebral cortex: 183.6 adrenal gland: 35.2 PTPRT KIAA0283, RPTPrho ENSG00000196090 Protein tyrosine phosphatase, receptor type, T 20 42072752-43189970 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017336, CAB069423 Approved Group enriched 5 cerebral cortex: 24.4;fallopian tube: 17.2 placenta: 3.9 REEP2 C5orf19, SGC32445, SPG72 ENSG00000132563 Receptor accessory protein 2 5 138439017-138446969 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031813 Supported Tissue enriched 5 cerebral cortex: 90.3 smooth muscle: 17.8 RGS4 SCZD9 ENSG00000117152 Regulator of G-protein signaling 4 1 163068775-163076802 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030802 Approved Endoplasmic reticulum Tissue enriched 5 cerebral cortex: 289.9 adrenal gland: 54.3 RGS8 MGC119067, MGC119068, MGC119069 ENSG00000135824 Regulator of G-protein signaling 8 1 182641816-182684576 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 cerebral cortex: 5.3;testis: 4.9;thyroid gland: 11.2 adrenal gland: 1.3 SCN2B ENSG00000149575 Sodium channel, voltage gated, type II beta subunit 11 118161951-118176673 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 5 cerebral cortex: 34.8 heart muscle: 6.7 SEPT4 ARTS, CE5B3, H5, hCDCREL-2, hucep-7, MART, PNUTL2 ENSG00000108387 Septin 4 17 58520250-58540818 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006855, HPA021587, HPA022905 Supported Supported Nucleoplasm Group enriched 5 adrenal gland: 218.2;cerebral cortex: 288.7;spleen: 57.8 adipose tissue: 36.8 SHISA4 C1orf40, hShisa4, TMEM58 ENSG00000198892 Shisa family member 4 1 201888680-201892306 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA061273 Uncertain Group enriched 5 adrenal gland: 23.6;cerebral cortex: 45.5;skeletal muscle: 94.5 heart muscle: 10.8 SLC6A1 GABATHG, GABATR, GAT1 ENSG00000157103 Solute carrier family 6 (neurotransmitter transporter), member 1 3 10992724-11039247 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013341, CAB022293 Supported Uncertain Mitochondria Group enriched 5 cerebral cortex: 119.7;liver: 50.3 parathyroid gland: 15.7 SNCA alpha-synuclein, NACP, PARK1, PARK4, PD1 ENSG00000145335 Synuclein, alpha (non A4 component of amyloid precursor) 4 89724099-89838315 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005459, CAB010877 Supported Group enriched 5 bone marrow: 161.2;cerebral cortex: 460.5 endometrium: 56.7 SRPK2 SFRSK2 ENSG00000135250 SRSF protein kinase 2 7 105110704-105399308 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015522, HPA020876 Approved Supported Nucleus
Cytosol Group enriched 5 cerebral cortex: 108.6;testis: 196.7 endometrium: 29.8 TMEFF1 C9orf2, CT120.1, H7365 ENSG00000241697 Transmembrane protein with EGF-like and two follistatin-like domains 1 9 100473113-100577636 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA051501 Uncertain Tissue enriched 5 cerebral cortex: 10.7 testis: 2.0 TMEM132E DFNB99 ENSG00000181291 Transmembrane protein 132E 17 34580749-34639318 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA070608 Approved Group enriched 5 cerebral cortex: 4.8;duodenum: 1.7;kidney: 3.2;small intestine: 1.1;testis: 1.5 cervix: 0.4 TMEM155 FLJ30834 ENSG00000164112 Transmembrane protein 155 4 121758933-121765427 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 cerebral cortex: 27.7;placenta: 5.7 lymph node: 3.0 TMEM233 IFITMD2 ENSG00000224982 Transmembrane protein 233 12 119593459-119643066 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA047506 Uncertain Group enriched 5 cerebral cortex: 16.3;skeletal muscle: 11.5;thyroid gland: 21.4 parathyroid gland: 3.1 WASF1 KIAA0269, SCAR1, WAVE, WAVE1 ENSG00000112290 WAS protein family, member 1 6 110099819-110180004 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004105, CAB022161 Approved Approved Group enriched 5 cerebral cortex: 139.4;testis: 149.1 ovary: 27.6 ZNF365 KIAA0844, UAN ENSG00000138311 Zinc finger protein 365 10 62374192-62672011 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052446 Approved Supported Vesicles
Microtubule organizing center Tissue enriched 5 cerebral cortex: 54.6 parathyroid gland: 10.7 AATK AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77 ENSG00000181409 Apoptosis-associated tyrosine kinase 17 81117295-81166077 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009073 Supported Uncertain Mitochondria Tissue enhanced 0 cerebral cortex: 36.5;duodenum: 24.0 small intestine: 18.7 ABAT GABAT ENSG00000183044 4-aminobutyrate aminotransferase 16 8674565-8784575 Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041528, HPA041690 Supported Supported Mitochondria Tissue enhanced 0 cerebral cortex: 165.0;kidney: 134.3;liver: 175.2 thyroid gland: 47.2 ABC7-42404400C24.1 ENSG00000277758 10 47750864-47763592 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level HPA036971, HPA036972, HPA064559 Approved Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 13.8;lung: 19.5 skin: 5.7 ABCC8 ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2 ENSG00000006071 ATP-binding cassette, sub-family C (CFTR/MRP), member 8 11 17392885-17476845 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011451, HPA042318 Approved Approved Nucleoli
Golgi apparatus
Cytosol Tissue enhanced 0 cerebral cortex: 11.7 adrenal gland: 7.6 AC006486.9 ENSG00000268643 19 42234583-42255132 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 7.8 endometrium: 5.1 AC007325.4 ENSG00000278817 Unmapped 131494-137392 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 36.9;skeletal muscle: 44.0 heart muscle: 33.2 AC138028.1 ENSG00000280603 16 88686544-88687053 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 21.4;epididymis: 12.5 bone marrow: 6.4 ACOT7 ACH1, ACT, BACH, CTE-II, hBACH, LACH1, MGC1126 ENSG00000097021 Acyl-CoA thioesterase 7 1 6264269-6394391 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA025735, HPA025762 Supported Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 129.6 small intestine: 63.6 ACSBG1 BG1, BGM, FLJ30320, hBG1, hsBG, KIAA0631, MGC14352 ENSG00000103740 Acyl-CoA synthetase bubblegum family member 1 15 78167468-78245688 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041642, CAB045955, HPA058869 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 25.7;skin: 13.3 adrenal gland: 8.1 ADAM11 MDC ENSG00000073670 ADAM metallopeptidase domain 11 17 44759031-44781846 Enzymes, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 19.8 heart muscle: 4.5 ADAM22 MDC2 ENSG00000008277 ADAM metallopeptidase domain 22 7 87934143-88202889 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050325 Approved Cell Junctions Tissue enhanced 0 cerebral cortex: 47.7 prostate: 17.5 ADAP1 CENTA1, GCS1L ENSG00000105963 ArfGAP with dual PH domains 1 7 897901-955407 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007033, HPA012049 Supported Supported Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 80.5 colon: 38.9 ADCY1 AC1 ENSG00000164742 Adenylate cyclase 1 (brain) 7 45574140-45723116 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018364, HPA068274 Uncertain Approved Mitochondria Tissue enhanced 0 cerebral cortex: 35.1 cervix: 8.2 ADCY2 AC2, HBAC2, KIAA1060 ENSG00000078295 Adenylate cyclase 2 (brain) 5 7396208-7830081 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB031482, HPA038015, HPA038483 Approved Tissue enhanced 0 cerebral cortex: 71.8;skeletal muscle: 35.8 prostate: 13.6 ADCYAP1 PACAP ENSG00000141433 Adenylate cyclase activating polypeptide 1 (pituitary) 18 904943-912172 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA065887 Approved Tissue enhanced 0 appendix: 19.7;cerebral cortex: 16.1;gallbladder: 15.7 testis: 5.7 ADCYAP1R1 PAC1, PAC1R, PACAPR ENSG00000078549 Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I 7 31052461-31111479 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049877 Approved Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 137.5;fallopian tube: 46.5 cervix: 20.6 ADGRA1 GPR123, KIAA1828 ENSG00000197177 Adhesion G protein-coupled receptor A1 10 133070929-133131675 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042773 Approved Tissue enhanced 0 adrenal gland: 4.9;cerebral cortex: 22.5 fallopian tube: 3.1 ADGRL1 CIRL1, KIAA0821, LEC2, LPHN1 ENSG00000072071 Adhesion G protein-coupled receptor L1 19 14147743-14206187 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037974 Uncertain Tissue enhanced 0 cerebral cortex: 60.3 parathyroid gland: 24.2 ADGRL3 KIAA0768, LEC3, LPHN3 ENSG00000150471 Adhesion G protein-coupled receptor L3 4 61201258-62078335 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015027, HPA015762, CAB022698 Uncertain Tissue enhanced 0 cerebral cortex: 42.1;parathyroid gland: 30.1 cervix: 8.5 ADORA1 RDC7 ENSG00000163485 Adenosine A1 receptor 1 203090654-203167405 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044383 Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 46.5;testis: 23.4 parathyroid gland: 17.5 ADRA1B ENSG00000170214 Adrenoceptor alpha 1B 5 159916783-159972544 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA074416 Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 14.8;spleen: 17.3 ovary: 4.8 AGBL4 CCP6, FLJ14442 ENSG00000186094 ATP/GTP binding protein-like 4 1 48532855-50023913 Enzymes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA037994 Approved Tissue enhanced 0 cerebral cortex: 7.9 fallopian tube: 4.6 AGPAT4 dJ473J16.2, LPAAT-delta ENSG00000026652 1-acylglycerol-3-phosphate O-acyltransferase 4 6 161129979-161274061 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053287, HPA060525 Approved Approved Nucleoli
Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 24.8 placenta: 12.2 AGT SERPINA8 ENSG00000135744 Angiotensinogen (serpin peptidase inhibitor, clade A, member 8) 1 230702523-230714297 Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001557, CAB025798 Supported Tissue enhanced 0 cerebral cortex: 227.1;liver: 649.2 gallbladder: 134.3 AIFM3 AIFL, FLJ30473 ENSG00000183773 Apoptosis-inducing factor, mitochondrion-associated, 3 22 20965108-20981360 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001271 Validated Mitochondria Tissue enhanced 0 cerebral cortex: 18.6;colon: 19.1 rectum: 9.1 AJAP1 MOT8, SHREW-1, SHREW1 ENSG00000196581 Adherens junctions associated protein 1 1 4654732-4792534 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 11.3;ovary: 6.0 seminal vesicle: 3.2 AKAP6 ADAP6, AKAP100, KIAA0311, mAKAP, PRKA6 ENSG00000151320 A kinase (PRKA) anchor protein 6 14 32329273-32837681 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001983, HPA048741 Supported Tissue enhanced 0 cerebral cortex: 49.1;heart muscle: 37.3 skeletal muscle: 16.6 AL365181.2 ENSG00000280316 1 156597173-156599410 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 4.5 epididymis: 1.6 ALK CD246 ENSG00000171094 Anaplastic lymphoma receptor tyrosine kinase 2 29192774-29921566 Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010694 Approved Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 3.5;testis: 2.3 adrenal gland: 0.9 AMZ1 KIAA1950 ENSG00000174945 Archaelysin family metallopeptidase 1 7 2679522-2775500 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA020233 Uncertain Tissue enhanced 0 cerebral cortex: 4.0 endometrium: 1.6 ANK2 LQT4 ENSG00000145362 Ankyrin 2, neuronal 4 112818109-113383740 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008007, CAB015178, HPA035970 Supported Tissue enhanced 0 cerebral cortex: 184.9 kidney: 124.2 ANKRD13B FLJ25555 ENSG00000198720 Ankyrin repeat domain 13B 17 29589769-29614761 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051886, HPA063748 Uncertain Supported Vesicles Tissue enhanced 0 cerebral cortex: 26.0 testis: 17.6 ANKRD24 KIAA1981 ENSG00000089847 Ankyrin repeat domain 24 19 4183354-4224814 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA041534, HPA048498 Uncertain Uncertain Microtubules
Cytosol Tissue enhanced 0 cerebral cortex: 13.6;testis: 7.0 prostate: 2.8 ANKRD34C ENSG00000235711 Ankyrin repeat domain 34C 15 79293285-79298235 Predicted intracellular proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA045329 Uncertain Approved Mitochondria Tissue enhanced 0 cerebral cortex: 1.9 skin: 0.9 ANLN ANILLIN, scra, Scraps ENSG00000011426 Anillin actin binding protein 7 36389806-36453791 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005680, CAB033902, HPA050556, CAB062547, CAB068175 Supported Supported Nucleoplasm Tissue enhanced 0 cerebral cortex: 87.4 bone marrow: 23.2 ANO8 KIAA1623, TMEM16H ENSG00000074855 Anoctamin 8 19 17323223-17334829 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031787, HPA049206 Uncertain Uncertain Nucleoplasm
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 34.6 skin: 20.0 APBA1 D9S411E, MINT1, X11 ENSG00000107282 Amyloid beta (A4) precursor protein-binding, family A, member 1 9 69427530-69672306 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061287 Supported Golgi apparatus Tissue enhanced 0 cerebral cortex: 18.4 parathyroid gland: 11.6 APBA2 D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L ENSG00000034053 Amyloid beta (A4) precursor protein-binding, family A, member 2 15 28884483-29118315 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB037065, HPA039400 Uncertain Approved Nucleoplasm
Golgi apparatus
Vesicles
Plasma membrane Tissue enhanced 0 cerebral cortex: 12.2 spleen: 3.3 APBB3 FE65L2 ENSG00000113108 Amyloid beta (A4) precursor protein-binding, family B, member 3 5 140558268-140593752 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA005571 Uncertain Supported Actin filaments
Cytosol Tissue enhanced 0 cerebral cortex: 11.7 testis: 6.8 APC DP2, DP2.5, DP3, PPP1R46 ENSG00000134982 Adenomatous polyposis coli 5 112707498-112846239 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013349, CAB025994 Approved Tissue enhanced 0 cerebral cortex: 60.3 parathyroid gland: 19.5 ARFGEF3 BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33 ENSG00000112379 ARFGEF family member 3 6 138161921-138344663 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036350 Uncertain Tissue enhanced 0 cerebral cortex: 23.7;parathyroid gland: 29.2 prostate: 19.3 ARHGDIG RHOGDI-3 ENSG00000242173 Rho GDP dissociation inhibitor (GDI) gamma 16 268727-283010 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 131.5;duodenum: 45.5 small intestine: 18.2 ARHGEF4 ASEF, KIAA1112, STM6 ENSG00000136002 Rho guanine nucleotide exchange factor (GEF) 4 2 130836916-131047263 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018267 Approved Tissue enhanced 0 cerebral cortex: 96.7;skin: 57.2 esophagus: 25.4 ASPHD1 ENSG00000174939 Aspartate beta-hydroxylase domain containing 1 16 29900375-29919864 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045175 Uncertain Tissue enhanced 0 cerebral cortex: 53.7 gallbladder: 11.9 ASPHD2 FLJ39838 ENSG00000128203 Aspartate beta-hydroxylase domain containing 2 22 26429273-26445015 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA000820 Uncertain Tissue enhanced 0 cerebral cortex: 12.9 stomach: 7.9 ATL1 AD-FSP, FSP1, SPG3, SPG3A ENSG00000198513 Atlastin GTPase 1 14 50532509-50633068 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027550 Approved Tissue enhanced 0 cerebral cortex: 97.2 smooth muscle: 22.1 ATP1A3 DYT12 ENSG00000105409 ATPase, Na+/K+ transporting, alpha 3 polypeptide 19 41966582-41997497 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033630, HPA045367, HPA056446 Supported Tissue enhanced 0 cerebral cortex: 376.4;heart muscle: 94.2 testis: 54.1 ATRNL1 ALP, FLJ45344, KIAA0534 ENSG00000107518 Attractin-like 1 10 115093365-115948992 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA038070 Uncertain Approved Nucleus
Mitochondria Tissue enhanced 0 cerebral cortex: 34.0 testis: 22.6 B3GALT1 beta3Gal-T1 ENSG00000172318 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 1 2 167868948-167874041 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 5.2;colon: 3.8;rectum: 4.1 skeletal muscle: 1.8 B3GALT2 beta3Gal-T2 ENSG00000162630 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 1 193179045-193186654 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA078659 Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 29.0;gallbladder: 26.0 heart muscle: 16.2 B3GNT4 B3GN-T4, beta3Gn-T4 ENSG00000176383 UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4 12 122203543-122208952 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA055261 Uncertain Approved Nucleoli
Mitochondria Tissue enhanced 0 cerebral cortex: 4.3;skin: 2.9 kidney: 1.9 B4GALNT4 FLJ25045, NGalNAc-T1 ENSG00000182272 Beta-1,4-N-acetyl-galactosaminyl transferase 4 11 369796-382116 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA053126 Uncertain Approved Nucleoplasm
Microtubules
Cytokinetic bridge
Mitotic spindle Tissue enhanced 0 cerebral cortex: 30.9;ovary: 11.7 endometrium: 6.9 B4GAT1 B3GN-T1, B3GNT1, B3GNT6, BETA3GNTI, iGAT, iGNT ENSG00000174684 Beta-1,4-glucuronyltransferase 1 11 66345372-66347692 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015484 Uncertain Tissue enhanced 0 cerebral cortex: 185.7 adrenal gland: 52.7 BAIAP3 BAP3, KIAA0734 ENSG00000007516 BAI1-associated protein 3 16 1333601-1349441 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015627 Uncertain Tissue enhanced 0 adrenal gland: 25.1;cerebral cortex: 25.2;fallopian tube: 41.9 testis: 13.8 BASP1 CAP-23, CAP23, NAP-22, NAP22 ENSG00000176788 Brain abundant, membrane attached signal protein 1 5 17065598-17276843 Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045218, HPA050333 Supported Validated Plasma membrane Tissue enhanced 0 cerebral cortex: 420.3;epididymis: 364.8 prostate: 133.3 BCAS1 AIBC1, NABC1 ENSG00000064787 Breast carcinoma amplified sequence 1 20 53936777-54070594 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB033558, HPA051816, HPA054745 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 109.0;stomach: 156.7 rectum: 82.3 BDNF ENSG00000176697 Brain-derived neurotrophic factor 11 27654893-27722058 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009564, HPA031440, HPA056104 Supported Supported Nuclear speckles
Mitochondria Tissue enhanced 0 cerebral cortex: 12.0 epididymis: 5.8 BEGAIN KIAA1446 ENSG00000183092 Brain-enriched guanylate kinase-associated 14 100537149-100587413 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002899 Uncertain Uncertain Nucleus
Golgi apparatus
Cytosol Tissue enhanced 0 cerebral cortex: 21.4 adrenal gland: 5.1 BEST3 MGC13168, MGC40411, VMD2L3 ENSG00000127325 Bestrophin 3 12 69643360-69699476 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA054582 Approved Tissue enhanced 0 cerebral cortex: 16.4;skeletal muscle: 12.2 testis: 5.9 BEX1 ENSG00000133169 Brain expressed, X-linked 1 X 103062651-103064240 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA045384 Approved Tissue enhanced 0 cerebral cortex: 506.7 parathyroid gland: 151.6 BEX2 DJ79P11.1 ENSG00000133134 Brain expressed X-linked 2 X 103309346-103311046 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA045384 Uncertain Tissue enhanced 0 cerebral cortex: 227.2 thyroid gland: 156.4 BEX5 NGFRAP1L1 ENSG00000184515 Brain expressed, X-linked 5 X 102153708-102156057 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA059058 Approved Tissue enhanced 0 cerebral cortex: 96.4 epididymis: 34.2 BHLHB9 GASP3, KIAA1701, p60TRP ENSG00000198908 Basic helix-loop-helix domain containing, class B, 9 X 102720688-102753540 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA000887 Approved Cytosol Tissue enhanced 0 cerebral cortex: 18.8 parathyroid gland: 8.3 BHLHE22 Beta3, BHLHB5, bHLHe22, CAGL85, TNRC20 ENSG00000180828 Basic helix-loop-helix family, member e22 8 64580367-64583628 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA064128, HPA064872, HPA067500 Supported Tissue enhanced 0 cerebral cortex: 12.2 seminal vesicle: 3.3 BRINP3 DBCCR1L, DBCCR1L1, FAM5C ENSG00000162670 Bone morphogenetic protein/retinoic acid inducible neural-specific 3 1 190097662-190478404 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054693 Uncertain Tissue enhanced 0 cerebral cortex: 44.6;small intestine: 20.0 prostate: 10.5 BRSK2 C11orf7, PEN11B, STK29 ENSG00000174672 BR serine/threonine kinase 2 11 1389899-1462689 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA073690 Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 61.8;pancreas: 19.2 testis: 9.5 C10orf105 FLJ00245 ENSG00000214688 Chromosome 10 open reading frame 105 10 71711701-71737824 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 2.3;spleen: 3.3 testis: 1.4 C10orf35 ENSG00000171224 Chromosome 10 open reading frame 35 10 69630251-69633599 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034591 Approved Approved Nucleus
Centrosome
Cytosol Tissue enhanced 0 cerebral cortex: 27.7 testis: 20.2 C15orf59 LOC388135, MGC131524 ENSG00000205363 Chromosome 15 open reading frame 59 15 73735431-73752747 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041563 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 56.1 seminal vesicle: 19.5 C16orf45 FLJ32618 ENSG00000166780 Chromosome 16 open reading frame 45 16 15434295-15625028 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041114 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 172.4 cervix: 59.2 C17orf51 FLJ12977, FLJ31874, FLJ33618 ENSG00000212719 Chromosome 17 open reading frame 51 17 21524790-21574458 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052106 Approved Approved Nucleoplasm
Nuclear bodies
Vesicles Tissue enhanced 0 cerebral cortex: 16.7 testis: 8.6 C17orf96 LOC100170841, PRR28 ENSG00000273604 Chromosome 17 open reading frame 96 17 38671703-38675421 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA055190, HPA056555 Uncertain Supported Nucleoplasm
Cytosol
Cytoplasmic bodies Tissue enhanced 0 cerebral cortex: 5.6;testis: 5.0 parathyroid gland: 2.1 C1orf216 FLJ38984 ENSG00000142686 Chromosome 1 open reading frame 216 1 35713875-35719472 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA028299, HPA031343 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 60.7 smooth muscle: 18.5 C1orf95 DKFZp761P211 ENSG00000203685 Chromosome 1 open reading frame 95 1 226548800-226609214 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 35.8 smooth muscle: 8.3 C2orf72 LOC257407 ENSG00000204128 Chromosome 2 open reading frame 72 2 231037490-231049719 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044962 Uncertain Approved Nucleus
Plasma membrane Tissue enhanced 0 cerebral cortex: 2.8;colon: 3.0;liver: 4.7 stomach: 1.3 C3orf80 ENSG00000180044 Chromosome 3 open reading frame 80 3 160225636-160228213 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA047439 Uncertain Tissue enhanced 0 cerebral cortex: 1.9 duodenum: 0.5 C4orf48 ENSG00000243449 Chromosome 4 open reading frame 48 4 2041993-2043970 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA052447 Uncertain Supported Cytosol Tissue enhanced 0 cerebral cortex: 22.2 testis: 11.3 C9orf172 ENSG00000232434 Chromosome 9 open reading frame 172 9 136844415-136848801 Predicted intracellular proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA021200 Uncertain Approved Focal adhesion sites
Cytosol Tissue enhanced 0 cerebral cortex: 7.4 spleen: 3.4 CA10 CA-RPX, CARPX, HUCEP-15 ENSG00000154975 Carbonic anhydrase X 17 51630313-52160017 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA054825, HPA057837 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 56.9;cervix, uterine: 31.9 testis: 10.6 CA11 CARP2, CARPX1 ENSG00000063180 Carbonic anhydrase XI 19 48637942-48646312 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041778 Approved Vesicles
Microtubules Tissue enhanced 0 cerebral cortex: 244.8 ovary: 49.6 CA14 ENSG00000118298 Carbonic anhydrase XIV 1 150257159-150265078 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008482 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 10.6;seminal vesicle: 21.1 skeletal muscle: 9.4 CABP7 MGC57793 ENSG00000100314 Calcium binding protein 7 22 29720084-29731839 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA016439 Uncertain Tissue enhanced 0 adrenal gland: 2.5;cerebral cortex: 3.4 small intestine: 1.4 CACNA1A APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6 ENSG00000141837 Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit 19 13206442-13623990 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064258 Supported Approved Nucleoplasm
Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 18.1 stomach: 6.4 CACNA1G Cav3.1, NBR13 ENSG00000006283 Calcium channel, voltage-dependent, T type, alpha 1G subunit 17 50561068-50627474 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA004714 Uncertain Tissue enhanced 0 cerebral cortex: 10.6;cervix, uterine: 8.5 endometrium: 5.2 CACNA1I Cav3.3 ENSG00000100346 Calcium channel, voltage-dependent, T type, alpha 1I subunit 22 39570753-39689737 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 4.7;thyroid gland: 2.7 adrenal gland: 2.3 CACNA2D3 HSA272268 ENSG00000157445 Calcium channel, voltage-dependent, alpha 2/delta subunit 3 3 54122547-55074557 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030849, HPA030850 Uncertain Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 16.3 adrenal gland: 5.4 CACNB4 EJM4 ENSG00000182389 Calcium channel, voltage-dependent, beta 4 subunit 2 151832776-152099079 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015601 Approved Tissue enhanced 0 cerebral cortex: 34.8 skin: 11.2 CACNG4 MGC11138, MGC24983 ENSG00000075461 Calcium channel, voltage-dependent, gamma subunit 4 17 66964910-67033398 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA005803, HPA065370 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 48.7;prostate: 18.8 lung: 9.3 CACNG5 ENSG00000075429 Calcium channel, voltage-dependent, gamma subunit 5 17 66835117-66885486 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA050115 Uncertain Tissue enhanced 0 cerebral cortex: 1.2 lymph node: 0.6 CADM3 BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1 ENSG00000162706 Cell adhesion molecule 3 1 159171609-159203313 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002981, CAB025746 Supported Tissue enhanced 0 cerebral cortex: 279.4;placenta: 113.9 cervix: 48.6 CADM4 IGSF4C, Necl-4, SynCAM4, TSLL2 ENSG00000105767 Cell adhesion molecule 4 19 43622368-43639839 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012612 Supported Approved Nucleus
Nuclear membrane Tissue enhanced 0 cerebral cortex: 164.1 parathyroid gland: 58.8 CALHM1 FAM26C ENSG00000185933 Calcium homeostasis modulator 1 10 103453387-103458888 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018317 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 kidney: 0.6 CAMK1D CKLiK ENSG00000183049 Calcium/calmodulin-dependent protein kinase ID 10 12349482-12835545 Enzymes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007266 Uncertain Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 52.2 skin: 22.0 CAMK1G CLICKIII, dJ272L16.1, VWS1 ENSG00000008118 Calcium/calmodulin-dependent protein kinase IG 1 209583717-209613938 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 32.4;ovary: 27.7 seminal vesicle: 7.3 CAMK2B CAM2, CAMK2, CAMKB ENSG00000058404 Calcium/calmodulin-dependent protein kinase II beta 7 44217150-44334577 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB006849, HPA026307, HPA051783, HPA051785, HPA053973 Supported Supported Uncertain Plasma membrane
Cell Junctions Tissue enhanced 0 cerebral cortex: 214.7 skeletal muscle: 46.1 CAMK2N1 CaMKIINalpha ENSG00000162545 Calcium/calmodulin-dependent protein kinase II inhibitor 1 1 20482391-20486220 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 322.1 small intestine: 97.5 CAMK2N2 CaM-KIIN ENSG00000163888 Calcium/calmodulin-dependent protein kinase II inhibitor 2 3 184259213-184261463 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA050835 Supported Nucleus
Centrosome Tissue enhanced 0 adrenal gland: 12.3;cerebral cortex: 40.5 pancreas: 5.6 CAMK4 CaMK-GR ENSG00000152495 Calcium/calmodulin-dependent protein kinase IV 5 111223653-111494886 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004347, HPA011753, HPA017206 Approved Supported Nucleoplasm
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 16.6;testis: 16.9 lymph node: 9.9 CAMKK1 CAMKKA, DKFZp761M0423, MGC34095 ENSG00000004660 Calcium/calmodulin-dependent protein kinase kinase 1, alpha 17 3860315-3894891 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009111, HPA028062 Approved Supported Cytosol Tissue enhanced 0 cerebral cortex: 51.6 seminal vesicle: 14.5 CAP2 ENSG00000112186 CAP, adenylate cyclase-associated protein, 2 (yeast) 6 17393216-17557792 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050530, HPA054147 Supported Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 125.5;skeletal muscle: 220.9 heart muscle: 69.1 CBARP BARP, C19orf26, DOS, MGC40084 ENSG00000099625 Calcium channel, voltage-dependent, beta subunit associated regulatory protein 19 1228287-1238027 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012777 Uncertain Approved Nucleoplasm Tissue enhanced 0 adrenal gland: 2.4;cerebral cortex: 7.0 testis: 1.1 CBLN4 CBLNL1, dJ885A10.1 ENSG00000054803 Cerebellin 4 precursor 20 55997440-56005472 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056335, HPA074497 Supported Uncertain Endoplasmic reticulum Tissue enhanced 0 adrenal gland: 24.7;cerebral cortex: 15.7;epididymis: 11.0 fallopian tube: 6.7 CBSL ENSG00000274276 Cystathionine-beta-synthase like 21 6444869-6468040 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA001223 Supported Approved Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 46.0;liver: 27.4 thyroid gland: 22.1 CCDC177 C14orf162, PLPL ENSG00000267909 Coiled-coil domain containing 177 14 69569816-69574837 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 2.3 epididymis: 0.7 CCDC184 C12orf68, LOC387856 ENSG00000177875 Coiled-coil domain containing 184 12 48183584-48185926 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA039947, HPA041715 Uncertain Approved Mitochondria
Cytosol Tissue enhanced 0 cerebral cortex: 15.4 adrenal gland: 6.7 CCDC85A KIAA1912 ENSG00000055813 Coiled-coil domain containing 85A 2 56184123-56386173 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043106, HPA057020 Uncertain Tissue enhanced 0 cerebral cortex: 21.1 thyroid gland: 15.8 CCSAP C1orf96, CSAP, FLJ41471 ENSG00000154429 Centriole, cilia and spindle-associated protein 1 229321005-229343294 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028402, HPA043443 Supported Uncertain Nucleoplasm
Cytokinetic bridge Tissue enhanced 0 cerebral cortex: 54.2 placenta: 18.6 CDH18 CDH14, EY-CADHERIN ENSG00000145526 Cadherin 18, type 2 5 19472951-20575873 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA014416 Uncertain Tissue enhanced 0 adrenal gland: 5.9;cerebral cortex: 19.1 testis: 3.2 CDH4 ENSG00000179242 Cadherin 4, type 1, R-cadherin (retinal) 20 61252426-61940617 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA015613 Validated Plasma membrane Tissue enhanced 0 cerebral cortex: 6.0;spleen: 4.9 seminal vesicle: 1.3 CDH7 ENSG00000081138 Cadherin 7, type 2 18 65750252-65890341 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA061419 Approved Tissue enhanced 0 cerebral cortex: 2.8;prostate: 1.2 testis: 0.7 CDH9 ENSG00000113100 Cadherin 9, type 2 (T1-cadherin) 5 26880600-27121150 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007167 Uncertain Tissue enhanced 0 breast: 16.7;cerebral cortex: 11.4 testis: 6.6 CDKL5 CFAP247, EIEE2, STK9 ENSG00000008086 Cyclin-dependent kinase-like 5 X 18425583-18653629 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA002847, CAB011577 Supported Validated Nucleoplasm Tissue enhanced 0 cerebral cortex: 31.2 testis: 14.6 CDR1 CDR, CDR34, CDR62A ENSG00000184258 Cerebellar degeneration-related protein 1, 34kDa X 140782405-140784871 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA073147 Approved Nucleoplasm
Golgi apparatus
Centrosome Tissue enhanced 0 cerebral cortex: 48.5 skin: 12.1 CECR2 KIAA1740 ENSG00000099954 Cat eye syndrome chromosome region, candidate 2 22 17359949-17558149 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002943 Approved Approved Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 7.8 skeletal muscle: 7.5 CELSR2 ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3 ENSG00000143126 Cadherin, EGF LAG seven-pass G-type receptor 2 1 109250019-109275750 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013952 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 45.2 skin: 31.1 CGREF1 CGR11 ENSG00000138028 Cell growth regulator with EF-hand domain 1 2 27098889-27119115 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA008241 Uncertain Tissue enhanced 0 cerebral cortex: 44.9 stomach: 11.6 CHADL SLRR4B ENSG00000100399 Chondroadherin-like 22 41229510-41240934 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005696, HPA024654 Uncertain Tissue enhanced 0 cerebral cortex: 28.5 skin: 6.7 CHI3L1 GP39, YKL40 ENSG00000133048 Chitinase 3-like 1 (cartilage glycoprotein-39) 1 203178931-203186749 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA072269 Approved Vesicles Tissue enhanced 0 appendix: 191.3;cerebral cortex: 267.7;urinary bladder: 185.7 bone marrow: 147.1 CHRM3 ENSG00000133019 Cholinergic receptor, muscarinic 3 1 239386565-239915452 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024106, HPA048036 Approved Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 15.7 esophagus: 8.5 CHRM4 ENSG00000180720 Cholinergic receptor, muscarinic 4 11 46385098-46386608 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB022444, HPA072083 Uncertain Uncertain Nucleus
Golgi apparatus Tissue enhanced 0 cerebral cortex: 8.1;small intestine: 7.9;spleen: 21.9 testis: 6.9 CHRM5 ENSG00000184984 Cholinergic receptor, muscarinic 5 15 33968720-34067457 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA013172 Uncertain Tissue enhanced 0 cerebral cortex: 3.1;testis: 4.1 placenta: 2.5 CHRNA4 BFNC, EBN, EBN1 ENSG00000101204 Cholinergic receptor, nicotinic, alpha 4 (neuronal) 20 63343223-63378401 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB034064 Uncertain Tissue enhanced 0 cerebral cortex: 6.8;parathyroid gland: 16.9 liver: 3.7 CHST1 C6ST, KSGal6ST ENSG00000175264 Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 11 45648877-45665622 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 49.1;parathyroid gland: 18.8 thyroid gland: 9.8 CHST10 HNK-1ST ENSG00000115526 Carbohydrate sulfotransferase 10 2 100391860-100417656 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA012884, HPA051545 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 46.6 endometrium: 19.3 CHST8 GALNAC-4-ST1 ENSG00000124302 Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8 19 33621955-33773509 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 2.5 breast: 1.4 CLCN4 ClC-4, CLC4 ENSG00000073464 Chloride channel, voltage-sensitive 4 X 10156945-10237660 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031313, HPA063637 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 49.2;epididymis: 27.6 skeletal muscle: 14.6 CLDN11 OSP, OTM ENSG00000013297 Claudin 11 3 170418865-170860380 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB009789, HPA013166 Supported Tissue enhanced 0 cerebral cortex: 89.2;testis: 184.3 ovary: 61.8 CLIP2 CLIP, CLIP-115, CYLN2, KIAA0291, WBSCR3, WBSCR4, WSCR3, WSCR4 ENSG00000106665 CAP-GLY domain containing linker protein 2 7 74289475-74405943 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020430, CAB020767 Supported Tissue enhanced 0 cerebral cortex: 76.0 ovary: 20.9 CLIP3 CLIPR-59, RSNL1 ENSG00000105270 CAP-GLY domain containing linker protein 3 19 36014660-36033343 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 248.3 smooth muscle: 55.5 CLSTN2 CDHR13, CS2, CSTN2, FLJ39113 ENSG00000158258 Calsyntenin 2 3 139935185-140577397 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031342, HPA061800 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 35.3;ovary: 95.1 adipose tissue: 19.8 CLSTN3 CDHR14, CSTN3, KIAA0726 ENSG00000139182 Calsyntenin 3 12 7129698-7158945 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 127.1 parathyroid gland: 40.7 CLVS1 C6orf212L, CRALBPL, MGC34646, RLBP1L1 ENSG00000177182 Clavesin 1 8 61057158-61501645 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 10.2;testis: 6.3 thyroid gland: 2.0 CNIH3 CNIH-3, FLJ38993 ENSG00000143786 Cornichon family AMPA receptor auxiliary protein 3 1 224434660-224740549 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 14.8 testis: 4.2 CNNM1 ACDP1 ENSG00000119946 Cyclin and CBS domain divalent metal cation transport mediator 1 10 99329099-99394330 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA040408 Approved Uncertain Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 10.2;testis: 16.7 ovary: 3.0 CNR1 CANN6, CB-R, CB1, CB1A, CB1K5, CNR ENSG00000118432 Cannabinoid receptor 1 (brain) 6 88139864-88166359 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005603, HPA042256 Approved Approved Plasma membrane
Actin filaments Tissue enhanced 0 cerebral cortex: 32.2 adipose tissue: 12.1 CNRIP1 C2orf32, CRIP1, CRIP1a, CRIP1b, DKFZP566K1924 ENSG00000119865 Cannabinoid receptor interacting protein 1 2 68284171-68320051 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035337 Approved Cytosol Tissue enhanced 0 cerebral cortex: 53.9 adipose tissue: 24.9 CNTFR ENSG00000122756 Ciliary neurotrophic factor receptor 9 34551432-34590140 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025310, HPA036635 Approved Approved Golgi apparatus Tissue enhanced 0 adipose tissue: 62.5;cerebral cortex: 53.6 spleen: 28.0 CNTN1 F3, GP135 ENSG00000018236 Contactin 1 12 40692442-41072418 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025200, HPA041060 Approved Tissue enhanced 0 cerebral cortex: 226.1 ovary: 65.4 CNTN3 BIG-1, PANG ENSG00000113805 Contactin 3 (plasmacytoma associated) 3 74262568-74521140 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003341 Approved Tissue enhanced 0 cerebral cortex: 12.4 fallopian tube: 11.9 CNTN5 hNB-2, NB-2 ENSG00000149972 Contactin 5 11 99020953-100358885 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039492, HPA041223 Approved Supported Cytosol Tissue enhanced 0 cerebral cortex: 2.6;placenta: 3.4;thyroid gland: 3.0 fallopian tube: 1.8 CNTNAP1 Caspr, CNTNAP, NRXN4, p190 ENSG00000108797 Contactin associated protein 1 17 42682613-42699814 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011772 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 62.0;smooth muscle: 38.6 endometrium: 19.2 CNTNAP5 caspr5, FLJ31966 ENSG00000155052 Contactin associated protein-like 5 2 124025287-124915287 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA069095, HPA069356 Supported Nucleus
Nucleoli fibrillar center
Vesicles Tissue enhanced 0 cerebral cortex: 5.8;gallbladder: 1.6 adrenal gland: 0.7 COL26A1 EMI6, EMID2, Emu2 ENSG00000160963 Collagen, type XXVI, alpha 1 7 101362820-101559024 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA027059 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 10.2;parathyroid gland: 5.5 prostate: 2.9 CORO2B ClipinC, KIAA0925 ENSG00000103647 Coronin, actin binding protein, 2B 15 68578969-68727806 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017960 Approved Approved Plasma membrane
Focal adhesion sites Tissue enhanced 0 cerebral cortex: 73.5;fallopian tube: 36.2 ovary: 17.8 CPLX2 CPX-2, DKFZp547D155 ENSG00000145920 Complexin 2 5 175796310-175884020 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA071191 Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 237.1;epididymis: 143.5 adrenal gland: 44.6 CPNE4 COPN4, CPN4 ENSG00000196353 Copine IV 3 131533555-132285410 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032036 Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 12.2;prostate: 41.7 seminal vesicle: 5.8 CPNE5 COPN5, CPN5, KIAA1599 ENSG00000124772 Copine V 6 36740775-36840002 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031369 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 119.3 testis: 34.7 CPT1C CPT1P, CPTIC, FLJ23809 ENSG00000169169 Carnitine palmitoyltransferase 1C 19 49690898-49713731 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014529 Supported Approved Centrosome Tissue enhanced 0 cerebral cortex: 34.3 adrenal gland: 7.0 CRB2 FLJ16786, FLJ38464 ENSG00000148204 Crumbs family member 2 9 123356170-123380324 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043674 Uncertain Tissue enhanced 0 cerebral cortex: 9.4 kidney: 2.1 CRH CRF, CRH1 ENSG00000147571 Corticotropin releasing hormone 8 66176382-66178725 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB010885, HPA046846, HPA062111 Uncertain Supported Tissue enhanced 0 cerebral cortex: 2.1;placenta: 8.0 adipose tissue: 1.2 CRHR1 CRF-R, CRF1, CRHR ENSG00000120088 Corticotropin releasing hormone receptor 1 17 45784280-45835828 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 4.0 endometrium: 0.8 CRLF1 CISS, CISS1, CLF, CLF-1 ENSG00000006016 Cytokine receptor-like factor 1 19 18572220-18607741 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041493, HPA041793 Approved Tissue enhanced 0 cerebral cortex: 17.2;placenta: 16.7 adipose tissue: 10.0 CRTAC1 ASPIC1, CEP-68, FLJ10320 ENSG00000095713 Cartilage acidic protein 1 10 97865000-98030828 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008175 Approved Tissue enhanced 0 cerebral cortex: 51.1;fallopian tube: 62.9;lung: 76.5;seminal vesicle: 47.6 urinary bladder: 13.3 CSMD1 KIAA1890, PPP1R24 ENSG00000183117 CUB and Sushi multiple domains 1 8 2935353-4994972 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA074707 Approved Vesicles Tissue enhanced 0 cerebral cortex: 6.2;testis: 4.7 fallopian tube: 1.1 CSMD2 KIAA1884 ENSG00000121904 CUB and Sushi multiple domains 2 1 33513999-34165842 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008622 Uncertain Tissue enhanced 0 cerebral cortex: 2.6;gallbladder: 1.8 testis: 1.0 CSRNP3 FAM130A2, FLJ32093, PPP1R73, TAIP-2 ENSG00000178662 Cysteine-serine-rich nuclear protein 3 2 165469647-165689407 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at transcript level HPA017905 Supported Approved Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 16.2 endometrium: 4.6 CTD-2207O23.12 ENSG00000267952 19 7507052-7519622 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 7.9;skeletal muscle: 5.8 kidney: 2.9 CTD-2410N18.5 ENSG00000272772 5 134167170-134226071 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 1.3 heart muscle: 0.6 CTNNA3 MGC26194, VR22 ENSG00000183230 Catenin (cadherin-associated protein), alpha 3 10 65912518-67696169 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017977, HPA061818 Supported Tissue enhanced 0 cerebral cortex: 8.5;heart muscle: 11.2 liver: 4.3 CTXN1 FLJ25968 ENSG00000178531 Cortexin 1 19 7924485-7926166 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA016669 Uncertain Approved Nucleoplasm
Plasma membrane
Cell Junctions Tissue enhanced 0 cerebral cortex: 100.8 endometrium: 22.7 CUX2 CDP2, CUTL2, KIAA0293 ENSG00000111249 Cut-like homeobox 2 12 111034024-111350554 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044772 Uncertain Tissue enhanced 0 cerebral cortex: 12.2;liver: 9.6;prostate: 17.1 thyroid gland: 6.8 CX3CL1 ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1 ENSG00000006210 Chemokine (C-X3-C motif) ligand 1 16 57372458-57385048 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB026192, HPA040361 Approved Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 100.4 lung: 69.4 CX3CR1 CCRL1, CMKBRL1, CMKDR1, GPR13, V28 ENSG00000168329 Chemokine (C-X3-C motif) receptor 1 3 39263494-39281735 Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032478, HPA046587 Approved Tissue enhanced 0 cerebral cortex: 59.4 spleen: 16.8 CXXC4 IDAX ENSG00000168772 CXXC finger protein 4 4 104468312-104494901 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA036600, HPA036925 Uncertain Uncertain Nucleus
Golgi apparatus Tissue enhanced 0 cerebral cortex: 8.9 thyroid gland: 4.1 DBNDD1 FLJ12582, MGC3101 ENSG00000003249 Dysbindin (dystrobrevin binding protein 1) domain containing 1 16 90004865-90020128 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA043018 Approved Approved Nuclear speckles
Cytosol Tissue enhanced 0 cerebral cortex: 24.1 skeletal muscle: 15.6 DCC IGDCC1, NTN1R1 ENSG00000187323 DCC netrin 1 receptor 18 52340172-53535903 Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055376, HPA069552 Supported Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 3.7;testis: 13.4 lung: 2.2 DCX DBCN, DC, LISX, SCLH, XLIS ENSG00000077279 Doublecortin X 111293780-111412375 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036121, HPA059243 Supported Supported Cytosol Tissue enhanced 0 cerebral cortex: 11.3 endometrium: 2.6 DGKG DAGK3 ENSG00000058866 Diacylglycerol kinase, gamma 90kDa 3 186105668-186362237 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036577 Approved Approved Vesicles
Plasma membrane Tissue enhanced 0 cerebral cortex: 21.3 placenta: 11.1 DIRAS1 Di-Ras1, GBTS1, RIG ENSG00000176490 DIRAS family, GTP-binding RAS-like 1 19 2714567-2721418 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 71.1;heart muscle: 48.4 parathyroid gland: 23.6 DISP2 DISPB, HsT16908, KIAA1742 ENSG00000140323 Dispatched homolog 2 (Drosophila) 15 40358235-40378639 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059903 Uncertain Approved Nucleoplasm
Vesicles Tissue enhanced 0 cerebral cortex: 7.5 thyroid gland: 1.9 DKK3 REIC, RIG ENSG00000050165 Dickkopf WNT signaling pathway inhibitor 3 11 11963106-12009769 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011868, CAB024949 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 374.5;heart muscle: 882.4 cervix: 138.0 DLG2 chapsyn-110, PPP1R58, PSD-93, PSD93 ENSG00000150672 Discs, large homolog 2 (Drosophila) 11 83455012-85627922 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021307, HPA023896, CAB072341 Approved Approved Vesicles
Plasma membrane Tissue enhanced 0 cerebral cortex: 73.0 thyroid gland: 25.9 DLX1 ENSG00000144355 Distal-less homeobox 1 2 172084740-172089677 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035666, HPA045884 Approved Approved Nucleus
Vesicles
Cell Junctions Tissue enhanced 0 adrenal gland: 1.6;cerebral cortex: 5.0 prostate: 0.7 DMRTC1 ENSG00000269502 DMRT-like family C1 X 72872025-72943814 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046874, HPA046992 Uncertain Tissue enhanced 0 cerebral cortex: 2.3 thyroid gland: 1.4 DMRTC1B ENSG00000184911 DMRT-like family C1B X 72777009-72848802 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046874, HPA046992 Uncertain Tissue enhanced 0 cerebral cortex: 16.7 ovary: 10.3 DNAH10OS FLJ45278 ENSG00000250091 Dynein, axonemal, heavy chain 10 opposite strand 12 123926424-123934984 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039786 Uncertain Tissue enhanced 0 cerebral cortex: 4.0 kidney: 1.5 DNM3 KIAA0820 ENSG00000197959 Dynamin 3 1 171841498-172418466 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064121 Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 41.2 adrenal gland: 15.7 DOCK4 FLJ34238, KIAA0716 ENSG00000128512 Dedicator of cytokinesis 4 7 111726110-112206411 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071516 Supported Nucleoli
Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 31.8 lung: 27.6 DOK5 C20orf180, dJ805C22.1 ENSG00000101134 Docking protein 5 20 54475597-54651171 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA054460, HPA065235 Uncertain Approved Focal adhesion sites Tissue enhanced 0 cerebral cortex: 22.1;fallopian tube: 19.8 skeletal muscle: 15.7 DOK6 DOK5L, HsT3226, MGC20785 ENSG00000206052 Docking protein 6 18 69401055-69849087 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041099, HPA063534 Approved Approved Focal adhesion sites
Cytosol Tissue enhanced 0 cerebral cortex: 21.1 placenta: 8.4 DPP6 DPPX ENSG00000130226 Dipeptidyl-peptidase 6 7 153887097-154894285 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050509 Supported Supported Tissue enhanced 0 cerebral cortex: 51.2;endometrium: 27.4 smooth muscle: 15.2 DPYSL4 DRP-4, ULIP4 ENSG00000151640 Dihydropyrimidinase-like 4 10 132186900-132205776 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049066 Approved Approved Vesicles
Mitochondria Tissue enhanced 0 cerebral cortex: 30.1 testis: 6.8 DRAXIN C1orf187, Draxin, FLJ34999, Neucrin ENSG00000162490 Dorsal inhibitory axon guidance protein 1 11691729-11725857 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA014302 Uncertain Tissue enhanced 0 cerebral cortex: 1.5 testis: 0.6 DRD1 ENSG00000184845 Dopamine receptor D1 5 175440039-175444208 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013393 Uncertain Tissue enhanced 0 cerebral cortex: 8.0 prostate: 1.6 DRD5 DRD1B, DRD1L2 ENSG00000169676 Dopamine receptor D5 4 9781680-9784009 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA048930 Supported Tissue enhanced 0 appendix: 1.8;cerebral cortex: 2.0;stomach: 3.7 testis: 0.8 DSCAML1 KIAA1132 ENSG00000177103 Down syndrome cell adhesion molecule like 1 11 117427773-117817525 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035230 Uncertain Tissue enhanced 0 cerebral cortex: 12.1 ovary: 4.4 DTNA D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3 ENSG00000134769 Dystrobrevin, alpha 18 34493290-34891844 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015196, HPA071177 Supported Approved Nucleoplasm
Cell Junctions
Intermediate filaments Tissue enhanced 0 cerebral cortex: 197.7 heart muscle: 100.9 DUSP26 DUSP24, MGC1136 ENSG00000133878 Dual specificity phosphatase 26 (putative) 8 33591332-33600106 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA018221 Approved Supported Nucleus Tissue enhanced 0 cerebral cortex: 47.3;skeletal muscle: 138.7 ovary: 39.6 DUSP8 C11orf81, FLJ42958, HB5, HVH-5 ENSG00000184545 Dual specificity phosphatase 8 11 1554044-1571920 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA020071 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 5.1 smooth muscle: 2.2 DYNC1I1 DNCI1, DNCIC1 ENSG00000158560 Dynein, cytoplasmic 1, intermediate chain 1 7 95772506-96110322 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061689 Supported Tissue enhanced 0 cerebral cortex: 84.2 adrenal gland: 16.9 EDIL3 DEL1 ENSG00000164176 EGF-like repeats and discoidin I-like domains 3 5 83940554-84384793 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020415 Approved Tissue enhanced 0 cerebral cortex: 131.9 gallbladder: 54.2 EFNB3 EPLG8, LERK-8 ENSG00000108947 Ephrin-B3 17 7705202-7711378 Cancer-related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001623 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 48.8 endometrium: 17.3 EFR3B FLJ37871, KIAA0953 ENSG00000084710 EFR3 homolog B 2 25042130-25159137 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038088, HPA038089 Uncertain Approved Nucleus Tissue enhanced 0 cerebral cortex: 33.3 skeletal muscle: 6.8 EHD3 PAST3 ENSG00000013016 EH-domain containing 3 2 31234337-31269447 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049890, HPA049986, HPA066751 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 83.0 esophagus: 33.5 EIF4E1B FLJ36951 ENSG00000175766 Eukaryotic translation initiation factor 4E family member 1B 5 176630682-176646641 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA045045 Approved Tissue enhanced 0 cerebral cortex: 1.6;epididymis: 1.2 testis: 0.3 ELFN1 PPP1R28 ENSG00000225968 Extracellular leucine-rich repeat and fibronectin type III domain containing 1 7 1688119-1747954 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 3.6;liver: 3.8 endometrium: 1.7 ELOVL4 CT118, SCA34, STGD2, STGD3 ENSG00000118402 ELOVL fatty acid elongase 4 6 79914812-79947580 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 24.1;skin: 50.8 parathyroid gland: 15.5 EMX1 ENSG00000135638 Empty spiracles homeobox 1 2 72916260-72936071 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA006230, HPA006421 Uncertain Approved Nucleoli Tissue enhanced 0 cerebral cortex: 8.3;kidney: 15.5;parathyroid gland: 5.1 testis: 2.6 EPHA4 Hek8, TYRO1 ENSG00000116106 EPH receptor A4 2 221418027-221574202 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB028368 Supported Tissue enhanced 0 cerebral cortex: 41.8 testis: 22.3 EPHB1 EPHT2, Hek6 ENSG00000154928 EPH receptor B1 3 134597801-135260467 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067740 Approved Approved Endoplasmic reticulum
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 23.7;testis: 22.9 thyroid gland: 12.0 EPHB6 HEP ENSG00000106123 EPH receptor B6 7 142855061-142871094 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035784 Approved Nuclear speckles Tissue enhanced 0 cerebral cortex: 22.6;skin: 25.0 cervix: 7.5 EPHX4 ABHD7, EPHXRP, FLJ90341 ENSG00000172031 Epoxide hydrolase 4 1 92029982-92063536 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA035067 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 14.6 thyroid gland: 3.0 ERICH3 C1orf173, DKFZp547I048, RP11-653A5.1 ENSG00000178965 Glutamate-rich 3 1 74568111-74673738 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA028655 Approved Tissue enhanced 0 cerebral cortex: 18.9;fallopian tube: 27.5;testis: 44.0 cervix: 8.6 ETV1 ER81 ENSG00000006468 Ets variant 1 7 13891228-13991425 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level HPA077249 Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 106.6 lung: 43.3 EXTL1 EXTL, MGC70794 ENSG00000158008 Exostosin-like glycosyltransferase 1 1 26019884-26036464 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA037749 Approved Tissue enhanced 0 cerebral cortex: 11.2 skeletal muscle: 4.3 FA2H FAAH, FAXDC1, FLJ25287, SPG35 ENSG00000103089 Fatty acid 2-hydroxylase 16 74712955-74774831 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA056614, HPA077840 Approved Approved Nuclear membrane Tissue enhanced 0 cerebral cortex: 51.7;stomach: 57.9 gallbladder: 28.7 FAM131C C1orf117, FLJ36766 ENSG00000185519 Family with sequence similarity 131, member C 1 16057769-16073632 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031046 Uncertain Approved Nucleoli
Intermediate filaments
Cytosol Tissue enhanced 0 adrenal gland: 3.3;cerebral cortex: 4.8;kidney: 3.8 heart muscle: 1.2 FAM167A C8orf13 ENSG00000154319 Family with sequence similarity 167, member A 8 11421463-11474715 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA023915, HPA030426 Approved Validated Endoplasmic reticulum Tissue enhanced 0 cerebral cortex: 32.5;thyroid gland: 87.6 lung: 15.8 FAM169A KIAA0888 ENSG00000198780 Family with sequence similarity 169, member A 5 74777574-74866951 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041574 Supported Supported Nuclear membrane
Cytosol Tissue enhanced 0 cerebral cortex: 29.3;testis: 25.1 epididymis: 20.5 FAM171A2 MGC34829 ENSG00000161682 Family with sequence similarity 171, member A2 17 44353215-44363875 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019770 Uncertain Tissue enhanced 0 cerebral cortex: 13.4 epididymis: 3.3 FAM184B KIAA1276 ENSG00000047662 Family with sequence similarity 184, member B 4 17629306-17781512 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA044119, HPA048458 Uncertain Tissue enhanced 0 cerebral cortex: 2.6;skeletal muscle: 1.4 epididymis: 0.5 FAM189A1 KIAA0574, TMEM228 ENSG00000104059 Family with sequence similarity 189, member A1 15 29120254-29570723 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA009410, HPA010637 Uncertain Supported Nucleus Tissue enhanced 0 cerebral cortex: 2.2;parathyroid gland: 2.0 testis: 0.8 FAM196A C10orf141, FLJ45557 ENSG00000188916 Family with sequence similarity 196, member A 10 127135426-127196158 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035898, HPA035899 Uncertain Tissue enhanced 0 cerebral cortex: 3.2 testis: 1.2 FAM196B C5orf57 ENSG00000204767 Family with sequence similarity 196, member B 5 169864264-169980740 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA047227 Uncertain Tissue enhanced 0 breast: 7.6;cerebral cortex: 7.0 ovary: 2.1 FAM19A2 TAFA-2 ENSG00000198673 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A2 12 61708259-62279150 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 26.4 seminal vesicle: 9.9 FAM19A5 TAFA-5 ENSG00000219438 Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5 22 48489460-48850912 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB025629 Approved Tissue enhanced 0 cerebral cortex: 50.1 cervix: 12.9 FAM222A C12orf34, FLJ14721 ENSG00000139438 Family with sequence similarity 222, member A 12 109714228-109770507 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA040181 Uncertain Approved Nucleoplasm
Plasma membrane
Focal adhesion sites
Mitochondria Tissue enhanced 0 cerebral cortex: 20.1;testis: 16.6 adrenal gland: 9.9 FAM234B KIAA1467 ENSG00000084444 Family with sequence similarity 234, member B 12 13044284-13142521 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA010803 Approved Endoplasmic reticulum Tissue enhanced 0 cerebral cortex: 32.5 breast: 20.5 FAM49A DKFZP566A1524, FLJ11080 ENSG00000197872 Family with sequence similarity 49, member A 2 16549459-16666331 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB017847, HPA060398 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 81.7 thyroid gland: 68.0 FAM69C C18orf51 ENSG00000187773 Family with sequence similarity 69, member C 18 74434099-74457944 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA048928 Supported Tissue enhanced 0 cerebral cortex: 28.9;testis: 8.4 skin: 4.9 FAM81A MGC26690 ENSG00000157470 Family with sequence similarity 81, member A 15 59372693-59523549 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA001847, HPA065797 Supported Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 33.4 fallopian tube: 9.8 FAT3 CDHF15, CDHR10, KIAA1989 ENSG00000165323 FAT atypical cadherin 3 11 92352096-92896470 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA026878 Uncertain Tissue enhanced 0 cerebral cortex: 3.9;seminal vesicle: 2.6 prostate: 1.6 FAXC C6orf168, dJ273F20, MGC2817 ENSG00000146267 Failed axon connections homolog 6 99271169-99350062 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039106 Uncertain Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 23.6 seminal vesicle: 14.7 FBLL1 LOC345630 ENSG00000188573 Fibrillarin-like 1 5 168529116-168530634 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA049546 Approved Nucleus
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 19.1 testis: 4.4 FBXO2 Fbg1, Fbs1, FBX2, Nfb42, OCP1 ENSG00000116661 F-box protein 2 1 11648367-11655785 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005472 Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 80.8 adrenal gland: 27.8 FBXO41 Fbx41, KIAA1940 ENSG00000163013 F-box protein 41 2 73254682-73284431 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA055246, HPA058386 Approved Nucleus
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 38.4 parathyroid gland: 11.0 FGF1 AFGF, ECGF, ECGF-beta, ECGFA, ECGFB, FGF-alpha, FGFA, GLIO703, HBGF1 ENSG00000113578 Fibroblast growth factor 1 (acidic) 5 142592178-142698070 Cancer-related genes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003265, CAB017519 Supported Validated Nucleoplasm Tissue enhanced 0 cerebral cortex: 130.3;kidney: 59.1 heart muscle: 32.8 FGF12 FGF12B, FHF1 ENSG00000114279 Fibroblast growth factor 12 3 192139395-192767764 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071557 Approved Nucleoplasm
Cytosol Tissue enhanced 0 adrenal gland: 46.9;cerebral cortex: 52.5;heart muscle: 94.9 spleen: 16.4 FGF14 FHF4, SCA27 ENSG00000102466 Fibroblast growth factor 14 13 101710804-102402457 Disease related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA049828 Approved Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 14.8;cervix, uterine: 22.8;fallopian tube: 17.1 testis: 4.2 FJX1 FLJ22416, FLJ25593 ENSG00000179431 Four jointed box 1 11 35618419-35620868 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059220 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.4 endometrium: 8.8 FKBP1B FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase ENSG00000119782 FK506 binding protein 1B, 12.6 kDa 2 24049701-24063681 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051798, HPA057830 Uncertain Approved Microtubules Tissue enhanced 0 cerebral cortex: 24.5 duodenum: 19.2 FLRT1 MGC21624, SPG68 ENSG00000126500 Fibronectin leucine rich transmembrane protein 1 11 64103188-64119173 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA054589 Uncertain Tissue enhanced 0 cerebral cortex: 12.5 adrenal gland: 5.9 FMNL2 FHOD2, KIAA1902 ENSG00000157827 Formin-like 2 2 152335237-152649834 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005464 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 138.2 placenta: 82.3 FOXO6 ENSG00000204060 Forkhead box O6 1 41361922-41383590 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.7 prostate: 0.7 FREM3 ENSG00000183090 FRAS1 related extracellular matrix 3 4 143577302-143700675 Predicted secreted proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA041641 Uncertain Tissue enhanced 0 cerebral cortex: 1.6 lung: 0.6 FRMPD3 KIAA1817, RP5-1070B1.1 ENSG00000147234 FERM and PDZ domain containing 3 X 107522450-107605251 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003164 Uncertain Tissue enhanced 0 cerebral cortex: 5.9;ovary: 6.7;thyroid gland: 5.5 seminal vesicle: 1.9 FRRS1L C9orf4, CG-6 ENSG00000260230 Ferric-chelate reductase 1-like 9 109130293-109167291 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA071086 Supported Tissue enhanced 0 cerebral cortex: 47.9 ovary: 14.1 FSCN1 FLJ38511, p55, SNL ENSG00000075618 Fascin actin-bundling protein 1 7 5592823-5606655 Cancer-related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000121, HPA005723, CAB035991, HPA050654 Supported Supported Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 85.7 spleen: 55.9 FSD1L CCDC10, CSDUFD1, FSD1CL, FSD1NL ENSG00000106701 Fibronectin type III and SPRY domain containing 1-like 9 105447796-105552433 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035138 Approved Approved Plasma membrane
Actin filaments Tissue enhanced 0 cerebral cortex: 17.8 testis: 13.4 FSTL4 KIAA1061 ENSG00000053108 Follistatin-like 4 5 133196455-133612564 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045920 Uncertain Approved Mitochondria Tissue enhanced 0 cerebral cortex: 9.6 urinary bladder: 7.6 GABBR1 GPRC3A, hGB1a ENSG00000204681 Gamma-aminobutyric acid (GABA) B receptor, 1 6 29555629-29633976 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050483, HPA058459 Uncertain Uncertain Centrosome Tissue enhanced 0 cerebral cortex: 20.9 spleen: 13.3 GABRB3 ENSG00000166206 Gamma-aminobutyric acid (GABA) A receptor, beta 3 15 26543546-26939539 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 80.1 gallbladder: 21.9 GABRQ THETA ENSG00000268089 Gamma-aminobutyric acid (GABA) A receptor, theta X 152638183-152657534 FDA approved drug targets, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA002063 Uncertain Tissue enhanced 0 cerebral cortex: 6.6;cervix, uterine: 12.8 adrenal gland: 3.0 GAL3ST3 GAL3ST2 ENSG00000175229 Galactose-3-O-sulfotransferase 3 11 66041952-66049180 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 4.3;endometrium: 4.3;smooth muscle: 4.7;thyroid gland: 8.2 seminal vesicle: 2.4 GALNT15 GALNT7, GALNTL2, pp-GalNAc-T15 ENSG00000131386 Polypeptide N-acetylgalactosaminyltransferase 15 3 16174649-16231992 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA017076, HPA051551 Uncertain Approved Vesicles
Plasma membrane Tissue enhanced 0 adipose tissue: 36.2;cerebral cortex: 41.4;placenta: 42.6 breast: 18.3 GALNTL6 GalNAc-T6L, GALNT17 ENSG00000174473 Polypeptide N-acetylgalactosaminyltransferase-like 6 4 171812254-173041559 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA031019 Uncertain Tissue enhanced 0 cerebral cortex: 5.5;testis: 4.8 spleen: 2.1 GALR1 GALNR, GALNR1 ENSG00000166573 Galanin receptor 1 18 77250549-77277896 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 2.1;cerebral cortex: 1.7 testis: 0.5 GAS7 KIAA0394, MGC1348 ENSG00000007237 Growth arrest-specific 7 17 9910609-10198551 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004838, HPA064678 Supported Approved Plasma membrane
Actin filaments
Focal adhesion sites Tissue enhanced 0 cerebral cortex: 155.2 cervix: 47.5 GATS DKFZp686B07267, STAG3OS ENSG00000239521 GATS, stromal antigen 3 opposite strand 7 100200653-100272218 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA043176 Uncertain Tissue enhanced 0 cerebral cortex: 3.3;skeletal muscle: 2.2 bone marrow: 0.7 GATSL2 GATSL1 ENSG00000274070 GATS protein-like 2 7 74964818-75024798 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057229 Uncertain Tissue enhanced 0 cerebral cortex: 15.0 skeletal muscle: 13.8 GDA ENSG00000119125 Guanine deaminase 9 72114595-72257193 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019352, HPA024099, HPA030387 Supported Approved Nucleus Tissue enhanced 0 cerebral cortex: 102.6;duodenum: 97.8;small intestine: 106.3 kidney: 43.2 GDAP1 CMT2K, CMT4, CMT4A ENSG00000104381 Ganglioside induced differentiation associated protein 1 8 74321130-74488872 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014266, HPA024334 Supported Supported Mitochondria
Cytosol Tissue enhanced 0 cerebral cortex: 77.0 parathyroid gland: 18.1 GDPD1 FLJ37451, GDE4 ENSG00000153982 Glycerophosphodiester phosphodiesterase domain containing 1 17 59220467-59275967 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 28.0 testis: 19.9 GJC2 CX46.6, CX47, GJA12, SPG44 ENSG00000198835 Gap junction protein, gamma 2, 47kDa 1 228149852-228159826 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 11.6 endometrium: 3.6 GLDN CLOM, COLM, colmedin, CRG-L2, UNC-112 ENSG00000186417 Gliomedin 15 51341629-51408013 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059441 Uncertain Tissue enhanced 0 cerebral cortex: 24.0 adipose tissue: 12.9 GLP1R ENSG00000112164 Glucagon-like peptide 1 receptor 6 39048798-39087743 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.9;heart muscle: 1.8 pancreas: 1.5 GLRB ENSG00000109738 Glycine receptor, beta 4 157076057-157172090 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052363 Approved Tissue enhanced 0 cerebral cortex: 62.2;parathyroid gland: 62.0 cervix: 14.0 GLT1D1 FLJ31978 ENSG00000151948 Glycosyltransferase 1 domain containing 1 12 128853427-128984968 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA039051, HPA039052 Validated Cytosol Tissue enhanced 0 cerebral cortex: 22.5;testis: 28.1 bone marrow: 18.6 GNAZ ENSG00000128266 Guanine nucleotide binding protein (G protein), alpha z polypeptide 22 23070361-23125037 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA003011 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 49.8 seminal vesicle: 22.7 GNG13 G(gamma)13, h2-35 ENSG00000127588 Guanine nucleotide binding protein (G protein), gamma 13 16 798041-800733 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA046272 Approved Tissue enhanced 0 cerebral cortex: 2.5;duodenum: 1.4;small intestine: 1.5 testis: 0.7 GNG4 ENSG00000168243 Guanine nucleotide binding protein (G protein), gamma 4 1 235547687-235650754 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 25.4;ovary: 18.3;prostate: 17.5 endometrium: 8.3 GPC5 ENSG00000179399 Glypican 5 13 91398607-92873682 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA040152, HPA044081 Supported Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 15.9;kidney: 8.1;testis: 11.5 lung: 4.9 GPR12 GPCR21, PPP1R84 ENSG00000132975 G protein-coupled receptor 12 13 26755200-26760785 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA050972 Uncertain Tissue enhanced 0 cerebral cortex: 8.0 breast: 1.7 GPR137C DKFZp762F0713, TM7SF1L2 ENSG00000180998 G protein-coupled receptor 137C 14 52553148-52637713 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003640, HPA030763 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 18.0;epididymis: 10.5 testis: 8.2 GPR150 PGR11 ENSG00000178015 G protein-coupled receptor 150 5 95620078-95622142 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA026635 Uncertain Tissue enhanced 0 cerebral cortex: 1.3;parathyroid gland: 2.0 pancreas: 1.0 GPR173 SREB3 ENSG00000184194 G protein-coupled receptor 173 X 53049091-53080615 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA003905 Approved Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 19.1 ovary: 9.0 GPR19 ENSG00000183150 G protein-coupled receptor 19 12 12660891-12696207 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA013955 Uncertain Tissue enhanced 0 cerebral cortex: 8.5;testis: 7.7 appendix: 2.8 GPR21 ENSG00000188394 G protein-coupled receptor 21 9 123034527-123035696 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041651 Uncertain Tissue enhanced 0 cerebral cortex: 2.1 endometrium: 0.9 GPR3 ACCA ENSG00000181773 G protein-coupled receptor 3 1 27392644-27395814 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB006254 Uncertain Tissue enhanced 0 cerebral cortex: 5.3 thyroid gland: 1.3 GPR37 EDNRBL, hET(B)R-LP, PAELR ENSG00000170775 G protein-coupled receptor 37 (endothelin receptor type B-like) 7 124745997-124765627 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042903, HPA068009 Approved Approved Nuclear membrane
Cytosol Tissue enhanced 0 cerebral cortex: 78.9;testis: 27.6 placenta: 12.7 GPR45 PSP24, PSP24A ENSG00000135973 G protein-coupled receptor 45 2 105241743-105243049 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055940 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 testis: 0.5 GPR61 BALGR ENSG00000156097 G protein-coupled receptor 61 1 109539872-109548406 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007326, HPA026088 Approved Tissue enhanced 0 cerebral cortex: 3.4;thyroid gland: 1.2 adrenal gland: 1.0 GPR75 WI-31133 ENSG00000119737 G protein-coupled receptor 75 2 53852913-53859989 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 17.8 parathyroid gland: 6.4 GPR75-ASB3 ENSG00000270898 GPR75-ASB3 readthrough 2 53670293-53860160 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level HPA003940 Uncertain Tissue enhanced 0 cerebral cortex: 1.0 spleen: 0.3 GPR85 SREB2 ENSG00000164604 G protein-coupled receptor 85 7 113078331-113087778 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 16.8 skeletal muscle: 11.5 GPRC5B RAIG-2 ENSG00000167191 G protein-coupled receptor, class C, group 5, member B 16 19856691-19886167 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA015247 Approved Supported Nucleus
Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 309.2 testis: 66.5 GRIA3 GluA3, GLUR3, GLURC, MRX94 ENSG00000125675 Glutamate receptor, ionotropic, AMPA 3 X 123184153-123490915 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058659 Uncertain Tissue enhanced 0 cerebral cortex: 56.8 adrenal gland: 11.4 GRID1 GluD1, KIAA1220 ENSG00000182771 Glutamate receptor, ionotropic, delta 1 10 85599555-86366493 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 7.7 thyroid gland: 3.4 GRIK1 GluK1, GLUR5 ENSG00000171189 Glutamate receptor, ionotropic, kainate 1 21 29536933-29940033 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014623 Uncertain Tissue enhanced 0 adrenal gland: 16.8;cerebral cortex: 9.1 prostate: 3.9 GRIK2 GluK2, GLUR6, MRT6 ENSG00000164418 Glutamate receptor, ionotropic, kainate 2 6 101398788-102070083 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014395, HPA014623, CAB022463 Approved Tissue enhanced 0 cerebral cortex: 22.6 thyroid gland: 6.2 GRIK4 GluK4, GRIK, KA1 ENSG00000149403 Glutamate receptor, ionotropic, kainate 4 11 120511759-120988904 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 10.6 thyroid gland: 2.8 GRIK5 GluK5, GRIK2, KA2 ENSG00000105737 Glutamate receptor, ionotropic, kainate 5 19 41998321-42069498 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 30.9;parathyroid gland: 21.7 testis: 19.2 GRIN2C GluN2C, NMDAR2C ENSG00000161509 Glutamate receptor, ionotropic, N-methyl D-aspartate 2C 17 74842023-74861504 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 9.6;heart muscle: 7.8;thyroid gland: 14.0 salivary gland: 4.4 GRIN2D EB11, GluN2D, NMDAR2D, NR2D ENSG00000105464 Glutamate receptor, ionotropic, N-methyl D-aspartate 2D 19 48394875-48444931 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 2.3 placenta: 1.3 GRM1 GPRC1A, mGlu1, MGLUR1, PPP1R85 ENSG00000152822 Glutamate receptor, metabotropic 1 6 146027646-146437598 Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015701 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 7.1 heart muscle: 1.4 GRM4 GPRC1D, mGlu4, MGLUR4 ENSG00000124493 Glutamate receptor, metabotropic 4 6 34018645-34155622 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB022096 Supported Tissue enhanced 0 cerebral cortex: 2.9 testis: 0.7 GRM7 GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87 ENSG00000196277 Glutamate receptor, metabotropic 7 3 6770001-7741533 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015964 Uncertain Cytosol Tissue enhanced 0 cerebral cortex: 10.1;parathyroid gland: 7.0 smooth muscle: 3.4 GRM8 GLUR8, GPRC1H, mGlu8, MGLUR8 ENSG00000179603 Glutamate receptor, metabotropic 8 7 126438598-127253294 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051481 Uncertain Tissue enhanced 0 cerebral cortex: 4.1 testis: 2.9 GSG1L KTSR5831, MGC18079, PRO19651 ENSG00000169181 GSG1-like 16 27787535-28063509 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014479 Approved Tissue enhanced 0 cerebral cortex: 11.7;heart muscle: 8.8 fallopian tube: 2.7 HAGHL MGC2605 ENSG00000103253 Hydroxyacylglutathione hydrolase-like 16 726936-735525 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 9.1 spleen: 4.5 HAP1 HAP2, hHLP1, HIP5, HLP ENSG00000173805 Huntingtin-associated protein 1 17 41717742-41734644 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA023394, HPA076992 Uncertain Supported Nucleoli
Cytosol Tissue enhanced 0 cerebral cortex: 11.5;stomach: 13.1 thyroid gland: 6.4 HECW1 KIAA0322, NEDL1 ENSG00000002746 HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 7 43112599-43566001 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007203, HPA007593, HPA007609 Approved Supported Cytosol Tissue enhanced 0 cerebral cortex: 10.9;kidney: 8.3 testis: 3.9 HES5 bHLHb38 ENSG00000197921 Hes family bHLH transcription factor 5 1 2528745-2530245 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA065458 Approved Nucleoplasm
Nuclear speckles
Cytosol Tissue enhanced 0 cerebral cortex: 1.8 skin: 0.9 HES6 bHLHb41 ENSG00000144485 Hes family bHLH transcription factor 6 2 238238267-238240662 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA061763 Approved Nucleus
Nucleoli
Nuclear bodies
Cytosol Tissue enhanced 0 cerebral cortex: 77.0 fallopian tube: 22.1 HEY1 bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1 ENSG00000164683 Hes-related family bHLH transcription factor with YRPW motif 1 8 79764010-79767863 Cancer-related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA055599, HPA063472 Uncertain Approved Nucleoplasm
Nuclear membrane
Cytosol Tissue enhanced 0 cerebral cortex: 96.6 placenta: 28.7 HHIPL1 KIAA1822 ENSG00000182218 HHIP-like 1 14 99645110-99680569 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052767 Approved Tissue enhanced 0 cerebral cortex: 6.6 smooth muscle: 2.6 HMGCLL1 bA418P12.1, DKFZP434G1411 ENSG00000146151 3-hydroxymethyl-3-methylglutaryl-CoA lyase-like 1 6 55434369-55579214 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 14.6;placenta: 9.0 testis: 5.0 HMX1 H6, NKX5-3 ENSG00000215612 H6 family homeobox 1 4 8846076-8871817 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 1.1 testis: 0.9 HOMER1 HOMER-1B, SYN47, Ves-1 ENSG00000152413 Homer scaffolding protein 1 5 79372636-79514217 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004437, HPA036521, HPA036522 Supported Approved Cytosol Tissue enhanced 0 cerebral cortex: 49.0 thyroid gland: 25.0 HS6ST3 ENSG00000185352 Heparan sulfate 6-O-sulfotransferase 3 13 96090839-96839562 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051513 Approved Nucleus
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 27.8 urinary bladder: 6.2 HSD11B1L SCDR10, SDR26C2 ENSG00000167733 Hydroxysteroid (11-beta) dehydrogenase 1-like 19 5680604-5688523 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049078 Approved Vesicles Tissue enhanced 0 cerebral cortex: 25.7 fallopian tube: 8.0 HSPA12A FLJ13874, KIAA0417 ENSG00000165868 Heat shock 70kDa protein 12A 10 116671192-116742574 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011273, HPA073244 Approved Approved Golgi apparatus
Cytosol Tissue enhanced 0 cerebral cortex: 65.2 adrenal gland: 26.9 HTR3B 5-HT3B ENSG00000149305 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic 11 113904677-113946565 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039559 Approved Tissue enhanced 0 cerebral cortex: 2.8 testis: 1.1 IBSP BSP, BSP-II, SP-II ENSG00000029559 Integrin-binding sialoprotein 4 87799581-87812435 Cancer-related genes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.6;cervix, uterine: 1.3 placenta: 0.3 IFITM10 ENSG00000244242 Interferon induced transmembrane protein 10 11 1732410-1750591 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 adrenal gland: 12.7;cerebral cortex: 12.0 seminal vesicle: 4.0 IGSF11 BT-IgSF, CT119, Igsf13, MGC35227, VSIG3 ENSG00000144847 Immunoglobulin superfamily, member 11 3 118900557-119146068 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046377 Uncertain Approved Nucleus
Cell Junctions
Cytosol Tissue enhanced 0 cerebral cortex: 31.1;testis: 64.7 ovary: 20.0 IGSF21 MGC15730, RP11-121A23.1 ENSG00000117154 Immunoglobin superfamily, member 21 1 18107746-18378483 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA044535 Approved Tissue enhanced 0 cerebral cortex: 29.0;spleen: 13.4 adrenal gland: 5.9 IL17D FLJ30846, IL-17D, IL-22, IL-27, IL27 ENSG00000172458 Interleukin 17D 13 20702127-20723098 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 100.5 skeletal muscle: 45.9 IL9 HP40, IL-9, P40 ENSG00000145839 Interleukin 9 5 135892246-135895827 Cancer-related genes, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 1.7 skin: 0.5 ILDR2 C1orf32 ENSG00000143195 Immunoglobulin-like domain containing receptor 2 1 166895711-166975482 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA012545 Uncertain Tissue enhanced 0 cerebral cortex: 11.4;testis: 17.4 kidney: 3.0 INSM2 IA-6 ENSG00000168348 Insulinoma-associated 2 14 35534042-35537054 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA044885, HPA051925 Uncertain Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 1.3 testis: 0.7 IQCJ-SCHIP1 ENSG00000250588 IQCJ-SCHIP1 readthrough 3 158962235-159897366 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA003243, HPA003445 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 99.2 smooth muscle: 36.3 IQSEC2 KIAA0522, MRX1 ENSG00000124313 IQ motif and Sec7 domain 2 X 53232876-53321324 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003973 Approved Vesicles Tissue enhanced 0 cerebral cortex: 30.6 parathyroid gland: 8.6 IQSEC3 KIAA1110, MGC30156 ENSG00000120645 IQ motif and Sec7 domain 3 12 66765-178460 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 16.2 fallopian tube: 5.4 ITPKA IP3-3KA, IP3KA ENSG00000137825 Inositol-trisphosphate 3-kinase A 15 41493393-41503551 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040454 Approved Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 25.8;duodenum: 18.2;small intestine: 20.2 stomach: 9.1 JAKMIP3 bA140A10.5, C10orf14, C10orf39, FLJ37857, KIAA4091, NECC2 ENSG00000188385 Janus kinase and microtubule interacting protein 3 10 132104671-132184809 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA022872 Uncertain Tissue enhanced 0 cerebral cortex: 5.8 prostate: 2.0 JPH4 JPHL1, KIAA1831 ENSG00000092051 Junctophilin 4 14 23568035-23578800 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB013492, HPA054232 Approved Nucleoplasm
Golgi apparatus Tissue enhanced 0 cerebral cortex: 107.4;seminal vesicle: 51.4 endometrium: 28.0 KALRN ARHGEF24, DUET, duo, HAPIP, Hs.8004, Kalirin, TRAD ENSG00000160145 Kalirin, RhoGEF kinase 3 124080023-124726325 Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011913, CAB026456 Approved Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 51.5 spleen: 12.0 KBTBD11 KIAA0711, KLHDC7C ENSG00000176595 Kelch repeat and BTB (POZ) domain containing 11 8 1973878-2006936 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051159 Uncertain Approved Intermediate filaments Tissue enhanced 0 cerebral cortex: 21.8 small intestine: 8.9 KCNA4 HK1, HPCN2, KCNA4L, Kv1.4 ENSG00000182255 Potassium channel, voltage gated shaker related subfamily A, member 4 11 30009741-30017023 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001977, HPA016422 Approved Tissue enhanced 0 adrenal gland: 7.9;cerebral cortex: 4.3 heart muscle: 1.2 KCNAB2 AKR6A5, HKvbeta2.1, HKvbeta2.2, KCNA2B ENSG00000069424 Potassium channel, voltage gated subfamily A regulatory beta subunit 2 1 5991466-6101193 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001975 Approved Tissue enhanced 0 cerebral cortex: 146.3 bone marrow: 74.9 KCNB1 Kv2.1 ENSG00000158445 Potassium channel, voltage gated Shab related subfamily B, member 1 20 49363877-49484297 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001979, HPA042434 Supported Tissue enhanced 0 adipose tissue: 11.0;cerebral cortex: 21.0 fallopian tube: 7.5 KCNB2 Kv2.2 ENSG00000182674 Potassium channel, voltage gated Shab related subfamily B, member 2 8 72537391-72938349 FDA approved drug targets, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA065970 Approved Nucleoli
Plasma membrane
Midbody Tissue enhanced 0 cerebral cortex: 3.2;spleen: 3.4 testis: 0.7 KCND2 KIAA1044, Kv4.2, RK5 ENSG00000184408 Potassium channel, voltage gated Shal related subfamily D, member 2 7 120273668-120750331 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029068 Approved Tissue enhanced 0 cerebral cortex: 20.8 gallbladder: 6.9 KCNE5 KCNE1L ENSG00000176076 Potassium channel, voltage gated subfamily E regulatory beta subunit 5 X 109623700-109625172 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042316 Uncertain Uncertain Cytosol Tissue enhanced 0 cerebral cortex: 2.1 adipose tissue: 1.1 KCNG3 Kv6.3 ENSG00000171126 Potassium channel, voltage gated modifier subfamily G, member 3 2 42442017-42494097 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA041625 Approved Cytoplasmic bodies Tissue enhanced 0 adrenal gland: 1.2;cerebral cortex: 1.3;testis: 1.1 endometrium: 0.4 KCNH4 elk1, Kv12.3 ENSG00000089558 Potassium channel, voltage gated eag related subfamily H, member 4 17 42156891-42181278 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.8 appendix: 0.7 KCNH5 eag2, H-EAG2, Kv10.2 ENSG00000140015 Potassium channel, voltage gated eag related subfamily H, member 5 14 62699454-63102037 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA030487 Uncertain Uncertain Microtubules
Mitotic spindle Tissue enhanced 0 adrenal gland: 1.4;cerebral cortex: 3.6 testis: 0.7 KCNH8 elk3, Kv12.1 ENSG00000183960 Potassium channel, voltage gated eag related subfamily H, member 8 3 19148454-19535646 Predicted membrane proteins, Voltage-gated ion channels Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 4.8 adrenal gland: 2.3 KCNIP1 KCHIP1 ENSG00000182132 Kv channel interacting protein 1 5 170353487-170736632 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022864, HPA066717 Uncertain Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 40.6;epididymis: 26.0 seminal vesicle: 7.8 KCNIP3 calsenilin, CSEN, DREAM, KCHIP3 ENSG00000115041 Kv channel interacting protein 3, calsenilin 2 95297304-95386083 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA066717, HPA069797 Approved Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 40.7;parathyroid gland: 43.4 thyroid gland: 27.9 KCNIP4 CALP, KCHIP4, MGC44947 ENSG00000185774 Kv channel interacting protein 4 4 20728616-21948799 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022862, HPA066717 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 57.4 cervix: 20.5 KCNJ3 GIRK1, KGA, Kir3.1 ENSG00000162989 Potassium channel, inwardly rectifying subfamily J, member 3 2 154698299-154858352 Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024231 Uncertain Tissue enhanced 0 cerebral cortex: 25.5;parathyroid gland: 39.5 seminal vesicle: 14.1 KCNK10 K2p10.1, PPP1R97, TREK-2, TREK2 ENSG00000100433 Potassium channel, two pore domain subfamily K, member 10 14 88180103-88326907 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030462 Approved Tissue enhanced 0 cerebral cortex: 5.6;duodenum: 5.3 small intestine: 2.8 KCNN3 hSK3, KCa2.3, SKCA3 ENSG00000143603 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 3 1 154697455-154870280 Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA017990, HPA057127 Uncertain Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 25.4 fallopian tube: 9.4 KCNQ5 Kv7.5 ENSG00000185760 Potassium channel, voltage gated KQT-like subfamily Q, member 5 6 72621792-73198851 Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA016655 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.4 thyroid gland: 7.8 KCNS1 Kv9.1 ENSG00000124134 Potassium voltage-gated channel, modifier subfamily S, member 1 20 45092310-45101112 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 9.3;gallbladder: 3.8;seminal vesicle: 4.2 testis: 1.7 KCNS2 Kv9.2 ENSG00000156486 Potassium voltage-gated channel, modifier subfamily S, member 2 8 98427022-98432848 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level HPA051417 Uncertain Tissue enhanced 0 cerebral cortex: 7.2 placenta: 2.2 KCTD17 FLJ12242 ENSG00000100379 Potassium channel tetramerization domain containing 17 22 37051736-37063390 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018459 Uncertain Tissue enhanced 0 cerebral cortex: 56.1 testis: 35.3 KCTD2 KIAA0176 ENSG00000180901 Potassium channel tetramerization domain containing 2 17 75032575-75065889 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adipose tissue: 3.4;cerebral cortex: 7.3 kidney: 2.0 KCTD8 ENSG00000183783 Potassium channel tetramerization domain containing 8 4 44173909-44448807 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA031562 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 11.5;thyroid gland: 5.1 testis: 2.4 KHDC1 bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1 ENSG00000135314 KH homology domain containing 1 6 73241314-73310365 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029032 Approved Approved Mitochondria
Cytosol Tissue enhanced 0 cerebral cortex: 10.0 testis: 6.7 KHDRBS2 MGC26664, SLM-1, SLM1 ENSG00000112232 KH domain containing, RNA binding, signal transduction associated 2 6 61679960-62286227 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000500, HPA029392 Supported Tissue enhanced 0 cerebral cortex: 6.7;lung: 5.6;thyroid gland: 10.9 spleen: 1.9 KIAA0408 ENSG00000189367 KIAA0408 6 127440343-127459391 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044035 Uncertain Approved Centrosome
Cytosol Tissue enhanced 0 cerebral cortex: 43.9 lung: 30.7 KIAA1107 ENSG00000069712 KIAA1107 1 92167052-92184723 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA024216, HPA027327 Supported Uncertain Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 47.0 testis: 13.4 KIAA1211L C2orf55, MGC42367 ENSG00000196872 KIAA1211-like 2 98793846-98936259 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA051082, HPA061678 Uncertain Approved Microtubules
Cytokinetic bridge
Centrosome Tissue enhanced 0 cerebral cortex: 36.9;epididymis: 38.1 fallopian tube: 35.8 KIAA1644 ENSG00000138944 KIAA1644 22 44243667-44312851 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051178 Uncertain Approved Vesicles
Cytosol Tissue enhanced 0 cerebral cortex: 27.6;endometrium: 42.5;smooth muscle: 44.0 cervix: 19.1 KIAA2022 MRX98, XPN ENSG00000050030 KIAA2022 X 74732849-74925485 Disease related genes, Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA000407 Uncertain Uncertain Nucleoplasm
Midbody Tissue enhanced 0 cerebral cortex: 5.4;parathyroid gland: 5.2 prostate: 1.8 KIF21A FEOM1, FLJ20052 ENSG00000139116 Kinesin family member 21A 12 39293228-39443390 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022079, HPA058432 Approved Supported Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 79.6 fallopian tube: 59.5 KIF21B DKFZP434J212, KIAA0449 ENSG00000116852 Kinesin family member 21B 1 200969390-201023700 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027249, HPA027274 Approved Tissue enhanced 0 cerebral cortex: 28.9 bone marrow: 22.9 KIF3A FLA10, KLP-20 ENSG00000131437 Kinesin family member 3A 5 132692628-132737638 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB037085 Approved Approved Nucleoplasm
Intermediate filaments
Cytosol Tissue enhanced 0 cerebral cortex: 83.0 testis: 43.8 KIF5C ENSG00000168280 Kinesin family member 5C 2 148875250-149026759 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035210 Approved Approved Nucleoli
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 205.9 prostate: 42.3 KLHL1 FLJ30047, KIAA1490, MRP2 ENSG00000150361 Kelch-like family member 1 13 69700594-70108493 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA021196 Uncertain Tissue enhanced 0 cerebral cortex: 1.9 prostate: 0.4 KLHL2 MAV ENSG00000109466 Kelch-like family member 2 4 165207618-165323156 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051637 Uncertain Nucleoplasm
Vesicles Tissue enhanced 0 cerebral cortex: 77.5 thyroid gland: 21.5 KLHL25 ENC-2, ENC2, FLJ12587 ENSG00000183655 Kelch-like family member 25 15 85759323-85795030 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023450 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 15.8 testis: 9.9 KLHL35 FLJ33790 ENSG00000149243 Kelch-like family member 35 11 75422394-75430629 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA039232, HPA039864 Uncertain Approved Nucleus
Nucleoli fibrillar center
Centrosome Tissue enhanced 0 cerebral cortex: 3.6;testis: 6.1 cervix: 1.0 KLRC3 NKG2-E ENSG00000205810 Killer cell lectin-like receptor subfamily C, member 3 12 10412312-10420595 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039910, HPA062570 Approved Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 9.3;spleen: 6.3 lymph node: 2.3 KNDC1 bB439H18.3, C10orf23, FLJ25027, KIAA1768, RASGEF2 ENSG00000171798 Kinase non-catalytic C-lobe domain (KIND) containing 1 10 133160447-133226412 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039624 Uncertain Tissue enhanced 0 cerebral cortex: 19.5;fallopian tube: 10.5 adrenal gland: 6.4 KRT222 KA21, KRT222P, MGC45562 ENSG00000213424 Keratin 222, type II 17 40654665-40665181 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA043708, HPA054586, HPA069774 Uncertain Approved Vesicles
Lipid droplets Tissue enhanced 0 cerebral cortex: 10.0;epididymis: 3.1 gallbladder: 2.7 KRTAP5-2 KRTAP5-8, KRTAP5.2 ENSG00000205867 Keratin associated protein 5-2 11 1597177-1598294 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 3.6 parathyroid gland: 1.6 KSR2 FLJ25965 ENSG00000171435 Kinase suppressor of ras 2 12 117453012-117968983 Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035536 Approved Tissue enhanced 0 cerebral cortex: 4.1 adrenal gland: 1.2 L1CAM CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1 ENSG00000198910 L1 cell adhesion molecule X 153861514-153909223 CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA005830, CAB010896 Approved Approved Nucleoplasm
Plasma membrane Tissue enhanced 0 adrenal gland: 36.2;cerebral cortex: 67.1 seminal vesicle: 12.7 LAMP5 BAD-LAMP, C20orf103, dJ1119D9.3, UNC-43 ENSG00000125869 Lysosomal-associated membrane protein family, member 5 20 9514358-9530524 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004802, HPA070765 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 45.0;ovary: 24.5 fallopian tube: 14.8 LANCL2 GPR69B, TASP ENSG00000132434 LanC lantibiotic synthetase component C-like 2 (bacterial) 7 55365448-55433742 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019711, HPA029535 Uncertain Supported Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 41.3 parathyroid gland: 16.4 LARP6 acheron, FLJ11196 ENSG00000166173 La ribonucleoprotein domain family, member 6 15 70829130-70854159 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA020338, HPA049029 Approved Approved Microtubules
Cytokinetic bridge Tissue enhanced 0 cerebral cortex: 84.9 thyroid gland: 40.7 LHFPL1 ENSG00000182508 Lipoma HMGIC fusion partner-like 1 X 112630648-112680054 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA003029 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 seminal vesicle: 1.3 LHX5 ENSG00000089116 LIM homeobox 5 12 113462034-113472280 Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA053908 Uncertain Tissue enhanced 0 cerebral cortex: 1.4 stomach: 0.3 LL0XNC01-16G2.1 ENSG00000225110 X 153317681-153321822 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 4.0 adrenal gland: 0.9 LLGL1 DLG4, HUGL, HUGL-1, LLGL ENSG00000131899 Lethal giant larvae homolog 1 (Drosophila) 17 18225587-18244875 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA022924, HPA023569 Approved Tissue enhanced 0 cerebral cortex: 42.3 endometrium: 14.1 LMO3 DAT1, RBTNL2, Rhom-3 ENSG00000048540 LIM domain only 3 (rhombotin-like 2) 12 16548373-16610594 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 191.6 thyroid gland: 67.4 LRFN1 KIAA1484, SALM2 ENSG00000128011 Leucine rich repeat and fibronectin type III domain containing 1 19 39306568-39315336 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 5.5 spleen: 2.2 LRIT2 AC022389.4, LRRC22 ENSG00000204033 Leucine-rich repeat, immunoglobulin-like and transmembrane domains 2 10 84220495-84225589 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA037788 Uncertain Tissue enhanced 0 cerebral cortex: 1.0;rectum: 1.2;skin: 3.1 colon: 0.6 LRP1B LRP-DIT, LRPDIT ENSG00000168702 Low density lipoprotein receptor-related protein 1B 2 140231423-142131701 Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069094, HPA074788 Approved Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 16.5;thyroid gland: 9.6 epididymis: 2.7 LRP4 CLSS, LRP-4, MEGF7, SOST2 ENSG00000134569 Low density lipoprotein receptor-related protein 4 11 46856868-46918642 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011934, HPA012300 Approved Uncertain Nucleus
Nucleoli
Mitochondria Tissue enhanced 0 cerebral cortex: 35.5;skin: 38.0 parathyroid gland: 12.9 LRRC16B BC008134, C14orf121, CARMIL3, crml-1 ENSG00000186648 Leucine rich repeat containing 16B 14 24052000-24069728 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030596 Uncertain Tissue enhanced 0 cerebral cortex: 6.8;skin: 6.2 testis: 3.0 LRRC24 LRRC14OS ENSG00000254402 Leucine rich repeat containing 24 8 144522377-144527032 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA028171, HPA052250 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 3.1;prostate: 3.0 parathyroid gland: 1.7 LRRC4 NAG14 ENSG00000128594 Leucine rich repeat containing 4 7 128027071-128032107 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051100 Uncertain Golgi apparatus Tissue enhanced 0 cerebral cortex: 53.0 parathyroid gland: 13.0 LRRC4B DKFZp761A179, HSM, LRIG4 ENSG00000131409 Leucine rich repeat containing 4B 19 50516892-50568045 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA058986 Uncertain Tissue enhanced 0 cerebral cortex: 61.6 cervix: 12.8 LRRC55 FLJ45686 ENSG00000183908 Leucine rich repeat containing 55 11 57181747-57191717 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014053 Uncertain Tissue enhanced 0 cerebral cortex: 6.6 lymph node: 2.4 LRRC7 densin-180, KIAA1365 ENSG00000033122 Leucine rich repeat containing 7 1 69568398-70151945 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 14.5 testis: 4.3 LRRC8B KIAA0231, TA-LRRP ENSG00000197147 Leucine rich repeat containing 8 family, member B 1 89524836-89597864 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017950 Uncertain Approved Nuclear speckles Tissue enhanced 0 cerebral cortex: 38.3 testis: 30.6 LRRN1 FIGLER3 ENSG00000175928 Leucine rich repeat neuronal 1 3 3799437-3847703 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA011071 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 44.4 parathyroid gland: 18.0 LRRN2 FIGLER7, GAC1, LRANK1, LRRN5 ENSG00000170382 Leucine rich repeat neuronal 2 1 204617170-204685733 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029124 Uncertain Approved Endoplasmic reticulum Tissue enhanced 0 cerebral cortex: 23.4;parathyroid gland: 21.0 fallopian tube: 11.9 LRRN3 FIGLER5, FLJ11129, NLRR3 ENSG00000173114 Leucine rich repeat neuronal 3 7 111091006-111125454 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043820, HPA046792 Uncertain Approved Nucleus
Cytosol Tissue enhanced 0 adrenal gland: 30.9;cerebral cortex: 31.2;testis: 29.0;thyroid gland: 33.4 lung: 11.6 LRRTM1 FLJ32082 ENSG00000162951 Leucine rich repeat transmembrane neuronal 1 2 80288351-80304749 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062660 Approved Tissue enhanced 0 cerebral cortex: 13.3;salivary gland: 4.9 thyroid gland: 2.2 LSAMP IGLON3, LAMP ENSG00000185565 Limbic system-associated membrane protein 3 115802363-117139389 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054051, HPA076122 Approved Cytosol Tissue enhanced 0 cerebral cortex: 103.1 prostate: 42.3 LY6G5C C6orf20, G5c, NG33 ENSG00000204428 Lymphocyte antigen 6 complex, locus G5C 6 31676684-31684040 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA038690 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 1.5 testis: 1.0 MAGED4B ENSG00000187243 Melanoma antigen family D4B X 52061827-52069248 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA003554 Approved Tissue enhanced 0 cerebral cortex: 35.2 endometrium: 13.8 MAGEE1 DAMAGE, KIAA1587 ENSG00000198934 Melanoma antigen family E1 X 76427724-76431353 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA003047 Approved Approved Cytokinetic bridge
Cytosol Tissue enhanced 0 cerebral cortex: 29.9 parathyroid gland: 14.0 MAGEE2 HCA3 ENSG00000186675 Melanoma antigen family E2 X 75782988-75785236 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA030625 Uncertain Tissue enhanced 0 cerebral cortex: 3.3 adrenal gland: 1.0 MAGEL2 NDNL1, nM15 ENSG00000254585 Melanoma antigen family L2 15 23643544-23647841 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 3.3 cervix: 2.9 MAGI2 ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2 ENSG00000187391 Membrane associated guanylate kinase, WW and PDZ domain containing 2 7 78017057-79453574 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013650 Approved Tissue enhanced 0 cerebral cortex: 44.0;parathyroid gland: 37.4 prostate: 13.0 MANEAL FLJ31434 ENSG00000185090 Mannosidase, endo-alpha-like 1 37793802-37801137 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA063423 Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 27.2 adrenal gland: 9.6 MAP3K10 MEKK10, MLK2, MST ENSG00000130758 Mitogen-activated protein kinase kinase kinase 10 19 40191744-40215575 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA007039 Approved Approved Nucleus
Actin filaments
Cytosol Tissue enhanced 0 cerebral cortex: 31.2 testis: 7.1 MAP6 FLJ41346, KIAA1878, MAP6-N, STOP ENSG00000171533 Microtubule-associated protein 6 11 75586918-75669120 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB015442, CAB022600, HPA039061, HPA039062 Supported Uncertain Plasma membrane Tissue enhanced 0 cerebral cortex: 68.4;fallopian tube: 64.7 parathyroid gland: 51.7 MAP7D2 FLJ14503 ENSG00000184368 MAP7 domain containing 2 X 20006713-20116917 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA051508, HPA059537 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 49.3;epididymis: 45.0 testis: 18.3 MAPK10 JNK3, p493F12, p54bSAPK, PRKM10 ENSG00000109339 Mitogen-activated protein kinase 10 4 86015123-86594131 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB022625, HPA060304 Approved Supported Nucleoplasm Tissue enhanced 0 cerebral cortex: 148.5 seminal vesicle: 59.2 MAPK4 Erk3-related, Erk4, PRKM4 ENSG00000141639 Mitogen-activated protein kinase 4 18 50560078-50731824 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 29.9;cerebral cortex: 33.5;parathyroid gland: 59.0 seminal vesicle: 13.7 MAPRE3 EB3, RP3 ENSG00000084764 Microtubule-associated protein, RP/EB family, member 3 2 26970612-27027196 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA009263 Uncertain Supported Cytosol Tissue enhanced 0 cerebral cortex: 177.8 testis: 70.0 MAS1 ENSG00000130368 MAS1 proto-oncogene, G protein-coupled receptor 6 159906690-159916530 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013564 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 cervix: 0.7 MATK CHK, CTK, DKFZp434N1212, HHYLTK, HYL, HYLTK, Lsk, MGC1708, MGC2101 ENSG00000007264 Megakaryocyte-associated tyrosine kinase 19 3777970-3802129 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004847 Approved Tissue enhanced 0 cerebral cortex: 22.1 spleen: 20.2 MCHR1 GPR24, MCH1R, SLC1 ENSG00000128285 Melanin-concentrating hormone receptor 1 22 40678750-40682814 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 8.6 ovary: 2.1 MED12L KIAA1635, TNRC11L, TRALP, TRALPUSH ENSG00000144893 Mediator complex subunit 12-like 3 151085697-151437072 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036807 Uncertain Approved Nucleoli Tissue enhanced 0 cerebral cortex: 26.7 testis: 8.6 METRN C16orf23, MGC2601 ENSG00000103260 Meteorin, glial cell differentiation regulator 16 715115-719655 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051164 Approved Approved Nucleoplasm
Nuclear membrane
Cytosol Tissue enhanced 0 cerebral cortex: 64.9 fallopian tube: 37.8 MGAT3 GNT-III ENSG00000128268 Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase 22 39457344-39492194 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA017598 Approved Tissue enhanced 0 cerebral cortex: 38.7 small intestine: 33.2 MICU3 DKFZp313A0139, EFHA2 ENSG00000155970 Mitochondrial calcium uptake family, member 3 8 17027238-17122644 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA024048, HPA024771, HPA024779 Uncertain Tissue enhanced 0 cerebral cortex: 34.9 parathyroid gland: 13.9 MKRN3 D15S9, MGC88288, RNF63, ZFP127, ZNF127 ENSG00000179455 Makorin ring finger protein 3 15 23565678-23630075 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029494 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 5.9;placenta: 4.1;testis: 3.7 epididymis: 1.1 MLLT11 AF1Q ENSG00000213190 Myeloid/lymphoid or mixed-lineage leukemia; translocated to, 11 1 151057758-151068497 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA000540 Uncertain Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 122.9 parathyroid gland: 26.9 MMP16 C8orf57, DKFZp761D112, MT3-MMP ENSG00000156103 Matrix metallopeptidase 16 (membrane-inserted) 8 88032009-88328025 Cancer-related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA023693 Uncertain Approved Vesicles
Cytosol Tissue enhanced 0 cerebral cortex: 9.6 gallbladder: 4.2 MMP17 MT4-MMP ENSG00000198598 Matrix metallopeptidase 17 (membrane-inserted) 12 131828393-131851783 Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 24.1 skin: 8.2 MMP24 MT5-MMP ENSG00000125966 Matrix metallopeptidase 24 (membrane-inserted) 20 35226654-35277000 Enzymes, FDA approved drug targets, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049280 Approved Nucleoli
Plasma membrane Tissue enhanced 0 cerebral cortex: 10.6 lung: 7.1 MPP2 DKFZp761D0712, DLG2 ENSG00000108852 Membrane protein, palmitoylated 2 (MAGUK p55 subfamily member 2) 17 43875357-43909711 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA026486 Approved Approved Mitochondria
Cytosol Tissue enhanced 0 cerebral cortex: 38.0;epididymis: 34.3;parathyroid gland: 43.0 testis: 24.1 MRAP2 bA51G5.2, C6orf117 ENSG00000135324 Melanocortin 2 receptor accessory protein 2 6 84033756-84090881 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 21.1 fallopian tube: 13.3 MRO B29, C18orf3, FLJ30140 ENSG00000134042 Maestro 18 50795120-50825402 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA022011 Approved Tissue enhanced 0 cerebral cortex: 27.6;kidney: 25.3;testis: 54.6 thyroid gland: 10.4 MSANTD3-TMEFF1 C9orf30-TMEFF1 ENSG00000251349 MSANTD3-TMEFF1 readthrough 9 100442271-100577636 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 48.1 testis: 10.1 MSI1 ENSG00000135097 Musashi RNA-binding protein 1 12 120341330-120369180 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064401 Approved Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 cerebral cortex: 17.6;testis: 14.7 skeletal muscle: 7.2 MTMR7 ENSG00000003987 Myotubularin related protein 7 8 17298030-17413528 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 23.0;parathyroid gland: 16.0 thyroid gland: 5.7 MYH15 KIAA1000 ENSG00000144821 Myosin, heavy chain 15 3 108380369-108529322 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034871 Uncertain Approved Nucleoplasm
Centrosome
Mitochondria Tissue enhanced 0 cerebral cortex: 1.9 rectum: 1.3 MYO16 KIAA0865, Myo16b, MYR8, NYAP3, PPP1R107 ENSG00000041515 Myosin XVI 13 108596152-109208007 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA040110, HPA058769, HPA071948 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 2.2 testis: 1.0 MYRF C11orf9, MRF, Ndt80, pqn-47 ENSG00000124920 Myelin regulatory factor 11 61752642-61788518 Enzymes, Plasma proteins, Predicted membrane proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018310 Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 67.6;stomach: 62.4 gallbladder: 38.4 MYRIP DKFZp586F1018, exophilin-8, MyRIP, SLAC2-C, SLAC2C ENSG00000170011 Myosin VIIA and Rab interacting protein 3 39808914-40260321 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006433 Approved Nucleus
Nucleoli
Golgi apparatus Tissue enhanced 0 cerebral cortex: 20.7 spleen: 10.1 NALCN bA430M15.1, CanIon, VGCNL1 ENSG00000102452 Sodium leak channel, non selective 13 101053776-101416492 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031889, HPA031890, HPA031958 Approved Tissue enhanced 0 cerebral cortex: 28.2 adrenal gland: 6.0 NAP1L3 MB20, MGC26312, NPL3 ENSG00000186310 Nucleosome assembly protein 1-like 3 X 93670930-93673568 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA026075 Approved Vesicles Tissue enhanced 0 cerebral cortex: 131.7 testis: 31.0 NAP1L5 DRLM ENSG00000177432 Nucleosome assembly protein 1-like 5 4 88695915-88698235 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA058227 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 91.4 adrenal gland: 29.6 NAV3 KIAA0938, POMFIL1 ENSG00000067798 Neuron navigator 3 12 77830905-78213008 Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA032111, HPA032112, CAB037063 Uncertain Approved Nuclear membrane
Cytosol Tissue enhanced 0 cerebral cortex: 23.1;ovary: 22.9 spleen: 12.1 NBEA BCL8B, FLJ10197, KIAA1544 ENSG00000172915 Neurobeachin 13 34942287-35673022 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA039730, HPA040385 Approved Approved Nucleus
Nucleoli
Golgi apparatus Tissue enhanced 0 cerebral cortex: 30.4 prostate: 12.3 NCAM1 CD56, NCAM ENSG00000149294 Neural cell adhesion molecule 1 11 112961247-113278436 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000142, CAB018071, HPA039835 Supported Validated Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 335.9 adrenal gland: 87.0 NCAM2 MGC51008, NCAM21 ENSG00000154654 Neural cell adhesion molecule 2 21 20998315-21543329 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030900, HPA030901 Approved Supported Nuclear bodies
Plasma membrane Tissue enhanced 0 cerebral cortex: 69.0 adrenal gland: 15.9 NCS1 FREQ, NCS-1 ENSG00000107130 Neuronal calcium sensor 1 9 130172578-130237304 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB018587, HPA019713 Approved Validated Plasma membrane Tissue enhanced 0 cerebral cortex: 178.6 seminal vesicle: 91.2 NDRG4 KIAA1180, SMAP-8 ENSG00000103034 NDRG family member 4 16 58462846-58513628 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015313, HPA017587 Supported Uncertain Nucleus
Cytosol Tissue enhanced 0 adrenal gland: 147.3;cerebral cortex: 421.4 heart muscle: 140.8 NDST3 HSST3 ENSG00000164100 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3 4 118033618-118258648 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056189 Uncertain Tissue enhanced 0 cerebral cortex: 3.0;spleen: 2.8 cervix: 0.7 NDST4 ENSG00000138653 N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 4 4 114827763-115113876 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA011129 Uncertain Tissue enhanced 0 cerebral cortex: 1.4;ovary: 1.8 spleen: 1.0 NECAB2 EFCBP2 ENSG00000103154 N-terminal EF-hand calcium binding protein 2 16 83968632-84002776 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013998, HPA014144, CAB068211 Supported Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 46.9 kidney: 10.5 NEFM NEF3, NF-M, NFM ENSG00000104722 Neurofilament, medium polypeptide 8 24913012-24919098 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010900, CAB012976, HPA022845, HPA023138 Supported Approved Cytosol Tissue enhanced 0 cerebral cortex: 172.2 seminal vesicle: 40.9 NEGR1 IGLON4, KILON, MGC46680, Ntra ENSG00000172260 Neuronal growth regulator 1 1 71395940-72282734 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011894 Uncertain Approved Vesicles
Actin filaments
Cytosol Tissue enhanced 0 cerebral cortex: 56.3 gallbladder: 17.5 NELL1 FLJ45906, IDH3GL ENSG00000165973 Neural EGFL like 1 11 20669551-21575681 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA051535 Approved Tissue enhanced 0 cerebral cortex: 22.9;kidney: 18.6 prostate: 8.2 NELL2 NRP2 ENSG00000184613 Neural EGFL like 2 12 44508275-44921848 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA035714, HPA035715 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 204.7;fallopian tube: 95.3 prostate: 40.8 NEUROD1 BETA2, BHF-1, bHLHa3, MODY6, NEUROD ENSG00000162992 Neuronal differentiation 1 2 181673088-181680876 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA003278, CAB022450 Approved Tissue enhanced 0 cerebral cortex: 6.0;duodenum: 6.2;small intestine: 4.5;stomach: 4.9 pancreas: 1.8 NFASC FLJ46866, KIAA0756, NF, NRCAML ENSG00000163531 Neurofascin 1 204828651-205022822 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008832 Supported Tissue enhanced 0 cerebral cortex: 55.8 seminal vesicle: 22.1 NGEF ARHGEF27 ENSG00000066248 Neuronal guanine nucleotide exchange factor 2 232878686-233013272 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008160 Approved Uncertain Plasma membrane
Cytosol Tissue enhanced 0 adrenal gland: 66.8;cerebral cortex: 151.9 duodenum: 44.0 NIPA1 MGC35570, SPG6 ENSG00000170113 Non imprinted in Prader-Willi/Angelman syndrome 1 15 22773063-22829791 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023269 Uncertain Tissue enhanced 0 cerebral cortex: 38.3 parathyroid gland: 16.6 NKAIN1 FAM77C, FLJ12650 ENSG00000084628 Na+/K+ transporting ATPase interacting 1 1 31179745-31239554 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA006873 Uncertain Tissue enhanced 0 adrenal gland: 13.9;cerebral cortex: 13.1;skeletal muscle: 7.4 epididymis: 4.4 NKX2-2 NKX2.2, NKX2B ENSG00000125820 NK2 homeobox 2 20 21511010-21514026 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA003468 Approved Tissue enhanced 0 cerebral cortex: 10.0;stomach: 2.6 duodenum: 2.4 NLGN1 KIAA1070 ENSG00000169760 Neuroligin 1 3 173396284-174286644 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006572, HPA006680 Approved Uncertain Nuclear bodies
Plasma membrane Tissue enhanced 0 cerebral cortex: 25.5 testis: 12.5 NLGN2 KIAA1366 ENSG00000169992 Neuroligin 2 17 7404874-7419860 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055321, HPA069278 Supported Approved Mitochondria Tissue enhanced 0 cerebral cortex: 81.7 endometrium: 43.6 NLGN3 ASPGX1, AUTSX1, HNL3, KIAA1480 ENSG00000196338 Neuroligin 3 X 71144831-71171201 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003183 Supported Tissue enhanced 0 cerebral cortex: 62.4 seminal vesicle: 17.1 NLGN4X HLNX, KIAA1260, NLGN, NLGN4 ENSG00000146938 Neuroligin 4, X-linked X 5840637-6228863 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001651 Approved Tissue enhanced 0 cerebral cortex: 20.2 ovary: 12.9 NMB MGC17211, MGC2277, MGC3936 ENSG00000197696 Neuromedin B 15 84655129-84658563 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB019302 Approved Approved Nucleus
Vesicles
Plasma membrane Tissue enhanced 0 adipose tissue: 46.1;cerebral cortex: 47.3 thyroid gland: 14.7 NOVA1 ENSG00000139910 Neuro-oncological ventral antigen 1 14 26443093-26597754 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004155 Uncertain Supported Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 62.3 breast: 31.3 NOVA2 ANOVA, NOVA3 ENSG00000104967 Neuro-oncological ventral antigen 2 19 45933734-45973546 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA045607 Supported Approved Nucleoplasm
Nuclear bodies
Golgi apparatus Tissue enhanced 0 cerebral cortex: 24.4 placenta: 5.9 NPAS3 bHLHe12, MOP6, PASD6 ENSG00000151322 Neuronal PAS domain protein 3 14 32934933-33804176 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA002892 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 25.0 cervix: 10.0 NPAS4 bHLHe79, Le-PAS, NXF, PASD10 ENSG00000174576 Neuronal PAS domain protein 4 11 66421004-66426707 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA039255 Uncertain Tissue enhanced 0 cerebral cortex: 4.1;endometrium: 1.9 smooth muscle: 1.5 NPTX2 ENSG00000106236 Neuronal pentraxin II 7 98617297-98629868 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB020801, HPA049799 Supported Tissue enhanced 0 adrenal gland: 33.6;cerebral cortex: 80.5;testis: 44.4 cervix: 12.0 NPY2R ENSG00000185149 Neuropeptide Y receptor Y2 4 155208629-155217078 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 breast: 1.0;cerebral cortex: 1.7;testis: 1.0 rectum: 0.6 NRCAM Bravo, KIAA0343 ENSG00000091129 Neuronal cell adhesion molecule 7 108147623-108456717 Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012606 Approved Tissue enhanced 0 cerebral cortex: 180.9 adrenal gland: 49.7 NRG3 ENSG00000185737 Neuregulin 3 10 81875314-82987179 Cancer-related genes, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 30.4 fallopian tube: 7.3 NRIP3 C11orf14 ENSG00000175352 Nuclear receptor interacting protein 3 11 8980576-9004049 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040573, HPA058827 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 36.6;testis: 55.5 adrenal gland: 13.3 NRN1 NRN ENSG00000124785 Neuritin 1 6 5997999-6007605 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 153.0 adipose tissue: 61.4 NRSN2 C20orf98, dJ1103G7.6 ENSG00000125841 Neurensin 2 20 346782-359660 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015967 Approved Approved Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 cerebral cortex: 126.5 parathyroid gland: 68.4 NRXN3 C14orf60, KIAA0743 ENSG00000021645 Neurexin 3 14 78170373-79868290 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002727 Approved Tissue enhanced 0 cerebral cortex: 43.1;smooth muscle: 28.6 testis: 21.4 NTM HNT, IGLON2, NTRI ENSG00000182667 Neurotrimin 11 131370478-132336822 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB024875 Supported Tissue enhanced 0 cerebral cortex: 116.3 lung: 39.1 NTNG1 KIAA0976, Lmnt1 ENSG00000162631 Netrin G1 1 107140007-107483458 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065954 Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 8.6 seminal vesicle: 6.6 NTRK2 TRKB ENSG00000148053 Neurotrophic tyrosine kinase, receptor, type 2 9 84668551-85027070 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007637 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 441.0;thyroid gland: 214.8 breast: 81.9 NTRK3 TRKC ENSG00000140538 Neurotrophic tyrosine kinase, receptor, type 3 15 87859751-88256768 Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009233, HPA027484, HPA048065 Supported Supported Nuclear membrane
Nucleoli Tissue enhanced 0 cerebral cortex: 39.7 testis: 15.2 NUAK1 ARK5, KIAA0537, NuaK1 ENSG00000074590 NUAK family, SNF1-like kinase, 1 12 106063340-106140033 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027455, HPA057143 Approved Supported Nucleus
Nucleoli fibrillar center
Microtubules Tissue enhanced 0 cerebral cortex: 47.1;parathyroid gland: 41.6 skin: 21.0 NUDT11 DIPP3b, FLJ10628, hDIPP3beta ENSG00000196368 Nudix (nucleoside diphosphate linked moiety X)-type motif 11 X 51490011-51496596 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047027, HPA057684 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 40.2;testis: 67.4 prostate: 16.1 NWD2 KIAA1239 ENSG00000174145 NACHT and WD repeat domain containing 2 4 37244220-37449465 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA046911 Uncertain Tissue enhanced 0 cerebral cortex: 6.2 thyroid gland: 1.4 NXPH3 NPH3 ENSG00000182575 Neurexophilin 3 17 49575858-49583827 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 15.6 seminal vesicle: 9.5 NXPH4 NPH4 ENSG00000182379 Neurexophilin 4 12 57216795-57226449 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 8.3;prostate: 6.7;skin: 12.2 placenta: 3.8 NYAP1 C7orf51, FLJ37538, KIAA1486L ENSG00000166924 Neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adaptor 1 7 100483927-100494799 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA022251 Uncertain Supported Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 25.2;testis: 7.7 adrenal gland: 3.3 OLFM2 NOE2, OlfC ENSG00000105088 Olfactomedin 2 19 9853718-9936552 Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049961, HPA057771 Uncertain Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 124.3;skin: 111.4 adipose tissue: 36.8 OPN4 melanopsin, MOP ENSG00000122375 Opsin 4 10 86654557-86666848 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA039147 Approved Tissue enhanced 0 cerebral cortex: 2.2;parathyroid gland: 1.4 skeletal muscle: 0.9 OPRD1 ENSG00000116329 Opioid receptor, delta 1 1 28812142-28871267 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013744 Uncertain Tissue enhanced 0 cerebral cortex: 2.6 adrenal gland: 0.8 OPRL1 KOR-3, NOCIR, OOR, ORL1 ENSG00000125510 Opiate receptor-like 1 20 64080173-64100643 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 12.3 testis: 4.8 OR2L13 OR2L14 ENSG00000196071 Olfactory receptor, family 2, subfamily L, member 13 1 247937191-248100922 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 4.0 prostate: 1.1 OSBPL6 ORP6 ENSG00000079156 Oxysterol binding protein-like 6 2 178194481-178402891 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032131 Supported Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 15.5 skin: 9.2 OSTN ENSG00000188729 Osteocrin 3 191199241-191265615 Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB024997, CAB025649, HPA030878 Uncertain Tissue enhanced 0 cerebral cortex: 4.4 epididymis: 2.7 OTUD7A C15orf16, CEZANNE2, OTUD7 ENSG00000169918 OTU deubiquitinase 7A 15 31475398-31870789 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044554 Uncertain Approved Nucleoli
Cytosol Tissue enhanced 0 cerebral cortex: 13.5 testis: 5.1 OTX1 ENSG00000115507 Orthodenticle homeobox 1 2 63050057-63057836 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB012341, HPA052122 Approved Uncertain Nuclear speckles
Cytosol Tissue enhanced 0 cerebral cortex: 1.7;skin: 6.1 prostate: 0.9 P2RX6 MGC129625, P2RXL1, P2X6, P2XM ENSG00000099957 Purinergic receptor P2X, ligand gated ion channel, 6 22 21009808-21028830 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA028776, HPA028777 Approved Approved Nucleoli
Cytosol Tissue enhanced 0 cerebral cortex: 3.4 skeletal muscle: 3.0 PADI2 KIAA0994, PDI2 ENSG00000117115 Peptidyl arginine deiminase, type II 1 17066761-17119435 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047735 Supported Tissue enhanced 0 cerebral cortex: 85.2;colon: 91.2;rectum: 101.6;skeletal muscle: 108.6 breast: 48.7 PAK3 bPAK, hPAK3, MRX30, MRX47 ENSG00000077264 P21 protein (Cdc42/Rac)-activated kinase 3 X 110944285-111227361 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044791, HPA060219 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 34.4 thyroid gland: 10.3 PALM KIAA0270 ENSG00000099864 Paralemmin 19 708939-748329 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041713, HPA049578 Approved Validated Nucleus
Plasma membrane Tissue enhanced 0 cerebral cortex: 85.1 adipose tissue: 52.9 PALM2 ENSG00000243444 Paralemmin 2 9 109640788-109946703 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA074153 Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 9.8 liver: 3.5 PANX2 hPANX2, PX2 ENSG00000073150 Pannexin 2 22 50170731-50180294 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA004624, HPA039117 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 8.7 seminal vesicle: 2.1 PAQR4 FLJ30002 ENSG00000162073 Progestin and adipoQ receptor family member IV 16 2969245-2973489 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA068394 Approved Vesicles Tissue enhanced 0 cerebral cortex: 54.1;parathyroid gland: 64.2 skin: 19.2 PCDH11X PCDH-X, PCDH11, PCDHX, PPP1R119 ENSG00000102290 Protocadherin 11 X-linked X 91779261-92623230 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA000432 Approved Tissue enhanced 0 cerebral cortex: 5.3;ovary: 9.9;parathyroid gland: 4.8 cervix: 1.7 PCDH15 CDHR15, DFNB23, USH1F ENSG00000150275 Protocadherin-related 15 10 53802771-55627942 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 adrenal gland: 25.1;cerebral cortex: 12.3 kidney: 8.1 PCDH17 PCDH68, PCH68 ENSG00000118946 Protocadherin 17 13 57631810-57729311 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA026817 Uncertain Approved Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 25.8;spleen: 34.3 lung: 18.3 PCDH19 EFMR, EIEE9, KIAA1313 ENSG00000165194 Protocadherin 19 X 100291644-100410273 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA027533 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 10.8 cervix: 2.5 PCDH20 FLJ22218, PCDH13 ENSG00000280165 Protocadherin 20 13 61409685-61415522 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 14.6;smooth muscle: 12.8 lung: 5.0 PCDHA1 ENSG00000204970 Protocadherin alpha 1 5 140786136-141012347 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035969 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 2.8;testis: 1.6 adrenal gland: 0.4 PCDHA10 CNR8, CNRN8, CNRS8, CRNR8, PCDH-ALPHA10 ENSG00000250120 Protocadherin alpha 10 5 140855883-141012344 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 17.5 thyroid gland: 4.2 PCDHA11 CNR7, CNRN7, CNRS7, CRNR7, PCDH-ALPHA11 ENSG00000249158 Protocadherin alpha 11 5 140868183-141012344 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA077160 Approved Vesicles
Cell Junctions Tissue enhanced 0 cerebral cortex: 7.6;parathyroid gland: 4.7 testis: 2.3 PCDHA4 CNR1, CNRN1, CRNR1, PCDH-ALPHA4 ENSG00000204967 Protocadherin alpha 4 5 140806929-141012344 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA043180, HPA073478 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 4.4 gallbladder: 2.6 PCDHA6 CNR2, CNRS2, CRNR2, PCDH-ALPHA6 ENSG00000081842 Protocadherin alpha 6 5 140827958-141012344 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059326 Approved Vesicles Tissue enhanced 0 cerebral cortex: 4.8 parathyroid gland: 1.9 PCDHA7 CNR4, CNRS4, CRNR4 ENSG00000204963 Protocadherin alpha 7 5 140834248-141012344 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 1.6;testis: 1.3 smooth muscle: 0.3 PCDHB10 ENSG00000120324 Protocadherin beta 10 5 141182560-141195642 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013445, HPA014668, HPA029441 Approved Approved Vesicles
Plasma membrane Tissue enhanced 0 cerebral cortex: 8.3 endometrium: 5.1 PCDHB9 PCDH-BETA9, PCDH3H ENSG00000177839 Protocadherin beta 9 5 141187127-141191541 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA013445, HPA029441 Uncertain Tissue enhanced 0 cerebral cortex: 7.9 ovary: 2.5 PCDHGA1 PCDH-GAMMA-A1 ENSG00000204956 Protocadherin gamma subfamily A, 1 5 141330571-141512981 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA008755, HPA036547 Uncertain Tissue enhanced 0 cerebral cortex: 3.2 testis: 1.4 PCDHGA3 PCDH-GAMMA-A3 ENSG00000254245 Protocadherin gamma subfamily A, 3 5 141343829-141512979 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA008755, HPA039295 Uncertain Approved Nucleoplasm
Centrosome Tissue enhanced 0 cerebral cortex: 6.5 ovary: 3.1 PCDHGA7 PCDH-GAMMA-A7 ENSG00000253537 Protocadherin gamma subfamily A, 7 5 141382739-141512979 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA008755, HPA077995 Uncertain Uncertain Plasma membrane
Cell Junctions Tissue enhanced 0 cerebral cortex: 7.4 thyroid gland: 3.2 PCDHGA9 PCDH-GAMMA-A9 ENSG00000261934 Protocadherin gamma subfamily A, 9 5 141402932-141512979 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA008755 Uncertain Tissue enhanced 0 cerebral cortex: 9.6 endometrium: 4.1 PCDHGB6 PCDH-GAMMA-B6 ENSG00000253305 Protocadherin gamma subfamily B, 6 5 141408021-141512979 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA008755 Uncertain Tissue enhanced 0 cerebral cortex: 20.9 parathyroid gland: 11.7 PCDHGC3 PC-43, PC43, PCDH-GAMMA-C3, PCDH2 ENSG00000240184 Protocadherin gamma subfamily C, 3 5 141475947-141512979 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008755, HPA077289 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 377.1 cervix: 93.4 PCLO ACZ, DKFZp779G1236, KIAA0559 ENSG00000186472 Piccolo presynaptic cytomatrix protein 7 82754013-83162930 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015858, HPA029579 Approved Approved Nuclear speckles
Plasma membrane Tissue enhanced 0 cerebral cortex: 17.5 parathyroid gland: 9.6 PCP4L1 IQM1 ENSG00000248485 Purkinje cell protein 4 like 1 1 161258727-161285450 Predicted intracellular proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA052833 Approved Nucleoplasm
Mitochondria Tissue enhanced 0 cerebral cortex: 45.4;urinary bladder: 41.0 seminal vesicle: 22.8 PCSK1 NEC1, PC1, PC3, SPC3 ENSG00000175426 Proprotein convertase subtilisin/kexin type 1 5 96390415-96434143 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA048564 Approved Tissue enhanced 0 cerebral cortex: 33.7 adrenal gland: 8.3 PCSK1N SAAS, SCG8, SgVIII ENSG00000102109 Proprotein convertase subtilisin/kexin type 1 inhibitor X 48831094-48835633 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003925, HPA064734 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 93.9;kidney: 65.8 adrenal gland: 28.6 PCSK2 NEC2, PC2, SPC2 ENSG00000125851 Proprotein convertase subtilisin/kexin type 2 20 17226107-17484578 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA049627 Approved Approved Vesicles Tissue enhanced 0 adrenal gland: 37.7;cerebral cortex: 31.8 skin: 16.5 PCYT1B CCT-beta, CTB ENSG00000102230 Phosphate cytidylyltransferase 1, choline, beta X 24558087-24672677 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006367 Uncertain Tissue enhanced 0 cerebral cortex: 22.0;testis: 17.4 smooth muscle: 4.7 PDE1B PDES1B ENSG00000123360 Phosphodiesterase 1B, calmodulin-dependent 12 54549350-54579239 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018492 Approved Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 18.5 parathyroid gland: 11.9 PDE2A ENSG00000186642 Phosphodiesterase 2A, cGMP-stimulated 11 72576141-72674591 Enzymes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009752, HPA031192 Approved Supported Cytosol Tissue enhanced 0 cerebral cortex: 142.1;spleen: 187.4 adipose tissue: 61.9 PDXP CIN, dJ37E16.5, FLJ32703 ENSG00000241360 Pyridoxal (pyridoxine, vitamin B6) phosphatase 22 37658727-37666934 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000531 Approved Tissue enhanced 0 cerebral cortex: 136.4 testis: 30.5 PGBD5 DKFZp761A0620, FLJ11413 ENSG00000177614 PiggyBac transposable element derived 5 1 230314482-230425729 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA065010 Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 40.2;cervix, uterine: 28.9 adrenal gland: 12.7 PHACTR1 dJ257A7.2, KIAA1733, RPEL1 ENSG00000112137 Phosphatase and actin regulator 1 6 12716805-13290484 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029755, HPA029756, HPA029757 Supported Uncertain Plasma membrane Tissue enhanced 0 cerebral cortex: 27.9 bone marrow: 15.6 PHF21B BHC80L, FLJ34161, PHF4 ENSG00000056487 PHD finger protein 21B 22 44881162-45009999 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA053834 Uncertain Uncertain Nucleus
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 6.7;cervix, uterine: 5.5;testis: 6.4 endometrium: 5.3 PHYHIP DYRK1AP3, KIAA0273, PAHX-AP ENSG00000168490 Phytanoyl-CoA 2-hydroxylase interacting protein 8 22219704-22232341 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA068030, HPA069318 Approved Supported Mitochondria Tissue enhanced 0 cerebral cortex: 183.2;skin: 58.3 adrenal gland: 29.0 PHYHIPL Em:AC025038.1, KIAA1796 ENSG00000165443 Phytanoyl-CoA 2-hydroxylase interacting protein-like 10 59176590-59247774 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038746 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 89.6 adrenal gland: 22.5 PIANP C12orf53, DKFZp547D2210, PANP ENSG00000139200 PILR alpha associated neural protein 12 6693792-6700800 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA010631 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 64.5 endometrium: 13.5 PIRT ENSG00000233670 Phosphoinositide-interacting regulator of transient receptor potential channels 17 10822475-10838445 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042337 Uncertain Uncertain Plasma membrane
Cytosol Tissue enhanced 0 adrenal gland: 3.1;cerebral cortex: 2.7;rectum: 2.7 colon: 2.1 PLCB1 KIAA0581, PLC-I, PLC154 ENSG00000182621 Phospholipase C, beta 1 (phosphoinositide-specific) 20 8114453-8968360 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004275, CAB005334, HPA034743, HPA057910 Supported Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 66.1;parathyroid gland: 110.6 placenta: 23.5 PLEKHH1 KIAA1200 ENSG00000054690 Pleckstrin homology domain containing, family H (with MyTH4 domain) member 1 14 67533301-67589612 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA047707, HPA051964 Uncertain Approved Centrosome Tissue enhanced 0 cerebral cortex: 43.4;thyroid gland: 51.0 parathyroid gland: 15.4 PLPP4 DPPL2, PPAPDC1, PPAPDC1A ENSG00000203805 Phospholipid phosphatase 4 10 120456954-120589855 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045188 Approved Approved Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 17.2;gallbladder: 10.4;testis: 12.7 kidney: 7.7 PLPPR3 FLJ11535, LPPR3, PRG-2, PRG2 ENSG00000129951 Phospholipid phosphatase related 3 19 812488-821977 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA052293, HPA057034 Uncertain Approved Nucleoplasm
Golgi apparatus
Cytosol Tissue enhanced 0 bone marrow: 6.1;cerebral cortex: 9.6;fallopian tube: 8.8 testis: 2.1 PLXNB3 PLEXB3, PLEXR, PLXN6 ENSG00000198753 Plexin B3 X 153764196-153779346 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA048046 Supported Tissue enhanced 0 cerebral cortex: 67.4 adrenal gland: 19.7 PNCK CaMK1b, MGC45419 ENSG00000130822 Pregnancy up-regulated nonubiquitous CaM kinase X 153669730-153689010 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA007458 Approved Approved Golgi apparatus
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 40.7;seminal vesicle: 51.7 smooth muscle: 22.1 PNMA6A MGC15827, PNMA6C ENSG00000235961 Paraneoplastic Ma antigen family member 6A X 153072482-153075018 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045007, HPA052115 Uncertain Uncertain Nucleoli
Mitochondria Tissue enhanced 0 cerebral cortex: 22.9 epididymis: 9.3 PNMAL1 FLJ10781, KIAA1183L ENSG00000182013 Paraneoplastic Ma antigen family-like 1 19 46466491-46471563 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012956 Approved Approved Nucleoplasm
Nuclear bodies
Cytosol Tissue enhanced 0 cerebral cortex: 134.3 testis: 42.5 PNOC N/OFQ, NOP, PPNOC ENSG00000168081 Prepronociceptin 8 28316986-28343355 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA044507, HPA056724 Supported Tissue enhanced 0 cerebral cortex: 44.3;fallopian tube: 26.0;lymph node: 29.3 tonsil: 22.9 PODXL2 endoglycan, PODLX2 ENSG00000114631 Podocalyxin-like 2 3 127629181-127672809 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB024934, HPA042265 Approved Approved Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 77.3 testis: 35.9 POU6F2 RPF-1 ENSG00000106536 POU class 6 homeobox 2 7 38977998-39493095 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA008699 Uncertain Tissue enhanced 0 cerebral cortex: 3.1;placenta: 1.8 testis: 1.2 PPFIA4 ENSG00000143847 Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 1 203026498-203078740 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA053419, HPA054132 Supported Tissue enhanced 0 cerebral cortex: 24.8;heart muscle: 13.3 skeletal muscle: 6.5 PPP1R16B ANKRD4, KIAA0823, TIMAP ENSG00000101445 Protein phosphatase 1, regulatory subunit 16B 20 38805705-38923024 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049571 Supported Nuclear speckles
Plasma membrane Tissue enhanced 0 cerebral cortex: 51.0 lymph node: 44.7 PPP1R3F Hb2E ENSG00000049769 Protein phosphatase 1, regulatory subunit 3F X 49269843-49301461 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA000244, HPA000918 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 27.0 epididymis: 15.0 PPP2R2B PR52B, PR55-BETA, SCA12 ENSG00000156475 Protein phosphatase 2, regulatory subunit B, beta 5 146581146-147084784 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038118, HPA042122, HPA042770 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 135.6 testis: 33.7 PPP2R2C IMYPNO, MGC33570, PR52, PR55G ENSG00000074211 Protein phosphatase 2, regulatory subunit B, gamma 4 6320578-6563600 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042122, HPA042770, HPA060473 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 164.9 endometrium: 52.9 PPP4R4 CFAP14, KIAA1622, PP4R4 ENSG00000119698 Protein phosphatase 4, regulatory subunit 4 14 94146128-94279735 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA041866, HPA050321 Uncertain Supported Cytosol Tissue enhanced 0 cerebral cortex: 14.0;testis: 11.1 ovary: 5.4 PRKCB PKCB, PRKCB1, PRKCB2 ENSG00000166501 Protein kinase C, beta 16 23836001-24220611 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003843, HPA048321, HPA054203 Approved Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 125.8 spleen: 65.5 PRKCE ENSG00000171132 Protein kinase C, epsilon 2 45651345-46187990 Cancer-related genes, Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001948, HPA044496, HPA054252 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 48.5 parathyroid gland: 20.3 PRKCZ PKC2 ENSG00000067606 Protein kinase C, zeta 1 2050470-2185395 Enzymes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021851 Supported Approved Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 100.0 placenta: 59.9 PROKR2 dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2 ENSG00000101292 Prokineticin receptor 2 20 5302040-5314369 Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA047281 Uncertain Tissue enhanced 0 cerebral cortex: 3.0 bone marrow: 0.8 PRR7 MGC10772 ENSG00000131188 Proline rich 7 (synaptic) 5 177446445-177456286 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046636 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 8.1 bone marrow: 3.7 PRRG3 TMG3 ENSG00000130032 Proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane) X 151695124-151705924 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA060566 Uncertain Tissue enhanced 0 cerebral cortex: 8.9 cervix: 7.5 PRRT2 DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC ENSG00000167371 Proline-rich transmembrane protein 2 16 29811382-29815892 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014447, HPA019203 Approved Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 92.9 ovary: 51.5 PRRT3 FLJ33674 ENSG00000163704 Proline-rich transmembrane protein 3 3 9945542-9952394 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035127, HPA035128 Uncertain Approved Nucleus
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 19.5;parathyroid gland: 27.5 fallopian tube: 12.3 PSAT1 PSA ENSG00000135069 Phosphoserine aminotransferase 1 9 78297143-78330093 Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB014882, CAB040567, HPA042924 Supported Validated Cytosol Tissue enhanced 0 cerebral cortex: 186.5 liver: 138.5 PSD EFA6, EFA6A, KIAA2011, PSD1, TYL ENSG00000059915 Pleckstrin and Sec7 domain containing 10 102402617-102421539 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA059237 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 77.8 endometrium: 25.4 PSD3 DKFZp761K1423, EFA6D, EFA6R, HCA67, KIAA0942 ENSG00000156011 Pleckstrin and Sec7 domain containing 3 8 18527301-19084730 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002455 Approved Nucleus
Vesicles Tissue enhanced 0 cerebral cortex: 83.5 testis: 29.5 PSRC1 DDA3 ENSG00000134222 Proline/serine-rich coiled-coil 1 1 109279556-109283186 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049315, HPA056561 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 36.6 testis: 14.0 PTPRD HPTP, PTPD ENSG00000153707 Protein tyrosine phosphatase, receptor type, D 9 8314246-10612723 Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA054829 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 32.5;parathyroid gland: 46.2 ovary: 11.6 PTPRN2 IA-2beta, ICAAR, KIAA0387, phogrin ENSG00000155093 Protein tyrosine phosphatase, receptor type, N polypeptide 2 7 157539056-158587788 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA006900, HPA026656 Approved Uncertain Vesicles
Plasma membrane Tissue enhanced 0 cerebral cortex: 82.5 stomach: 39.0 PTPRR EC-PTP, PCPTP1, PTP-SL, PTPBR7, PTPRQ ENSG00000153233 Protein tyrosine phosphatase, receptor type, R 12 70638073-70920843 Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011461, HPA011851, HPA071067 Uncertain Supported Plasma membrane
Cell Junctions
Cytosol Tissue enhanced 0 cerebral cortex: 20.9 endometrium: 8.9 PURG PURG-A, PURG-B ENSG00000172733 Purine-rich element binding protein G 8 30995802-31033715 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA047746 Uncertain Approved Nucleus
Nucleoli
Plasma membrane Tissue enhanced 0 cerebral cortex: 6.6;testis: 4.8 endometrium: 2.6 RAB11FIP4 FLJ00131, KIAA1821, MGC11316, RAB11-FIP4 ENSG00000131242 RAB11 family interacting protein 4 (class II) 17 31391624-31538217 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA021595, HPA063203 Approved Supported Vesicles Tissue enhanced 0 cerebral cortex: 68.1 testis: 42.4 RAB26 ENSG00000167964 RAB26, member RAS oncogene family 16 2140803-2154165 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA075624 Uncertain Vesicles
Plasma membrane
Centrosome Tissue enhanced 0 cerebral cortex: 21.2 liver: 11.4 RAB33A RabS10 ENSG00000134594 RAB33A, member RAS oncogene family X 130171649-130184870 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059737 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 32.0 lymph node: 9.2 RAB39A RAB39 ENSG00000179331 RAB39A, member RAS oncogene family 11 107928503-107963482 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042505 Uncertain Tissue enhanced 0 cerebral cortex: 7.0 spleen: 4.3 RAB39B MRX72 ENSG00000155961 RAB39B, member RAS oncogene family X 155258241-155264589 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001114, HPA042505 Approved Tissue enhanced 0 cerebral cortex: 19.5 epididymis: 7.4 RAB3B ENSG00000169213 RAB3B, member RAS oncogene family 1 51907956-51990764 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003159, CAB023293 Supported Tissue enhanced 0 cerebral cortex: 8.2;prostate: 18.0 adrenal gland: 4.1 RAB40B RAR, SEC4L ENSG00000141542 RAB40B, member RAS oncogene family 17 82654973-82698728 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 56.9 epididymis: 17.8 RALYL HNRPCL3 ENSG00000184672 RALY RNA binding protein-like 8 84182787-84921844 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA055868, HPA059112 Supported Supported Nucleoplasm Tissue enhanced 0 adrenal gland: 26.2;cerebral cortex: 49.3;kidney: 19.6 gallbladder: 8.2 RANBP3L FLJ25422 ENSG00000164188 RAN binding protein 3-like 5 36248434-36302114 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA037471, HPA037472, HPA061526 Approved Uncertain Nucleoplasm Tissue enhanced 0 cerebral cortex: 31.1;kidney: 28.5;prostate: 21.7 breast: 10.0 RAP1GAP KIAA0474, RAP1GA1, RAP1GAP1, RAP1GAPII ENSG00000076864 RAP1 GTPase activating protein 1 21596215-21669363 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001922 Supported Supported Tissue enhanced 0 cerebral cortex: 122.5;thyroid gland: 232.1 adrenal gland: 93.7 RAPGEF4 cAMP-GEFII, CGEF2 ENSG00000091428 Rap guanine nucleotide exchange factor (GEF) 4 2 172735274-173052893 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB004388, HPA028968 Approved Approved Focal adhesion sites Tissue enhanced 0 adrenal gland: 53.6;cerebral cortex: 119.5 liver: 18.2 RASGEF1A CG4853, FLJ37817 ENSG00000198915 RasGEF domain family, member 1A 10 43194535-43266919 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035593 Approved Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 22.7 parathyroid gland: 12.5 RASGRF2 GRF2, Ras-GRF2 ENSG00000113319 Ras protein-specific guanine nucleotide-releasing factor 2 5 80960672-81230156 Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA018679 Uncertain Supported Endoplasmic reticulum Tissue enhanced 0 cerebral cortex: 22.4 ovary: 15.1 RASGRP1 CalDAG-GEFII, RASGRP ENSG00000172575 RAS guanyl releasing protein 1 (calcium and DAG-regulated) 15 38488103-38565575 Disease related genes, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046216 Supported Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 28.5;lymph node: 25.3 tonsil: 15.8 RASSF2 CENP-34, KIAA0168 ENSG00000101265 Ras association (RalGDS/AF-6) domain family member 2 20 4780023-4823645 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051200 Uncertain Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 148.9 lymph node: 69.7 RBFOX1 A2BP1, FOX-1, HRNBP1 ENSG00000078328 RNA binding protein, fox-1 homolog (C. elegans) 1 16 6019094-7713338 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA040809 Supported Approved Nucleus
Golgi apparatus
Cytosol Tissue enhanced 0 cerebral cortex: 110.9;skeletal muscle: 32.9 heart muscle: 14.8 RBFOX3 FOX-3, HRNBP3, NeuN ENSG00000167281 RNA binding protein, fox-1 homolog (C. elegans) 3 17 79089345-79516148 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA030790 Supported Supported Nucleoplasm Tissue enhanced 0 cerebral cortex: 62.5;seminal vesicle: 33.0 prostate: 21.5 RCOR2 ENSG00000167771 REST corepressor 2 11 63911221-63916844 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021638 Uncertain Approved Nucleus
Vesicles
Midbody Tissue enhanced 0 cerebral cortex: 13.2 testis: 3.7 REEP1 C2orf23, FLJ13110, SPG31 ENSG00000068615 Receptor accessory protein 1 2 86213993-86338083 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058061 Approved Tissue enhanced 0 cerebral cortex: 54.2;testis: 90.8 smooth muscle: 34.1 RELL2 C5orf16, FLJ90583 ENSG00000164620 RELT-like 2 5 141636950-141641077 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA077928 Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 13.2;parathyroid gland: 20.4 testis: 4.2 RESP18 ENSG00000182698 Regulated endocrine-specific protein 18 2 219327409-219333177 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045849 Uncertain Tissue enhanced 0 cerebral cortex: 2.1 testis: 0.6 RFTN2 C2orf11, FLJ30574, Raftlin-2 ENSG00000162944 Raftlin family member 2 2 197568224-197676045 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035232 Approved Tissue enhanced 0 cerebral cortex: 31.5 ovary: 8.7 RGMA RGM, RGMa ENSG00000182175 Repulsive guidance molecule family member a 15 93035273-93089204 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012343, HPA039880, HPA044222 Approved Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 116.9;smooth muscle: 83.8 skeletal muscle: 42.6 RGS11 ENSG00000076344 Regulator of G-protein signaling 11 16 268301-275980 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041692, HPA043039 Uncertain Tissue enhanced 0 cerebral cortex: 20.4 adipose tissue: 8.1 RGS20 RGSZ1, ZGAP1 ENSG00000147509 Regulator of G-protein signaling 20 8 53851808-53959303 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 10.2 thyroid gland: 2.1 RGS6 ENSG00000182732 Regulator of G-protein signaling 6 14 71932439-72566529 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003067 Uncertain Tissue enhanced 0 cerebral cortex: 17.5;testis: 18.6 thyroid gland: 8.7 RGS7BP R7BP ENSG00000186479 Regulator of G-protein signaling 7 binding protein 5 64506257-64612312 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA039600 Approved Tissue enhanced 0 cerebral cortex: 39.0 fallopian tube: 13.1 RHBDL1 RHBDL, RRP ENSG00000103269 Rhomboid, veinlet-like 1 (Drosophila) 16 675666-678268 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA030359, HPA030360, HPA046593 Uncertain Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 8.0 adrenal gland: 3.3 RHBDL3 RHBDL4, VRHO ENSG00000141314 Rhomboid, veinlet-like 3 (Drosophila) 17 32266176-32324661 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA059607 Uncertain Tissue enhanced 0 cerebral cortex: 20.7 adrenal gland: 5.5 RHPN1 KIAA1929, ODF5, RHPN ENSG00000158106 Rhophilin, Rho GTPase binding protein 1 8 143368855-143384220 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024288, HPA024671 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 7.3 parathyroid gland: 4.8 RIMKLA FAM80A, MGC47816, NAAGS-II, RP11-157D18.1 ENSG00000177181 Ribosomal modification protein rimK-like family member A 1 42380795-42422578 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA027826 Uncertain Uncertain Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 10.3 rectum: 3.9 RIMS1 CORD7, KIAA0340, RAB3IP2, RIM, RIM1 ENSG00000079841 Regulating synaptic membrane exocytosis 1 6 71886703-72403143 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 30.3 testis: 7.4 RIMS2 KIAA0751, OBOE, RAB3IP3, RIM2 ENSG00000176406 Regulating synaptic membrane exocytosis 2 8 103500748-104256094 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046538, HPA066498 Supported Approved Cytosol Tissue enhanced 0 adrenal gland: 68.1;cerebral cortex: 45.4 cervix: 11.5 RIMS4 C20orf190, dJ781B1.3 ENSG00000101098 Regulating synaptic membrane exocytosis 4 20 44751808-44810338 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA060928 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 27.4;testis: 20.3 fallopian tube: 13.2 RND1 ARHS, Rho6, RHOS ENSG00000172602 Rho family GTPase 1 12 48857145-48865898 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA077800 Supported Vesicles
Plasma membrane
Actin filaments Tissue enhanced 0 cerebral cortex: 39.9;liver: 31.0 gallbladder: 23.7 RND2 ARHN, Rho7, RhoN ENSG00000108830 Rho family GTPase 2 17 43025241-43032036 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 37.1;testis: 30.7 thyroid gland: 11.0 RNF103-CHMP3 RNF103-VPS24 ENSG00000249884 RNF103-CHMP3 readthrough 2 86505668-86721122 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level HPA015673 Uncertain Tissue enhanced 0 cerebral cortex: 4.2 bone marrow: 2.7 RNF112 BFP, ZNF179 ENSG00000128482 Ring finger protein 112 17 19411125-19417276 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA015970 Approved Approved Nuclear speckles Tissue enhanced 0 cerebral cortex: 33.0 prostate: 9.6 RNF157 KIAA1917 ENSG00000141576 Ring finger protein 157 17 76142453-76240373 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA021854, HPA021991, HPA023922 Uncertain Approved Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 60.8;testis: 58.1 skeletal muscle: 24.9 RNF165 ARKL2, RNF111L2 ENSG00000141622 Ring finger protein 165 18 46326809-46463140 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA041615, HPA047798 Uncertain Approved Nucleus
Plasma membrane Tissue enhanced 0 cerebral cortex: 9.3;parathyroid gland: 9.6 thyroid gland: 6.9 RNF175 FLJ34190 ENSG00000145428 Ring finger protein 175 4 153710125-153760235 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035837 Uncertain Tissue enhanced 0 cerebral cortex: 13.2 seminal vesicle: 4.8 RNF182 MGC33993 ENSG00000180537 Ring finger protein 182 6 13924446-13980302 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012309 Approved Approved Nucleus
Golgi apparatus
Vesicles Tissue enhanced 0 cerebral cortex: 14.6 testis: 6.8 RNF208 DKFZP761H1710 ENSG00000212864 Ring finger protein 208 9 137220247-137221581 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA021256, HPA021429 Uncertain Supported Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 25.2 adrenal gland: 7.4 RNFT2 FLJ14627, TMEM118 ENSG00000135119 Ring finger protein, transmembrane 2 12 116738178-116853631 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA064161 Approved Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 15.4 testis: 6.1 ROBO2 KIAA1568 ENSG00000185008 Roundabout guidance receptor 2 3 75906695-77649964 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013371 Approved Approved Nucleus
Microtubule organizing center Tissue enhanced 0 cerebral cortex: 33.9 lung: 15.2 ROM1 ROM, TSPAN23 ENSG00000149489 Retinal outer segment membrane protein 1 11 62611722-62615120 Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028910 Supported Approved Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 25.5 ovary: 13.2 RORB NR1F2, ROR-BETA, RZRB ENSG00000198963 RAR-related orphan receptor B 9 74497365-74693177 Nuclear receptors, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008393 Uncertain Approved Nucleus Tissue enhanced 0 cerebral cortex: 12.6;cervix, uterine: 14.0 prostate: 7.6 RP1-130H16.18 ENSG00000248751 22 30285238-30299482 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 1.2 testis: 1.0 RP11-192H23.4 ENSG00000258472 17 28455752-28614197 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA046590 Uncertain Approved Nucleoplasm
Vesicles
Plasma membrane Tissue enhanced 0 cerebral cortex: 2.2 lung: 1.2 RP11-231C18.3 ENSG00000282278 4 53377839-54295272 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA058202 Approved Nucleoplasm Tissue enhanced 0 appendix: 1.3;cerebral cortex: 3.3 ovary: 0.7 RP11-540D14.8 ENSG00000251246 1 155063748-155086807 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 1.2 testis: 0.7 RP11-73M18.2 ENSG00000256500 14 103562962-103685924 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA044617, HPA052450 Uncertain Uncertain Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 21.6;testis: 21.5 skeletal muscle: 9.1 RP13-1032I1.10 ENSG00000262660 17 81703371-81720539 Predicted intracellular proteins Evidence at protein level Evidence at protein level HPA022853, HPA023043, HPA023048 Approved Validated Mitochondria Tissue enhanced 0 cerebral cortex: 1.1;duodenum: 2.1 small intestine: 0.8 RP4-576H24.4 ENSG00000260861 20 1540144-1620009 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Tissue enhanced 0 appendix: 3.3;cerebral cortex: 4.5 testis: 2.6 RP5-1187M17.10 ENSG00000088899 Leucine zipper putative tumor suppressor 3 20 3162617-3173592 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA031008, HPA031009 Approved Tissue enhanced 0 cerebral cortex: 58.7 parathyroid gland: 19.9 RPE65 BCO3, LCA2, rd12, RP20 ENSG00000116745 Retinal pigment epithelium-specific protein 65kDa 1 68428822-68449959 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 2.8;prostate: 3.1;seminal vesicle: 6.1 endometrium: 1.0 RPRM FLJ90327, REPRIMO ENSG00000177519 Reprimo, TP53 dependent G2 arrest mediator candidate 2 153477338-153478808 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 21.3;endometrium: 21.9 smooth muscle: 17.3 RPS6KL1 MGC11287 ENSG00000198208 Ribosomal protein S6 kinase-like 1 14 74903954-74923396 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA027451, HPA027794 Approved Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 31.4 testis: 14.6 RSPO2 MGC35555 ENSG00000147655 R-spondin 2 8 107899316-108083648 Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA024764, CAB025900, HPA053068 Approved Tissue enhanced 0 cerebral cortex: 20.3;placenta: 25.6 prostate: 14.7 RTN4R NOGOR ENSG00000040608 Reticulon 4 receptor 22 20241415-20283246 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB012443 Supported Plasma membrane
Actin filaments
Focal adhesion sites Tissue enhanced 0 cerebral cortex: 23.8 spleen: 5.1 RTN4RL1 DKFZp547J144, NgR3, NGRH2 ENSG00000185924 Reticulon 4 receptor-like 1 17 1934677-2025345 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA044428 Uncertain Tissue enhanced 0 cerebral cortex: 12.5 skin: 6.2 RTP1 MGC35450, Z3CXXC1 ENSG00000175077 Receptor (chemosensory) transporter protein 1 3 187197486-187201465 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 1.3 testis: 0.7 RXFP1 LGR7, RXFPR1 ENSG00000171509 Relaxin/insulin-like family peptide receptor 1 4 158315311-158653372 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA027067 Approved Tissue enhanced 0 cerebral cortex: 21.7;endometrium: 10.1 adrenal gland: 5.7 S1PR5 Edg-8, EDG8 ENSG00000180739 Sphingosine-1-phosphate receptor 5 19 10512742-10517931 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029683 Supported Tissue enhanced 0 cerebral cortex: 14.9;skin: 22.1 spleen: 12.2 SALL3 ZNF796 ENSG00000256463 Spalt-like transcription factor 3 18 78980275-79002677 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA016656 Uncertain Tissue enhanced 0 cerebral cortex: 4.1;prostate: 2.5 kidney: 0.9 SAMD14 FLJ36890 ENSG00000167100 Sterile alpha motif domain containing 14 17 50110040-50129882 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051916 Uncertain Approved Nucleus
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 6.3 testis: 1.8 SAPCD2 C9orf140, p42.3 ENSG00000186193 Suppressor APC domain containing 2 9 137062124-137070588 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA044154 Approved Supported Nucleus
Nucleoli
Cytosol Tissue enhanced 0 cerebral cortex: 12.9 small intestine: 4.9 SBK1 Sbk ENSG00000188322 SH3 domain binding kinase 1 16 28292519-28323849 Enzymes, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 10.9;skeletal muscle: 12.0 parathyroid gland: 4.0 SCAMP5 MGC24969 ENSG00000198794 Secretory carrier membrane protein 5 15 74957219-75021496 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046645 Approved Tissue enhanced 0 cerebral cortex: 276.3 parathyroid gland: 80.7 SCD5 ACOD4, FADS4, FLJ21032, HSCD5, SCD4 ENSG00000145284 Stearoyl-CoA desaturase 5 4 82629539-82798857 Enzymes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042380 Uncertain Tissue enhanced 0 adrenal gland: 201.7;cerebral cortex: 502.5 epididymis: 117.9 SCG5 7B2, SGNE1, SgV ENSG00000166922 Secretogranin V 15 32641676-32697098 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013136 Supported Tissue enhanced 0 cerebral cortex: 234.3;parathyroid gland: 189.3 adrenal gland: 80.7 SCHIP1 SCHIP-1 ENSG00000151967 Schwannomin interacting protein 1 3 159839861-159897360 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA003243 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 103.2;heart muscle: 52.0 skeletal muscle: 25.5 SCN1A FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI ENSG00000144285 Sodium channel, voltage gated, type I alpha subunit 2 165989160-166128047 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA078664 Approved Nucleoplasm
Nuclear bodies
Plasma membrane Tissue enhanced 0 cerebral cortex: 12.0;fallopian tube: 4.4;lung: 3.2 testis: 2.2 SCRG1 SCRG-1 ENSG00000164106 Stimulator of chondrogenesis 1 4 173384701-173406380 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012882 Approved Tissue enhanced 0 cerebral cortex: 24.5;testis: 15.6 smooth muscle: 11.1 SCRN1 KIAA0193 ENSG00000136193 Secernin 1 7 29920103-29990289 Enzymes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024517 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 172.5 parathyroid gland: 126.6 SEC61A2 FLJ10578 ENSG00000065665 Sec61 translocon alpha 2 subunit 10 12129637-12169961 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 51.4 testis: 32.3 SEMA5B FLJ10372, KIAA1445, SEMAG, SemG ENSG00000082684 Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B 3 122909193-123028605 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA017084, HPA066548 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 11.5 heart muscle: 4.2 SEMA6B SEM-SEMA-Y, SEMA-VIB, SEMAN, semaZ ENSG00000167680 Sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B 19 4542593-4559808 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB025157, HPA055778, HPA058523 Approved Tissue enhanced 0 cerebral cortex: 65.7 spleen: 24.9 SERP2 bA269C23.1, C13orf21 ENSG00000151778 Stress-associated endoplasmic reticulum protein family member 2 13 44373665-44397714 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA038970 Uncertain Approved Endoplasmic reticulum Tissue enhanced 0 cerebral cortex: 52.9;testis: 23.7 epididymis: 11.3 SERTM1 C13orf36 ENSG00000180440 Serine-rich and transmembrane domain containing 1 13 36673912-36697839 Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence HPA054814, HPA070485 Uncertain Supported Vesicles Tissue enhanced 0 cerebral cortex: 47.8;endometrium: 37.3;fallopian tube: 29.3 smooth muscle: 24.5 SEZ6L2 FLJ90517, PSK-1 ENSG00000174938 Seizure related 6 homolog (mouse)-like 2 16 29871159-29899547 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA064471 Approved Tissue enhanced 0 cerebral cortex: 82.7;parathyroid gland: 57.3 adrenal gland: 30.8 SFXN5 BBG-TCC ENSG00000144040 Sideroflexin 5 2 72942036-73075619 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015473, HPA056866 Approved Approved Nucleoplasm
Mitochondria Tissue enhanced 0 cerebral cortex: 39.5 epididymis: 18.2 SGCZ ZSG1 ENSG00000185053 Sarcoglycan, zeta 8 14089864-15238339 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA017585 Uncertain Tissue enhanced 0 cerebral cortex: 1.3;ovary: 3.4 breast: 0.7 SGIP1 DKFZp761D221 ENSG00000118473 SH3-domain GRB2-like (endophilin) interacting protein 1 1 66533383-66748299 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017963 Approved Approved Mitochondria Tissue enhanced 0 cerebral cortex: 36.3 endometrium: 16.9 SGSM1 KIAA1941, RUTBC2 ENSG00000167037 Small G protein signaling modulator 1 22 24806169-24927578 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003986 Approved Tissue enhanced 0 cerebral cortex: 14.8;parathyroid gland: 18.7 heart muscle: 9.8 SGTB FLJ39002, Sgt2 ENSG00000197860 Small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta 5 65665928-65723035 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA044689, HPA063674 Approved Uncertain Nucleus Tissue enhanced 0 cerebral cortex: 52.3 appendix: 10.7 SHANK2 CORTBP1, CTTNBP1, ProSAP1, SHANK, SPANK-3 ENSG00000162105 SH3 and multiple ankyrin repeat domains 2 11 70467856-71252577 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008174 Approved Tissue enhanced 0 cerebral cortex: 20.2 thyroid gland: 11.2 SHC3 N-Shc, NSHC, SHCC ENSG00000148082 SHC (Src homology 2 domain containing) transforming protein 3 9 89005771-89178767 Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031427, HPA046656, HPA072448 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 45.5 parathyroid gland: 12.4 SHISA9 ENSG00000237515 Shisa family member 9 16 12901620-13240413 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA072399 Approved Endoplasmic reticulum Tissue enhanced 0 cerebral cortex: 23.0 prostate: 7.7 SHTN1 KIAA1598, shootin-1, shootin1 ENSG00000187164 Shootin 1 10 116881482-117126586 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037942, HPA037943 Supported Approved Nucleus
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 36.2 parathyroid gland: 18.6 SLC10A4 MGC29802 ENSG00000145248 Solute carrier family 10, member 4 4 48483343-48489196 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028835 Uncertain Supported Tissue enhanced 0 adrenal gland: 6.2;cerebral cortex: 4.0 cervix: 1.5 SLC24A4 NCKX4 ENSG00000140090 Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4 14 92322581-92501483 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 7.1 spleen: 2.7 SLC25A18 ENSG00000182902 Solute carrier family 25 (glutamate carrier), member 18 22 17563439-17590994 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 74.7;liver: 25.2 adipose tissue: 14.0 SLC25A41 APC4, FLJ40442, MGC34725 ENSG00000181240 Solute carrier family 25, member 41 19 6426037-6433779 Predicted intracellular proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043591 Uncertain Tissue enhanced 0 cerebral cortex: 1.0;testis: 1.9 esophagus: 0.4 SLC25A48 FLJ44862, HDMCP ENSG00000145832 Solute carrier family 25, member 48 5 135834649-135888637 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014674 Uncertain Approved Intermediate filaments
Actin filaments Tissue enhanced 0 cerebral cortex: 17.7;kidney: 7.3 skeletal muscle: 2.7 SLC2A13 HMIT ENSG00000151229 Solute carrier family 2 (facilitated glucose transporter), member 13 12 39755021-40106089 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA006584 Approved Approved Nuclear membrane Tissue enhanced 0 cerebral cortex: 49.5;parathyroid gland: 73.3 cervix: 20.3 SLC35F3 FLJ37712 ENSG00000183780 Solute carrier family 35, member F3 1 233904933-234324516 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA051327, HPA061582 Uncertain Approved Nucleoli
Golgi apparatus Tissue enhanced 0 cerebral cortex: 10.2 breast: 3.0 SLC39A10 DKFZp564L2123, FLJ90515, KIAA1265 ENSG00000196950 Solute carrier family 39 (zinc transporter), member 10 2 195575977-195737702 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA036512, HPA036513, HPA066087 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 78.0;thyroid gland: 79.0 prostate: 27.6 SLC45A1 DNB5 ENSG00000162426 Solute carrier family 45, member 1 1 8317826-8344167 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 11.7 endometrium: 3.2 SLC4A8 NBC3 ENSG00000050438 Solute carrier family 4, sodium bicarbonate cotransporter, member 8 12 51391317-51515763 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA031536 Uncertain Actin filaments Tissue enhanced 0 cerebral cortex: 14.6;testis: 15.4 ovary: 4.2 SLC6A11 GAT3 ENSG00000132164 Solute carrier family 6 (neurotransmitter transporter), member 11 3 10816200-10940733 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA037981 Supported Supported Tissue enhanced 0 cerebral cortex: 18.2;skin: 6.7 esophagus: 5.5 SLC6A15 FLJ10316, hv7-3, NTT73, SBAT1, V7-3 ENSG00000072041 Solute carrier family 6 (neutral amino acid transporter), member 15 12 84859488-84913615 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008609 Uncertain Approved Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 23.1 placenta: 5.5 SLC6A7 PROT ENSG00000011083 Solute carrier family 6 (neurotransmitter transporter), member 7 5 150189957-150222788 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA028907 Uncertain Tissue enhanced 0 cerebral cortex: 17.0;rectum: 4.3 colon: 2.9 SLC7A11 xCT ENSG00000151012 Solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 4 138164097-138242349 FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064215 Approved Vesicles Tissue enhanced 0 cerebral cortex: 22.5 epididymis: 8.2 SLC7A5 CD98, D16S469E, E16, LAT1, MPE16 ENSG00000103257 Solute carrier family 7 (amino acid transporter light chain, L system), member 5 16 87830023-87869488 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052673, HPA056077 Approved Supported Vesicles
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 90.5;testis: 84.4 bone marrow: 66.3 SLC9A6 KIAA0267, NHE6 ENSG00000198689 Solute carrier family 9, subfamily A (NHE6, cation proton antiporter 6), member 6 X 135985424-136047269 Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059445, HPA059590 Approved Supported Vesicles Tissue enhanced 0 cerebral cortex: 76.1 parathyroid gland: 17.3 SLC9B2 FLJ23984, NHA2, NHEDC2 ENSG00000164038 Solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 4 103019868-103085829 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047008 Uncertain Approved Nucleoplasm
Cell Junctions Tissue enhanced 0 cerebral cortex: 32.6 liver: 20.5 SLCO1A2 OATP, OATP-A, OATP1A2, SLC21A3 ENSG00000084453 Solute carrier organic anion transporter family, member 1A2 12 21264600-21419594 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level HPA071152 Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 28.8 salivary gland: 6.6 SLITRK2 CXorf2, KIAA1854, SLITL1 ENSG00000185985 SLIT and NTRK-like family, member 2 X 145817832-145825842 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 25.7 seminal vesicle: 7.3 SLITRK3 KIAA0848 ENSG00000121871 SLIT and NTRK-like family, member 3 3 165186720-165197109 Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA017636 Approved Mitochondria Tissue enhanced 0 cerebral cortex: 17.4;endometrium: 12.4 fallopian tube: 9.7 SLITRK4 DKFZp547M2010 ENSG00000179542 SLIT and NTRK-like family, member 4 X 143622790-143635777 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA000431 Approved Uncertain Microtubules Tissue enhanced 0 adrenal gland: 14.0;cerebral cortex: 12.8 cervix: 8.3 SLITRK5 bA364G4.2, KIAA0918, LRRC11 ENSG00000165300 SLIT and NTRK-like family, member 5 13 87672615-87696272 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013843 Uncertain Supported Nucleoplasm
Golgi apparatus Tissue enhanced 0 cerebral cortex: 4.9;fallopian tube: 4.7 seminal vesicle: 1.8 SMIM10L2A LED, LINC00086, MGC39606, NCRNA00086 ENSG00000178947 Small integral membrane protein 10 like 2A X 135421943-135428074 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 adrenal gland: 21.9;cerebral cortex: 22.6 epididymis: 17.4 SMIM10L2B LINC00087, NCRNA00087, RP11-85L21.2 ENSG00000196972 Small integral membrane protein 10 like 2B X 135095028-135098634 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 cerebral cortex: 24.2 heart muscle: 8.5 SMIM13 C6orf228 ENSG00000224531 Small integral membrane protein 13 6 11094033-11138733 Predicted membrane proteins Evidence at protein level Evidence at transcript level No evidence Evidence at protein level HPA065706 Approved Approved Nucleus
Nuclear membrane
Golgi apparatus Tissue enhanced 0 cerebral cortex: 47.3 placenta: 18.7 SMIM17 ENSG00000268182 Small integral membrane protein 17 19 56643145-56655766 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence HPA071857, HPA071861 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 8.7 epididymis: 2.0 SMOC1 ENSG00000198732 SPARC related modular calcium binding 1 14 69854131-70032366 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004153, CAB034427 Approved Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 136.1 testis: 64.9 SMOX C20orf16, dJ779E11.1, FLJ20746, MGC1010, PAO, PAOh1, SMO ENSG00000088826 Spermine oxidase 20 4120980-4187747 Enzymes, FDA approved drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047117, HPA060198 Approved Supported Nucleoplasm
Nuclear membrane
Vesicles Tissue enhanced 0 cerebral cortex: 49.8 gallbladder: 23.5 SNPH bA314N13.5 ENSG00000101298 Syntaphilin 20 1266316-1309328 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049393 Approved Uncertain Cytokinetic bridge
Mitochondria Tissue enhanced 0 cerebral cortex: 33.7 seminal vesicle: 15.4 SNTG1 G1SYN, SYN4 ENSG00000147481 Syntrophin, gamma 1 8 49909789-50794118 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA072282 Supported Tissue enhanced 0 cerebral cortex: 8.6;spleen: 3.9 testis: 1.2 SNX10 ENSG00000086300 Sorting nexin 10 7 26291895-26374329 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015605, HPA064782 Approved Approved Nucleus
Nucleoli
Microtubules Tissue enhanced 0 cerebral cortex: 94.6 lung: 60.7 SNX22 FLJ13952 ENSG00000157734 Sorting nexin 22 15 64151715-64157481 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038470 Approved Approved Nucleoplasm
Vesicles Tissue enhanced 0 cerebral cortex: 16.4;thyroid gland: 14.7 tonsil: 9.7 SNX32 FLJ30934, SNX6B ENSG00000172803 Sorting nexin 32 11 65833641-65856896 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA041775 Uncertain Uncertain Cell Junctions
Focal adhesion sites Tissue enhanced 0 cerebral cortex: 7.8 testis: 1.7 SOBP FLJ10159 ENSG00000112320 Sine oculis binding protein homolog 6 107489958-107660167 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA029242 Uncertain Approved Nucleoplasm
Vesicles Tissue enhanced 0 cerebral cortex: 26.5 ovary: 13.7 SOGA3 C6orf174, dJ403A15.3 ENSG00000214338 SOGA family member 3 6 127472794-127519191 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level No evidence Evidence at protein level HPA035388, HPA035389 Uncertain Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 10.2 endometrium: 2.1 SORCS1 sorCS1 ENSG00000108018 Sortilin-related VPS10 domain containing receptor 1 10 106573663-107164534 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011948 Approved Approved Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 12.2;thyroid gland: 18.0 kidney: 4.8 SORCS2 KIAA1329 ENSG00000184985 Sortilin-related VPS10 domain containing receptor 2 4 7192538-7742836 Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA061916 Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 19.4 cervix: 10.4 SORCS3 KIAA1059, SORCS ENSG00000156395 Sortilin-related VPS10 domain containing receptor 3 10 104641101-105265235 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 11.9 adrenal gland: 2.6 SOX10 DOM, WS2E, WS4 ENSG00000100146 SRY (sex determining region Y)-box 10 22 37970686-37987422 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003171, HPA068898 Supported Supported Nucleoplasm Tissue enhanced 0 cerebral cortex: 56.8;salivary gland: 50.8 breast: 24.0 SPOCK1 SPOCK, testican-1, TIC1 ENSG00000152377 Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 5 136975298-137598379 Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA007450, HPA026770 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 209.7 prostate: 103.6 SPOCK2 KIAA0275, testican-2 ENSG00000107742 Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 10 72059035-72089032 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044605 Supported Uncertain Nuclear speckles Tissue enhanced 0 cerebral cortex: 162.2;lung: 128.2 lymph node: 76.0 SPRED3 ENSG00000188766 Sprouty-related, EVH1 domain containing 3 19 38388421-38399587 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA071521 Uncertain Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 6.6 parathyroid gland: 2.6 SPSB4 SSB-4 ENSG00000175093 SplA/ryanodine receptor domain and SOCS box containing 4 3 141051402-141148611 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA073015 Approved Nucleoplasm
Plasma membrane Tissue enhanced 0 cerebral cortex: 1.3;spleen: 1.5;testis: 2.4 pancreas: 1.2 SPTBN2 SCA5 ENSG00000173898 Spectrin, beta, non-erythrocytic 2 11 66685248-66729226 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009844, HPA039293, HPA043529 Supported Supported Cell Junctions
Cytosol Tissue enhanced 0 cerebral cortex: 73.2;skin: 59.4;testis: 48.5 parathyroid gland: 24.2 SRCIN1 KIAA1684, p140Cap, SNIP ENSG00000277363 SRC kinase signaling inhibitor 1 17 38530016-38605930 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA009701, HPA063795 Approved Approved Cell Junctions Tissue enhanced 0 cerebral cortex: 22.2 skin: 4.7 SRGAP3 ARHGAP14, KIAA0411, MEGAP, SRGAP2, WRP ENSG00000196220 SLIT-ROBO Rho GTPase activating protein 3 3 8980591-9363053 Cancer-related genes, Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA036959, HPA044074 Supported Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 26.6;fallopian tube: 17.3 cervix: 7.9 SST SMST ENSG00000157005 Somatostatin 3 187668906-187670399 Cancer-related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000075, HPA019472 Supported Supported Tissue enhanced 0 cerebral cortex: 212.6;duodenum: 387.3;stomach: 304.0 small intestine: 145.4 SSTR1 ENSG00000139874 Somatostatin receptor 1 14 38207999-38213067 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031506 Approved Tissue enhanced 0 cerebral cortex: 13.6;duodenum: 14.6;stomach: 21.4 small intestine: 9.3 SSTR2 ENSG00000180616 Somatostatin receptor 2 17 73165012-73176633 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007264 Uncertain Supported Cytosol Tissue enhanced 0 cerebral cortex: 22.9 spleen: 5.9 ST6GAL2 KIAA1877, SIAT2, St6gal2, St6GalII ENSG00000144057 ST6 beta-galactosamide alpha-2,6-sialyltranferase 2 2 106801600-106887108 Enzymes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014459 Uncertain Approved Nucleus
Nucleoli fibrillar center Tissue enhanced 0 cerebral cortex: 22.2;thyroid gland: 47.8 testis: 9.9 ST8SIA2 HsT19690, SIAT8B, ST8SIA-II, STX ENSG00000140557 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 15 92393828-92468728 Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA054518 Approved Approved Microtubule organizing center Tissue enhanced 0 cerebral cortex: 2.1;heart muscle: 1.9 cervix: 1.2 ST8SIA5 SIAT8E ENSG00000101638 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 18 46667821-46759257 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA043813, HPA046771 Approved Approved Plasma membrane
Midbody Tissue enhanced 0 adrenal gland: 5.5;cerebral cortex: 11.5 parathyroid gland: 3.4 STH MAPTIT ENSG00000256762 Saitohin 17 45999250-45999694 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.4 breast: 0.5 STMN3 SCLIP ENSG00000197457 Stathmin-like 3 20 63639705-63657682 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012947 Supported Tissue enhanced 0 cerebral cortex: 226.4 thyroid gland: 52.4 STOX2 DKFZp762K222 ENSG00000173320 Storkhead box 2 4 183853431-184023526 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA049776, HPA065002 Uncertain Uncertain Nucleoplasm
Actin filaments
Cytosol Tissue enhanced 0 cerebral cortex: 15.4 parathyroid gland: 9.1 STRC DFNB16 ENSG00000242866 Stereocilin 15 43599398-43618800 Disease related genes, Predicted intracellular proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA015731 Uncertain Tissue enhanced 0 cerebral cortex: 1.4;epididymis: 1.5;testis: 1.7 skin: 0.8 STRIP2 FAM40B, FAR11B, KIAA1170 ENSG00000128578 Striatin interacting protein 2 7 129434433-129488399 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019657 Uncertain Supported Cytosol Tissue enhanced 0 cerebral cortex: 14.0;testis: 23.5 skeletal muscle: 9.7 STXBP5L KIAA1006, LLGL4 ENSG00000145087 Syntaxin binding protein 5-like 3 120908072-121424761 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 15.7;ovary: 12.3;thyroid gland: 14.0 seminal vesicle: 4.7 SV2A KIAA0736, SV2 ENSG00000159164 Synaptic vesicle glycoprotein 2A 1 149903318-149917882 FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002226, HPA007863 Supported Approved Cytosol Tissue enhanced 0 cerebral cortex: 167.4;parathyroid gland: 70.8 epididymis: 27.9 SV2C ENSG00000122012 Synaptic vesicle glycoprotein 2C 5 76083172-76353939 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA040722, HPA040770 Supported Approved Nucleoplasm
Vesicles Tissue enhanced 0 adrenal gland: 1.7;cerebral cortex: 3.4 ovary: 0.6 SYBU FLJ20366, GOLSYN, KIAA1472, OCSYN, SNPHL ENSG00000147642 Syntabulin (syntaxin-interacting) 8 109573978-109691791 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053057 Uncertain Supported Vesicles Tissue enhanced 0 cerebral cortex: 76.3 adrenal gland: 40.8 SYN3 ENSG00000185666 Synapsin III 22 32512552-33058372 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034566 Uncertain Tissue enhanced 0 cerebral cortex: 9.6;testis: 8.2 placenta: 5.0 SYNDIG1 C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B ENSG00000101463 Synapse differentiation inducing 1 20 24469199-24666616 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059267 Uncertain Supported Vesicles Tissue enhanced 0 cerebral cortex: 26.9 heart muscle: 14.6 SYNJ1 INPP5G, PARK20 ENSG00000159082 Synaptojanin 1 21 32628759-32728048 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA011916 Supported Approved Nucleoplasm
Centrosome
Cytosol Tissue enhanced 0 cerebral cortex: 66.1 testis: 18.3 SYT13 KIAA1427 ENSG00000019505 Synaptotagmin XIII 11 45240301-45286319 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046224, HPA056602 Uncertain Supported Vesicles Tissue enhanced 0 cerebral cortex: 70.1;gallbladder: 33.0 small intestine: 14.7 SYT17 ENSG00000103528 Synaptotagmin XVII 16 19167971-19268334 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA040811, HPA042059 Approved Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 39.9;parathyroid gland: 32.0 prostate: 14.6 SYT2 ENSG00000143858 Synaptotagmin II 1 202590596-202710417 Disease related genes, FDA approved drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030372, HPA063655 Supported Approved Vesicles Tissue enhanced 0 cerebral cortex: 2.1 adrenal gland: 1.8 SYT4 HsT1192, KIAA1342 ENSG00000132872 Synaptotagmin IV 18 43267878-43277650 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010574 Approved Supported Vesicles
Plasma membrane Tissue enhanced 0 adrenal gland: 20.5;cerebral cortex: 82.7 seminal vesicle: 11.1 SYT6 ENSG00000134207 Synaptotagmin VI 1 114089291-114153919 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA058362 Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 6.5 kidney: 1.5 SYT7 IPCA-7, MGC150517, PCANAP7, SYT-VII ENSG00000011347 Synaptotagmin VII 11 61515313-61581148 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA012869 Supported Tissue enhanced 0 cerebral cortex: 109.0;prostate: 79.3 placenta: 26.5 SYT9 ENSG00000170743 Synaptotagmin IX 11 7238778-7469042 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 6.1;seminal vesicle: 5.1 adrenal gland: 2.8 TAC1 NKNA, NPK, TAC2 ENSG00000006128 Tachykinin, precursor 1 7 97731908-97740472 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB004588, HPA014429 Approved Tissue enhanced 0 cerebral cortex: 78.0;spleen: 47.6 appendix: 13.5 TCEAL2 my048, MY0876G05, WEX1 ENSG00000184905 Transcription elongation factor A (SII)-like 2 X 102125688-102127711 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA076317 Approved Nuclear speckles
Cytosol Tissue enhanced 0 cerebral cortex: 192.2 ovary: 77.9 TCEAL7 MGC23947, WEX5 ENSG00000182916 Transcription elongation factor A (SII)-like 7 X 103330196-103332326 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA051507, HPA065080 Supported Supported Nucleus Tissue enhanced 0 cerebral cortex: 146.0 endometrium: 76.6 TECTA DFNA12, DFNA8, DFNB21 ENSG00000109927 Tectorin alpha 11 121101173-121191493 Disease related genes, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA018870 Approved Tissue enhanced 0 cerebral cortex: 2.7 parathyroid gland: 2.0 TENM2 KIAA1127, ODZ2, Ten-M2 ENSG00000145934 Teneurin transmembrane protein 2 5 167284799-168264157 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA038018, HPA038420, HPA068691 Uncertain Approved Nucleoli Tissue enhanced 0 cerebral cortex: 9.2;heart muscle: 17.7 prostate: 3.4 THY1 CD90 ENSG00000154096 Thy-1 cell surface antigen 11 119417378-119424985 CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003733, CAB068243, CAB068244 Supported Approved Nucleus
Plasma membrane Tissue enhanced 0 cerebral cortex: 422.9;smooth muscle: 428.6 gallbladder: 161.7 TIAM2 STEF ENSG00000146426 T-cell lymphoma invasion and metastasis 2 6 154832697-155257723 Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA011134, HPA013903 Approved Supported Nucleoplasm
Nucleoli fibrillar center
Cytosol Tissue enhanced 0 cerebral cortex: 18.1;testis: 24.4 thyroid gland: 10.4 TLL2 ENSG00000095587 Tolloid-like 2 10 96364606-96513918 Enzymes, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.9 heart muscle: 0.9 TLN2 ILWEQ, KIAA0320 ENSG00000171914 Talin 2 15 62390526-62844631 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017194 Approved Supported Focal adhesion sites
Cytosol Tissue enhanced 0 cerebral cortex: 41.0;kidney: 40.3 thyroid gland: 21.5 TMCC2 FLJ38497, HUCEP11 ENSG00000133069 Transmembrane and coiled-coil domain family 2 1 205228176-205273343 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014254 Approved Tissue enhanced 0 bone marrow: 53.3;cerebral cortex: 25.0 placenta: 8.1 TMEFF2 CT120.2, HPP1, TENB2, TPEF, TR ENSG00000144339 Transmembrane protein with EGF-like and two follistatin-like domains 2 2 191949043-192195709 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015587 Uncertain Approved Microtubules
Cytokinetic bridge Tissue enhanced 0 cerebral cortex: 41.1;prostate: 54.9;seminal vesicle: 19.4 epididymis: 10.5 TMEM121 hole, MGC4659 ENSG00000184986 Transmembrane protein 121 14 105526603-105530202 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049857 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 4.8 spleen: 2.4 TMEM132A FLJ20539, GBP, HSPA5BP1 ENSG00000006118 Transmembrane protein 132A 11 60924463-60937159 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA051979, HPA060492 Supported Approved Mitochondria Tissue enhanced 0 cerebral cortex: 94.5 placenta: 24.9 TMEM144 FLJ11155 ENSG00000164124 Transmembrane protein 144 4 158201604-158255411 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043767, HPA063554 Uncertain Approved Mitochondria Tissue enhanced 0 cerebral cortex: 90.8 testis: 46.6 TMEM169 FLJ34263 ENSG00000163449 Transmembrane protein 169 2 216081866-216102783 Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA070657 Uncertain Approved Focal adhesion sites Tissue enhanced 0 cerebral cortex: 12.0 thyroid gland: 4.8 TMEM170B ENSG00000205269 Transmembrane protein 170B 6 11538278-11583524 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA055134 Uncertain Approved Centrosome Tissue enhanced 0 cerebral cortex: 21.4 bone marrow: 16.9 TMEM178A MGC33926, TMEM178 ENSG00000152154 Transmembrane protein 178A 2 39664982-39717963 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052128, HPA058560 Uncertain Approved Nucleus
Vesicles Tissue enhanced 0 cerebral cortex: 55.6 kidney: 19.1 TMEM178B DKFZp547G036 ENSG00000261115 Transmembrane protein 178B 7 141074232-141480380 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA048771 Uncertain Uncertain Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 19.4;parathyroid gland: 28.5;thyroid gland: 14.3 heart muscle: 7.4 TMEM196 MGC42090 ENSG00000173452 Transmembrane protein 196 7 19719310-19773598 Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA043163 Uncertain Tissue enhanced 0 cerebral cortex: 9.2 endometrium: 2.1 TMEM198 MGC99813, TMEM198A ENSG00000188760 Transmembrane protein 198 2 219543663-219550595 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042385, HPA056598 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 15.8 duodenum: 9.1 TMEM200C TTMA ENSG00000206432 Transmembrane protein 200C 18 5882072-5895955 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA047253, HPA050490 Uncertain Approved Microtubules Tissue enhanced 0 adrenal gland: 3.1;cerebral cortex: 3.5 salivary gland: 1.8 TMEM206 C1orf75, FLJ10874 ENSG00000065600 Transmembrane protein 206 1 212363931-212414901 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008540 Uncertain Tissue enhanced 0 cerebral cortex: 25.4 kidney: 10.6 TMEM229A ENSG00000234224 Transmembrane protein 229A 7 124030916-124033023 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA056391 Uncertain Approved Plasma membrane Tissue enhanced 0 cerebral cortex: 7.1;duodenum: 8.9;testis: 10.4 small intestine: 4.4 TMEM240 C1orf70, SCA21 ENSG00000205090 Transmembrane protein 240 1 1535174-1540453 Disease related genes, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 18.6 endometrium: 7.7 TMEM244 bA174C7.4, C6orf191 ENSG00000203756 Transmembrane protein 244 6 129831244-129861547 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA045247 Uncertain Tissue enhanced 0 cerebral cortex: 1.7 lymph node: 0.6 TMEM266 C15orf27, FLJ38190 ENSG00000169758 Transmembrane protein 266 15 76059837-76229121 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA041921 Uncertain Supported Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 1.9;skeletal muscle: 1.5 placenta: 1.1 TMEM35 FLJ14084 ENSG00000126950 Transmembrane protein 35 X 101078720-101096364 Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA048583 Supported Tissue enhanced 0 cerebral cortex: 42.5;seminal vesicle: 64.8 prostate: 34.0 TMEM63C C14orf171, CSC1, DKFZp434P0111, hsCSC1 ENSG00000165548 Transmembrane protein 63C 14 77116568-77259495 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030657 Uncertain Approved Centrosome Tissue enhanced 0 adrenal gland: 12.9;cerebral cortex: 18.6;testis: 13.8 epididymis: 5.5 TMEM74 FLJ30668, NET36 ENSG00000164841 Transmembrane protein 74 8 108606850-108787615 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA015672 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 6.3 testis: 1.5 TMIE DFNB6 ENSG00000181585 Transmembrane inner ear 3 46701333-46710886 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA038298 Uncertain Uncertain Vesicles
Cytosol Tissue enhanced 0 adrenal gland: 7.5;cerebral cortex: 5.3 testis: 1.7 TMPRSS5 MGC141886, MGC148044 ENSG00000166682 Transmembrane protease, serine 5 11 113687550-113706373 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA010992 Approved Nucleoplasm Tissue enhanced 0 cerebral cortex: 10.1 salivary gland: 3.0 TNFSF18 AITRL, hGITRL, TL6 ENSG00000120337 Tumor necrosis factor (ligand) superfamily, member 18 1 173039960-173050963 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA012699 Uncertain Tissue enhanced 0 cerebral cortex: 2.9;gallbladder: 3.1 parathyroid gland: 1.4 TPBGL ENSG00000261594 Trophoblast glycoprotein-like 11 75240905-75243697 Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence Tissue enhanced 0 cerebral cortex: 3.1;testis: 5.0 adrenal gland: 2.3 TPH2 FLJ37295, NTPH ENSG00000139287 Tryptophan hydroxylase 2 12 71938846-72186618 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB078198 Supported Tissue enhanced 0 cerebral cortex: 1.0 testis: 0.2 TREM2 TREM-2, Trem2a, Trem2b, Trem2c ENSG00000095970 Triggering receptor expressed on myeloid cells 2 6 41158506-41163186 Disease related genes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA010917, HPA012571 Approved Supported Vesicles Tissue enhanced 0 cerebral cortex: 37.1;lung: 40.5 adrenal gland: 16.2 TRIL KIAA0644 ENSG00000255690 TLR4 interactor with leucine-rich repeats 7 28953358-28958292 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 25.0 kidney: 5.7 TRIM2 CMT2R, KIAA0517, RNF86 ENSG00000109654 Tripartite motif containing 2 4 153152342-153339320 Disease related genes, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035853, HPA035854 Supported Approved Centrosome Tissue enhanced 0 cerebral cortex: 155.5 thyroid gland: 110.5 TRIM46 FLJ23229, TRIFIC ENSG00000163462 Tripartite motif containing 46 1 155173787-155184971 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA030389 Uncertain Approved Intermediate filaments
Cytosol Tissue enhanced 0 cerebral cortex: 7.9 epididymis: 1.8 TRPC5 PPP1R159 ENSG00000072315 Transient receptor potential cation channel, subfamily C, member 5 X 111774315-112082776 Predicted membrane proteins, Transporters, Voltage-gated ion channels Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.9 liver: 0.4 TSPAN5 NET-4, TM4SF9, Tspan-5 ENSG00000168785 Tetraspanin 5 4 98470367-98658629 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 cerebral cortex: 76.1 ovary: 57.0 TTLL7 FLJ23033 ENSG00000137941 Tubulin tyrosine ligase-like family member 7 1 83865028-83999150 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052249, HPA059321 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 47.0 smooth muscle: 10.6 TUBB4A beta-5, DYT4, TUBB4 ENSG00000104833 Tubulin, beta 4A class IVa 19 6494319-6502848 Disease related genes, Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010768, HPA043640, HPA046280 Approved Validated Microtubules Tissue enhanced 0 adrenal gland: 138.8;cerebral cortex: 556.4 testis: 102.6 TVP23A FAM18A, YDR084C ENSG00000166676 Trans-golgi network vesicle protein 23 homolog A (S. cerevisiae) 16 10760919-10818794 Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA060582 Uncertain Approved Vesicles Tissue enhanced 0 cerebral cortex: 6.3 ovary: 3.2 TYRO3 Brt, Dtk, Etk-2, Rek, RSE, Sky, Tif ENSG00000092445 TYRO3 protein tyrosine kinase 15 41557675-41583586 Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA071245 Approved Tissue enhanced 0 cerebral cortex: 67.6;ovary: 61.4 testis: 36.9 UBE2QL1 FLJ25076 ENSG00000215218 Ubiquitin-conjugating enzyme E2Q family-like 1 5 6448623-6494909 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA057414 Supported Nucleus
Plasma membrane Tissue enhanced 0 cerebral cortex: 42.0 seminal vesicle: 10.3 UGT8 CGT ENSG00000174607 UDP glycosyltransferase 8 4 114598455-114678224 Enzymes, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014405, HPA065785 Approved Approved Mitochondria Tissue enhanced 0 cerebral cortex: 101.6 kidney: 29.8 UNC5D KIAA1777, Unc5h4 ENSG00000156687 Unc-5 netrin receptor D 8 35235457-35796550 Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042940 Uncertain Tissue enhanced 0 cerebral cortex: 9.2;duodenum: 6.2;prostate: 9.0 cervix: 3.4 UNC79 KIAA1409 ENSG00000133958 Unc-79 homolog (C. elegans) 14 93333219-93707876 Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 5.2;testis: 3.0 adrenal gland: 1.0 UNC80 C2orf21, FLJ33496, KIAA1843, UNC-80 ENSG00000144406 Unc-80 homolog (C. elegans) 2 209771993-209999300 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042472 Approved Approved Vesicles Tissue enhanced 0 adrenal gland: 5.1;cerebral cortex: 15.8;testis: 5.2 gallbladder: 1.9 VAX1 ENSG00000148704 Ventral anterior homeobox 1 10 117128521-117138301 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level HPA028946 Uncertain Approved Nucleus
Nucleoli Tissue enhanced 0 cerebral cortex: 1.4 testis: 0.5 VAX2 DRES93 ENSG00000116035 Ventral anterior homeobox 2 2 70900590-70933446 Plasma proteins, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA009708 Approved Nuclear speckles Tissue enhanced 0 cerebral cortex: 3.3 breast: 0.7 VSTM2A MGC33530, VSTM2 ENSG00000170419 V-set and transmembrane domain containing 2A 7 54542325-54571080 Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA021404, HPA024134 Uncertain Tissue enhanced 0 adrenal gland: 12.7;cerebral cortex: 40.9;prostate: 13.4 stomach: 4.8 VSTM2L C20orf102, dJ1118M15.2 ENSG00000132821 V-set and transmembrane domain containing 2 like 20 37903104-37945350 Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043832 Uncertain Tissue enhanced 0 cerebral cortex: 55.2 gallbladder: 26.9 WASF3 KIAA0900, SCAR3, WAVE3 ENSG00000132970 WAS protein family, member 3 13 26557703-26688948 Cancer-related genes, Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB037086 Approved Tissue enhanced 0 cerebral cortex: 86.7 thyroid gland: 28.0 WBSCR17 GalNAc-T5L, GALNTL3 ENSG00000185274 Williams-Beuren syndrome chromosome region 17 7 71132169-71713600 Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013624, HPA047986 Approved Uncertain Nucleus
Nucleoli
Nuclear bodies
Golgi apparatus Tissue enhanced 0 cerebral cortex: 76.7 ovary: 28.9 WDR17 ENSG00000150627 WD repeat domain 17 4 176065834-176182818 Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042766 Uncertain Approved Nuclear speckles Tissue enhanced 0 cerebral cortex: 25.3;parathyroid gland: 19.0 thyroid gland: 11.0 WDR7 KIAA0541, TRAG ENSG00000091157 WD repeat domain 7 18 56651343-57036606 Plasma proteins, Predicted intracellular proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042074 Uncertain Approved Nucleoplasm
Cytosol Tissue enhanced 0 cerebral cortex: 38.8 parathyroid gland: 16.7 WNT10B SHFM6, WNT-12 ENSG00000169884 Wingless-type MMTV integration site family, member 10B 12 48965340-48971763 Disease related genes, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA055048, HPA062539 Approved Approved Golgi apparatus Tissue enhanced 0 cerebral cortex: 11.6 skin: 3.0 WNT7A ENSG00000154764 Wingless-type MMTV integration site family, member 7A 3 13816258-13880121 Disease related genes, Plasma proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA015719, CAB025894 Approved Tissue enhanced 0 cerebral cortex: 6.7;gallbladder: 3.7;placenta: 3.9 lung: 3.0 WSCD1 KIAA0523 ENSG00000179314 WSC domain containing 1 17 5772234-6124427 Predicted intracellular proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA015919 Uncertain Approved Nucleoplasm
Golgi apparatus Tissue enhanced 0 cerebral cortex: 30.4;spleen: 19.2 testis: 15.3 YJEFN3 FLJ44968, hYjeF_N3-19p13.11 ENSG00000250067 YjeF N-terminal domain containing 3 19 19528861-19537581 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA060789 Approved Approved Mitochondria Tissue enhanced 0 cerebral cortex: 15.7;testis: 5.6 epididymis: 3.0 YPEL4 FLJ30213 ENSG00000166793 Yippee-like 4 11 57645087-57649944 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045621 Uncertain Tissue enhanced 0 cerebral cortex: 19.0 ovary: 4.0 ZCCHC18 PNMA7B, SIZN2 ENSG00000166707 Zinc finger, CCHC domain containing 18 X 104112131-104115846 Predicted intracellular proteins Evidence at transcript level Evidence at transcript level No evidence HPA034940 Uncertain Tissue enhanced 0 cerebral cortex: 5.6 ovary: 4.2 ZIC3 HTX, HTX1, ZNF203 ENSG00000156925 Zic family member 3 X 137566142-137577691 Disease related genes, Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA047934, HPA052936 Approved Supported Nucleoplasm Tissue enhanced 0 cerebral cortex: 1.6;testis: 1.3 epididymis: 0.3 ZIC4 ENSG00000174963 Zic family member 4 3 147386046-147406860 Predicted intracellular proteins, Predicted secreted proteins, Transcription factors Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA030194 Uncertain Approved Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 4.3;skin: 1.4 testis: 0.7 ZNF385D FLJ22419, ZNF659 ENSG00000151789 Zinc finger protein 385D 3 21412222-22373321 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA036190 Uncertain Tissue enhanced 0 cerebral cortex: 4.8 adipose tissue: 3.0 ZNF536 KIAA0390 ENSG00000198597 Zinc finger protein 536 19 30228290-30713538 Predicted intracellular proteins, Transcription factors Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 19.1 thyroid gland: 5.3 ZNF804A C2orf10 ENSG00000170396 Zinc finger protein 804A 2 184598366-184939492 Predicted intracellular proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA029195 Uncertain Approved Endoplasmic reticulum Tissue enhanced 0 cerebral cortex: 6.4 thyroid gland: 2.7